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Traditional medicines are used by approximately 80% of South African population for 
their primary health care needs, but the chemistry and biological activity of many 
medicinal plants have not yet been investigated. This study focused on the isolation and 
structural elucidation of natural products, as well as developing a high-performance 
liquid chromatography (HPLC) method to fingerprint the crude extract of Elytropappus 
rhinocerotis (L.f.) Less. E. rhinocerotis is well known in traditional medicine for the 
treatment of colic, wind, diarrhoea, indigestion, dyspepsia, gastric ulcers and stomach 
cancer. This study was also conducted to isolate, elucidate structures and evaluate the 
uterotonic activity of natural products from Rhoicissus tridentata (L.f.) Wild & Drumm. 
subsp. cuneifolia, a medicinal plant used by many South African women to induce 
labour and to tone the uterus during pregnancy.   
From the ethyl acetate extract of the aerial parts of E. rhinocerotis, 6,7-
dimethoxycoumarin, 5,6,4'-trihydroxyflavone, 5,7-dihydroxy-4'-methoxyflavone, 5,7-
dihydroxy-6,4'-dimethoxyflavone, kaempferol-3-methyl ether, (+)-13-epi-labdanolic 
acid, (+)-labdanolic acid, (+)-labdanolic acid methyl ester, and (+)-labdanediol were 
isolated. These compounds are reported for the first time from E. rhinocerotis. The 
isolated flavonoids may justify the traditional use of this plant in the treatment of 
cancer, while the labdane diterpenes have shown anti-inflammatory activities in other 
studies. A HPLC method to fingerprint the crude extract from the aerial parts of E. 
rhinocerotis was successfully developed and minor variations were observed in the 
chemical compositions of E. rhinocerotis plants collected from different geographic 
locations.  
From the acetone fraction of the methanol extracts of the root of R. tridentata, catechin, 
quercetrin, morin 3-O-α-L-rhamnopyranoside, trans-resveratrol glucoside, an 
inseparable mixture of asiatic acid and arjunolic acid, β-sitosterol, and linoleic acid 
were isolated and characterised. Except for catechin and β-sitosterol, these compounds 
are reported for the first time from Rhoicissus and the occurrence of morin 3-O-α-L-
rhamnopyranoside is reported for the first time from the family Vitaceae.  
The uterotonic activity of the crude methanol extract of the root of R. tridentata as well 
as the activity of the isolated pure compounds was evaluated using the isolated uterine 
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smooth muscle strips obtained from stilboestrol-primed Sprague-Dawley rats. The 
mixture of asiatic acid and arjunolic acid showed a response of approximately 13% in 
the force of uterine muscle contractility at 1.23 µg/mL while β-sitosterol demonstrated a 
change of 40% in the force of uterine muscle contractility at a concentration of 57.1 
µg/mL. Hence it was concluded that the mixture of asiatic acid and arjunolic acid is the 
most uteroactive component in the extract of R. tridentata. Morin 3-O-α-L-
rhamnopyranoside and trans-resveratrol glucoside caused a relaxation in the 
contractions of the uterine smooth muscle. Both compounds showed a higher inhibition 
in the force of contractions when compared to the rate of contractions. These findings 
confirmed that R. tridentata possesses both oxytocic and tocolytic activities at different 
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CHAPTER 1: Introduction and aims of study 
 
1.1 General introduction 
 
Since ancient times, humans have relied on medicinal plants to treat a wide spectrum of 
diseases and these plants have formed the basis of various sophisticated traditional 
medicine systems (Cragg and Newman, 2013). The Chinese Materia Medica was 
amongst the earliest documented systems, with the first record dating to 1100 BCE 
(Huang, 2010). The first records on the Indian Ayurvedic system, namely Charaka (341 
drugs), Sushruta and Samhita (561 drugs), dates before 1000 BCE (Dev, 2001; Kapoor, 
1989). A famous record, known as “Ebers Papyrus”, listing over 700 drugs used in 
Egypt, was documented in 1500 BCE (Borchardt, 2002).  
Approximately 1000 plant-derived products used in Mesopotamia were documented as 
early as 2600 BCE and these products are still used today to treat several diseases. 
Examples of these products are the oils from Cedrus species (cedar), Cupressus 
sempevirens (cypress), Glycyrrhiza glabra (licorice), Commiphora species (myrrh), and 
Papaver somniferum (poppy juice) (Cragg and Newman, 2013). While plants have been 
a source of human medicines for thousands of years, the isolation of bioactive 
components from plants only started about 200 years ago (Cragg and Newman, 2013).  
Some of the early plant-derived drugs discovered were morphine (1.1), which was 
isolated from Papaver somniferum L. (Papaveraceae), aspirin (1.3), which is a synthetic 
analogue of salicylic acid (1.2) present in willow bark (Salicaceae), quinine (1.4), 
isolated from Cinchona species e.g. C. officinalis (Rubiaceae) and digoxin (1.5), 
obtained from Digitalis lanata Ehrh. (Plantaginaceae). These drugs, which are still used 
today, show activity against pain, rheumatism and headache, malaria, arrhythmia and 
congestive heart failure respectively (Buss et al., 2003; Butler, 2004; Rishton, 2008; 
Schuster and Wolber, 2010). 





































The diverse biological activities exhibited by compounds such as 1.1-1.5 prompted 
many laboratories and pharmaceutical companies to embark on natural product (NP) 
research. During the 1990’s, 80% of drugs were NP or derived from NP. From the year 
2000 to 2002, NP or NP-derived drugs were amongst the 35 top-selling drugs 
worldwide (Butler, 2004; Kingston, 2010). Regardless of this great contribution of NP 
in drug discovery, most pharmaceutical companies lost interest in NP research during 
the period of 2001-2008. Approximately 25% and 50% of marketed drugs at that time 
were from natural sources. The loss of interest in NP was attributed to difficulties 
experienced in the isolation and identification of hit compounds from crude extracts 
(Butler, 2004; Kingston, 2010; Li and Vederas, 2009).  
At that stage, combinatorial chemistry was identified as the solution to drug discovery 
as it allowed for the fast production of large numbers of compounds as potential drugs. 
However, the libraries created through this method often did not produce novel 
structural types of compounds. This can be attributed to the difficulty in synthesizing 
complex structures to produce novel compounds. As a result, many scientists regained 
interest in NP research for drug discovery and development since the complexity of NP 
structures makes them good lead compounds. In addition, advances in modern 
technology such as molecular modeling, virtual screening, high-throughput cell-based 




screenings and advanced spectroscopic methods for structural elucidation ensured 
quicker identification of hit compounds from the crude plant extracts (Kingston, 2010; 
Rishton, 2008; Schuster and Wolber, 2010). 
In particular, natural products have contributed to the treatment of infectious, 
neurological, cardiovascular and metabolic, immunological and inflammation, and 
oncological diseases (Fennell et al., 2004; Kingston, 2010; McGaw et al., 2008; Mishra 
and Tiwari, 2011; Mukhtar et al., 2008; Newman and Cragg, 2012). Example of plant-
derived drugs and lead compounds in clinical use for the treatment of infectious 
diseases are artemisinin (1.6) and betulinic acid (1.8).  
Artemisinin (1.6) is an antimalarial drug isolated from Artemisia annua (sweet 
wormwood, qinghao), a plant with long historical use in Traditional Chinese Medicine 
(TCM) for the treatment of fevers. This compound was also isolated from several other 
Artemisia species (for example, A. vulgaris, A. japonica, A. vulgaris L. (mugwort) syn, 
and A. nilagirica), and it is used in many countries for its antimalarial activity (Efferth, 
2009; Rashmi et al., 2014). Besides the antimalarial properties, 1.6 and its derivatives 
have shown in vitro anti-cancer activity against radiation-resistant breast cancer cells 
(Singh and Lai, 2001), drug-resistant small cell lung carcinoma cells (Sadava et al., 
2002), human leukemia cell lines (Lai and Singh, 1995), and colon cancer and active 
melanomas (Efferth et al., 2001).  
In addition, 1.6 demonstrated antifungal activity against some plant pathogens (for 
instance, Gaeumannomyces graminis var. tritici, Rhizoctonia cerealis, Gerlachia nivalis 
and Verticillium dahlia) (Tang et al., 2000). A synthetic analogue of artemisinin, 
arterolane (1.7) in combination with piperaquine phosphate, is in Phase III clinical trials 
for the treatment of malaria in India, Bangladesh, and Thailand (Mishra and Tiwari, 
2011). 


















Betulinic acid (1.8) was isolated as an anti-HIV principle from the leaves of Syzigium 
claviflorum. This compound showed inhibition of HIV-1 replication in H9 lymphocytes 
with an EC50 of 1.4 µM and a therapeutic index (TI) of 9.3(Lee, 2010; Mishra and 
Tiwari, 2011; Schuster and Wolber, 2010; Sun et al., 1998). Compound 1.8 is present in 
many plant species and considerable quantities of this compound can be obtained from 
the bark of the birch tree (Betula spp., Betulaceae) (Moghaddam et al., 2012; Pisha et 
al., 1995). Betulinic acid was reported to exhibit a variety of other biological properties, 
for example, anti-bacterial (Chandramu et al., 2003), anti-malarial (Bringmann et al., 
1997), anti-inflammatory (Alakurtti et al., 2006; Mukherjee et al., 1997) anthelmintic 
(Enwerem et al., 2001), antinociceptive (Kinoshita et al., 1998), and anticancer 
activities (Fulda and Debatin, 2000; Zuco et al., 2002). 
Betulinic acid (1.8) has served as a valuable anti-HIV lead compound and amongst its 
derivatives, 3-O-(3',3'-dimethylsuccinyl)betulinic acid (Bevirimat®) (1.9) was extremely 
potent. Compound 1.9 inhibited HIV replication with an EC50 < 0.35 nM and TI of 20 
000 (Mishra and Tiwari, 2011). Interestingly, 1.9 retained activity even against virus 
isolates resistant to NRTIs, NNRTIs, and PIs. Bevirimat® also exhibited synergistic 
effects with other AIDS drugs (Lee, 2010). 
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The two vinca alkaloids, vinblastine (1.10) and vincristine (1.11) were isolated from 
Catharanthus roseus (L.) G. Don (Apocynaceae) or Vinca rosea L. (known as “Chang 
Chung Hua” in Chinese medicine) (Barnett et al., 1978). Compounds 1.10 and 1.11 are 
some of the well-known plant-derived drugs used to treat Hodgkin’s lymphoma and 
acute childhood leukemia. Local people of Jamaica and India use C. roseus as a 
diuretic, anti-dysenteric, hemorrhagic and antiseptic as well as for the treatment of 
diabetes. The anticancer activity of this plant was discovered by serendipity when the 
extracts were investigated as a source for potential oral hypoglycemic agents (Cragg 
and Newman, 2005). Numerous synthetic analogues of 1.10, e.g. vinorelbine 
(Nabelbine®) (1.12) were designed to target other types of tumor or to minimize side 
effects shown by compound 1.10. Vinorelbine (1.12) showed activity against non-small 
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Another important plant-derived anticancer drug approved for clinical use is paclitaxel 
(Taxol®) (1.13). In 1992 paclitaxel was approved for the treatment of ovarian cancer, 




and later (1994) was approved to treat breast cancer. Paclitaxel (1.13) was first isolated 
from the leaves of Taxus brevifolia Nutt. (Taxaceae) (Cragg and Newman, 2005; Wani 
et al., 1971). Unfortunately, the supply of paclitaxel (1.13) was limited since only trace 
amounts of this compound (0.01% of dry weight of the bark) could be isolated (Cragg 
and Newman, 2005). Furthermore, the natural source was nonrenewable as the tree 
grows very slowly. As a result, many studies were pursued to synthesize analogues of 
1.13 (Denis et al., 1988; Funk and Yost, 1996; Holton et al., 1994). Docetaxel (1.14) is 
a clinically used anti-cancer drug which was synthesized from 10-deacetyl-baccatin III 
(1.15). Baccatins such as compound 1.15, are key precursors of paclitaxel and are 
readily available in various Taxus species (e.g. 1.15 was obtained from T. baccata L.) 
(Guenard et al., 1993). 
1.13 R
1


































In spite of the great success of the pharmaceutical industries in the search for drug lead 
compounds from plants, most of the plant biodiversity still remain unexplored (Aremu 
et al., 2010; Okem et al., 2012). It is estimated that South Africa has more than 24 000 
indigenous plant species and about 3000 of these species are used as medicinal plants. 
A large number of these plant species have never been studied. Moreover, 80% of the 
South African Black population still relies on traditional medicines for their primary 
health care needs. This is because traditional medicine is an important part of the 
culture of African people and traditional herbs are generally more accessible and 
affordable than the western medicines (Aremu et al., 2010; Okem et al., 2012; Street et 
al., 2008). 
Traditional medicines are normally assumed to be safe for human consumption as 
plants have a long history of usage in the treatment of diseases. However, recent 




research has shown an increase in the number of deaths due to plant poisoning. Some 
factors linked to this acute poisoning include misidentification of plant species and 
incorrect preparation or dosage of plant extracts (Fennell et al., 2004; Street et al., 
2008). Hence, the identification, isolation, and evaluation of natural products for their 
biological activities and toxicity before they are applied as therapeutic agents are of 
great importance. 
This project is aimed at the isolation, identification and biological evaluation of natural 
products from two Zulu medicinal plants, Elytropappus rhinocerotis (L.f.) Less. 
(Asteraceae) and Rhoicissus tridentata (L.f.) Wild & Drumm. subsp. cuneifolia (Eckl. 
& Zehr.) N.R. Urton (Vitaceae). The specific aims of the project are listed in Section 
1.2. In Section 1.3, a brief description of the organization of this thesis is given. 
 
1.2 Aims of the study 
 
The aims of this study were: 
 To isolate secondary metabolites from Elytropappus rhinocerotis and to 
determine the structures of the isolated compounds.  
 To develop a method of determining the chemical markers present in E. 
rhinocerotis using HPLC-PDA/LCMS and to compare the chemical profiles of 
different E. rhinocerotis plants collected from different locations. 
 To test and compare the uterotonic activity of the methanol (MeOH) extracts of 
two Zulu medicinal plants (Rhoicissus tridentata and Gunnera perpensa). These 
plants are amongst the most cited plants used in the preparation of Isihlambezo, 
a traditional herbal drink taken by pregnant women in their last trimester of 
pregnancy to induce labor and improve health of the baby and the mother. 
 To investigate the phytochemistry of the most uteroactive fraction from R. 
tridentata and to evaluate the uterotonic activity of the isolated pure compounds.   
 




1.3 Organization of the thesis 
 
Following this chapter (Chapter 1), this thesis contains three more chapters. In Chapter 
2, a literature review of the family Asteraceae is presented and the isolation, structural 
characterization, and HPLC-PDA analysis of the compounds from E. rhinocerotis are 
discussed. Chapter 2 also includes a discussion on the variation of chemical profiles of 
different E. rhinocerotis plants collected in different locations. Chapter 3 focuses on the 
literature review of oxytocic plants and the isolation and structural characterization of 
compounds from R. tridentata. The oxytocic activity of the crude R. tridentata extracts, 
G. perpensa, and the compounds isolated from R. tridentata will also be discussed in 
Chapter 3. General conclusions about the findings of this research and future 




















The family Asteraceae includes mainly herbaceous plants, with a rare occurrence of 
trees, shrubs, and climbers. To date, Asteraceae is documented as the largest flowering 
plant family, with about 25 000 species grouped into 1700 genera and 12 subfamilies 
(Funk et al., 2009; Zavada and de Villiers, 2000). These species are widely distributed 
throughout the world, but a majority are found in the tropical and subtropical regions, 
such as central America, eastern Brazil, the Andes, the Mediterranean, Levant parts of 
Middle East, central Asia, South Africa and southwestern China (Bohm and Stuessy, 
2001; Jansen and Palmer, 1987; Stuessy, 2010). The species are characterized by the 
following features: (i) a group of closely packed flowers into heads (known as an 
inflorescence), (ii) small leaf like structures surrounding the flowers (phyllaries), (iii) 
the existence of a modified calyx attached to apex of the ovary (pappus) (Barreda et al., 
2012; Jansen and Palmer, 1987; Stuessy, 2010).  
The Aims of this Chapter are: 
- To present an overview of the documented economic and medicinal uses of 
some Asteraceae species, with a particular focus on the South African 
indigenous plants. 
- To summarise the reported traditional uses, biological activities, and to provide 
an overview of the phytochemical studies undertaken for the genus 
Elytropappus (an endemic South African Asteraceae genus). 
- To present the findings from the phytochemical investigation of Elytropappus 
rhinocerotis undertaken in the current study. 
 




2.2 Economic and medicinal uses of some Asteraceae plants 
 
 Members of the genus Heliathus (sunflower) and Carthamus (safflower) are cultivated 
worldwide for their oil and nuts production, as well as the feeding of birds and small 
animals (Milner et al., 1945; Torres et al., 2014; Weiss, 2000). Other genera, such as, 
Lactuva (lettuce) and Cynara (artichokes) are popular in food production. Several 
genera in the Asteraceae family are important in horticulture, for instance, Tagetes and 
Chrysanthemums (ornaments) (Jansen and Palmer, 1987), Dahlia (cultigen), Zinnia and 
Helenium (garden flower) (Funk et al., 2009).  
The orange-yellow carotenoid lutein (2.1) extracted from Tagetes erecta, is well-known 
in Europe for providing colour to foods, such as pasta, vegetable oil, margarine, 
mayonnaise, confectionery, dairy products, citrus juice and mustard (Hadden et al., 
1999; Piccaglia et al., 1998; Vasudevan et al., 1997). Lutein is approved as a food 
colourant in the European Union, Australia and New Zealand, but it is only used in 





The large number of Asteraceae species are found worldwide and their wide array of 
natural products make them useful in the treatment of a wide variety of ailments. The 
largest genus in this family is the genus Baccharis, which consists of about 500 species. 
Baccharis plants are mainly found in the warm temperate and tropical regions of Brazil, 
Argentina, Colombia, Chile and Mexico. The genus Baccharis, commonly known as 
carqueja, is popularly used in traditional medicine in southern Brazil, Uruguay and 
Argentina for the treatment of stomachache, backache, headache and bellyache. The 
essential oil composition of several Baccharis species have been studied and slight 
variations in the composition is observed. Other types of compounds isolated from this 
genus are kaurane, labdane and neo-clerodane diterpenes. 




Two species from this genus (B. articulate and B. crispa) have been recently cited 
amongst the six most popularly used plants for pain relief in Rio Grande do Sul, 
Southern Brazil (Florão et al., 2012; Stolz et al., 2014). B. articulate is also taken as a 
tonic, febrifuge, diuretic, for digestion, for control of the anemia and weakness, 
anthelmintic and weight loss. GC-MS analysis of the volatile oil from B. articulate 
from Southern Brazil revealed the major chemical constituents to be β-pinene (39.0%) 
(2.2), cis-β-guaiene (9.8%) (2.3), γ-muurolene (5.8%) (2.4), limonene (4.8%) (2.5), α-
pinene (4.5%) (2.6), α-gurjunene (2.7) (4.4%) and spathulenol (4.2%) (2.8) (Simionatto 





2.4 2.5        







                                      
B. crispa is popularly used in Brazil for the treatment of gastrointestinal, liver and 
kidney diseases as well as inflammation. From pre-clinical studies performed on the 
crude aerial aqueous extract and butanolic fraction, this plant was shown to possess 
antinociceptive and anti-inflammatory properties (Gené et al., 1996; Nogueira et al., 
2011; Paul et al., 2009; Stolz et al., 2014). These activities have been associated with 
the presence of a saponin (echinocystic acid, 2.9), rutin (2.10) and other phenolic 
compounds in the extracts (de Oliveira et al., 2012; Gené et al., 1996; Stolz et al., 
2014).  























2.10        
Species from the genus Brickella (known as brickellbushes) are native to Mexico and 
southwestern United States. In traditional medicine, the herbal tea is prepared from 
these species to cure ulcers, migraines, heart diseases and diabetes. The chemical 
composition of some Brickella species have been studied, and some isolated 
compounds have hypoglycemic and antioxidant properties (Andrade-Cetto and 
Heinrich, 2005; Marles and Farnsworth, 1995; Rivero-Cruz et al., 2006). Rivero-Cruz et 
al. (2006) studied the phytochemistry of B. veronicaefolia and reported that 86% of its 
essential oil consists of benzoates and sesquiterpenoids. A hypoglycemic flavone 
(5,7,3'-trihydroxy-3,6,4'-trimethoxyflavone, 2.11) was isolated from the chloroform 








Brickella cavanillesii (prodigiosa or hamula) is a bitter-tasting herb widely 
commercialized in Mexico (alone or in combination with other plants) for treating 
ulcers, dyspepsia, and diabetes. This plant is amongst the 306 most frequently used 
species for the treatment of type-II diabetes mellitus (DM), and is sold as a cheaper 
alternative to insulin (Andrade-Cetto and Heinrich, 2005; Escandón-Rivera et al., 2012; 
Eshiet et al., 2014). Phytochemical studies on the aerial parts led to the isolation of 6-
acetyl-5-hydroxy-2,2-dimethyl-2H-chromene (2.12) (Rodríguez-López et al., 2006), 




pendulin (2.13), and atanasin (2.14) (Flores and Herrán, 1960; Flores and Herrán, 1958; 
Mata et al., 2013). An O-methylated flavonol (brickellin, 2.15) (Iinuma et al., 1985) 
was reported as a major constituent of B. cavanillesii and was associated with the 
antidiabetic properties shown by this plant (Eshiet et al., 2014). Bioassay-guided 
fractionation led to the isolation of several natural products, including, 6-hydroxyacetyl-
5-hydroxy-2,2-dimethyl-2H-chromene (2.16), sesquiterpene lactones (caleins C, 2.17) 
and several flavonoids [isorhamnetin (2.18) and quercetin (2.19)]. Compound 2.16-2.19 





















































2.19  OH  
Members of the genus Echinacea are well known in North America and Europe due to 
their ability to stimulate the immune system, which is important in the treatment and 
prevention of upper respiratory tract infections (Barrett, 2003; Toselli et al., 2009). In 




traditional medicine, native American Indians use Echinacea species for the treatment 
of wounds, burns, insect and snake bites. The roots of these plants are chewed to cure 
toothache, throat infection, pain, cough and stomach cramps (Percival, 2000; Shah et 
al., 2007). Echinacea extracts and whole plant extracts are commercially prepared as 
direct pressed juices, freeze-dried ethanolic or hydrophilic extracts, and powdered dried 
leaves and flowers. These products are available in groceries, pharmacies, and health 
food stores throughout the world (Barrett, 2003). In the United States alone, Echinacea 
products annual sales are estimated to be worth $300 million (Barrett, 2003; Brevoort, 
1998). 
Artemisia L. is one of the widely used Asteraceae genera across different traditional 
medicine systems worldwide. Local communities of India, Myanmar, Pakistan, Nepal, 
Bhutan, Afghanistan and Japan uses Artemisia species for fever and eczema, treatment 
of wounds and skin diseases, febrifuge, depurative properties, digestive disorders, 
epilepsy, psychoneurosis, depression, irritability, insomnia, anxiety, stress, treatment of 
amenorrhea and dysmenorrhea. These plants are also used for their anthelminthic, 
antiseptic, antispasmodic properties and in ethnoveterinary medicine (Govindaraj et al., 
2008; Rajeshkumar and Hosagoudar, 2012).  
The significance of this genus in medicinal chemistry was increased due to the isolation 
of an antimalarial drug, artemisinin (1.5) from Artemisia annua (De Vries and Dien, 
1996; Rashmi et al., 2014). As discussed in Chapter 1, artemisinin (1.5) was first 
isolated from Asian Artemisia specie, A. annua. A. annua is cultivated in Africa and its 
tea is well-known for the treatment of malaria (Abad et al., 2012). The only indigenous 
member of Artemisia in South Africa is Artemisia afra Jacq. ex Willd (wilde als). A. 
afra is amongst the oldest indigenous plants used in the traditional medicine in South 
Africa (Van Wyk, 2008a). The local uses of this plant, as well as uses of several South 
African Asteraceae plants are discussed below.  
 
 




2.3 Medicinal uses of some South African Asteraceae plants  
 
As mentioned earlier, Asteraceae is the largest family of flowering plants worldwide. In 
South Africa these plants often occur in the Cape fynbos biome. Cape fynbos is the 
flora of the Western Cape which forms part of the Cape Floral Kingdom and consists of 
about 8550 species. Since this fynbos is dominated by Asteraceae, many traditional 
medicines used by indigenous people here are derived from plants belonging to this 
family (Salie et al., 1996). Several Asteraceae species discussed below are indigenous 
to South Africa, with a high occurrence in the Cape fynbos.   
Artemisia afra Jacq. ex Willd (wilde als in Afrikaans, lengana in Sotho, and 
umhlonyane in Xhosa and Zulu) is a South African indigenous species popularly used 
in traditional medicine as a bitter tonic and a stimulant for Cape herbal medicine 
(Thring and Weitz, 2006; Van Wyk, 2008b). Amongst other ailments treated by this 
plant are respiratory disorders, colic, flatulence, constipation, gastritis, poor appetite, 
heartburn, measles, headache, earache, gout, diabetes,  malaria, diarrhea and wounds 
(Hutchings et al., 1996; Neuwinger, 2000; Van Wyk, 2008a; Watt and Breyer-
Brandwijk, 1962).  
Biological studies on A. afra extracts showed that this plant has antimicrobial, 
antioxidant, anti-nematodal, antimalarial, cardiovascular, cytotoxic and sedative 
properties. A. afra is one of the commercially important medicinal plants in South 
Africa, with its first commercial product based on low-thujone material developed as a 
tincture (1996) and tablets (2002) under the brand names Healer’s Choice and Phyto 
Nova, respectively (Van Wyk, 2011). 
Flavonoids found in A. afra extracts include apigenin, chrysoeriol, tamarixetin, 
acacetin, genkwanin and kaempferol (Avula et al., 2009; Kraft et al., 2003; Waithaka, 
2004). Significant amounts of luteolin and quercetin were isolated from the aqueous 
extract (Muganga, 2007; Mukinda et al., 2010; Waithaka, 2004). Luteolin (2.20) and 
quercetin (2.19) are reported to be easily extractable, stable under various processing 
conditions and selectively quantifiable using HPLC. These compounds were therefore 




assigned as ideal markers when evaluating A. afra extracts (Markham, 1982; Mjiqiza, 
2006; Mjiqiza et al., 2013; Mukinda et al., 2010; Waithaka, 2004).  
Several other types of compounds have been isolated from A. afra. These include, 
sesquiterpene lactones (for instance, guaianolides and glaucolides) (Jakupovic et al., 
1988), triterpenes (such as, α-amyrin, β-amyrin, and friedelin), as well as alkanes (e.g. 
ceryl cerotinate and N-nonacosane) (Silbernagel et al., 1990). Volatile oil from this 
plant is very useful and has been used as a substitute for armois oil.  Armois oil is 
produced by A. vulgarisa L. and is used in perfumes and as a flavoring agent. Although 
the composition of this oil varies with geographic origin, some common constituents 
have been identified such as 1,8-cineole (2.21), α-thujone (2.22), β-thujone (2.23), 









2.22                       






                              
Species of the genus Eriocephalus L. are used by South African local communities for 
treatment of coughs and colds, flatulence and colic, digestive disorders, as well as 
stomach pain. Eriocephalus punctulatus DC. (Cape chamomile) and E. africanus L. 
(wild rosemary) were used as diuretic and diaphoretic (Mierendorff et al., 2003). E. 
africanus is also used for treating gastro-intestinal, gynaecological complaints, 
inflammatory and other dermal complications. The oil extracted from wild rosemary 
and Cape chamomile is commercially important in the preparation of perfume, skin care 
and beauty products (Amabeoku et al., 2000; Njenga and Viljoen, 2006). The 
sesquiterpene, 8-O-isobutanoylcumambrin B (2.26) with antiplasmodial properties was 




isolated from E. tenuifolius DC. The compound had a low IC50 of 6.25 µg/mL against 









Other Asteraceae species commonly cited in South African traditional medicines are 
Tarchonanthus camphoratus L. (camphor bush) and Athrixia phylicoides DC. (bush tea 
or Zulu tea). The green leaves of the camphor bush are used for a range of ailments 
depending on how they are prepared. While the burnt leaves are inhaled to cure blocked 
sinuses, asthma and headache (Pretorius, 2008), the infusion of boiled leaves is taken 
orally to treat coughs, toothache, abdominal pain and bronchitis. Camphor bush leaves 
are also used for massaging the body and as a perfume (Aiyegoro and Van Dyk, 2013; 
Amabeoku et al., 2000; Hutchings et al., 1996; Watt and Breyer-Brandwijk, 1962).  
The herbal tea prepared from leaves of Athrixia phylicoides is used as a “blood purifier” 
for sores and boils. The decoction of leaves and stems is used as a lotion for sore feet, 
boils, acne and infected wounds. Leaf infusions are also used as a stimulant, aphrodisiac 
drink and gargle for infected throat. In addition, leaf infusions have been reported to 
treat hypertension, heart diseases, diabetes, diarrhea and vomiting. Roots are used as a 
purgative and to treat coughs (Hutchings et al., 1996; Joubert et al., 2008; Rampedi and 
Olivier, 2005; Van Wyk and Gericke, 2000; Watt and Breyer-Brandwijk, 1962). 
Phytochemical investigation on the aerial parts of A. phylicoides led to the isolation of 
germacren D, linoleic acid and p-hydroxyphenylpropan-3-ol coumarate (Bohlmann and 
Zdero, 1977; Joubert et al., 2008). Mashimbye et al. (2006) reported on the isolation of 
a new flavonoid, 5-hydroxy-6,7,8,3',4',5'-hexamethoxyflavon-3-ol (2.27) from the 
leaves of A. phylicoides (Joubert et al., 2008; Mashimbye et al., 2006). Several 
diterpenes related to kaurane, triterpene and thymol derivatives were isolated from the 

















Fouche et al. (2008) conducted a study which was aimed at evaluating the in vitro 
anticancer activity of South African plants against breast MCF7, renal TK10 and 
melanoma UACC62 human cell lines. For Asteraceae, the hit rate for cytotoxicity 
against cancer cell lines was substantially larger than for any of the other plant families. 
Schkuhria pinnata (Lam) Kuntze demonstrated anticancer activity and the active 
principle was identified as eucannabinolide (2.28). Compound 2.28 showed a total 
growth inhibition (TGI) of < 6.25 µg/mL for melanoma UACC62, 7.75 µg/mL for 
breast MCF7 and 12.00 µg/mL for renal TK10 cancer cell lines. Eucannabinolide (2.28) 
was also isolated from other members of the genus Schkuhria (e.g. S. virgata), where it 











Another Asteraceae representative in the study mentioned above was Oncosiphon 
piluliferum. Two active constituents, namely, tetradin A (2.29) and deacetyl-β-
cyclopyrethrosin (2.30) were isolated from the dichloromethane extract of O. 
piluliferum. Tetradin A (2.29) exhibited a TGI of 4.50 µg/mL for TK10, 86.10 µg/mL 




for MCF7 and 18.72 µg/mL for UACC62. Compound 2.30 TGI for TK10 was 5.89 











               
Salie et al. (1996) evaluated the in vitro antimicrobial activity of four indigenous 
Asteraceae species (Arctotis auriculata Jacq., Eriocephalus africanus L., Felicia 
erigeroides DC. and Helichrysum crispum (L.) D. Don). The organic extract of A. 
auriculata and E. africanus showed antimycobacterial activity against Mycobacterium 
smegmatis. These findings were very interesting as they showed that these plants also 
could inhibit the growth of M. tuberculosis (Salie et al., 1996).  
These extracts, as well as extract from F. erigeroides also inhibited growth of 
Pseudomonas aeruginosa, a microorganism causing one of the most difficult infections 
to treat with normal antibiotics (Levinson and Jawetz, 2002). Organic extracts of E. 
africanus and H. crispum and aqueous extract of F. ergeroides exhibited antifungal 
activity against Candida albicans. Activity against Staphyllococcus aureus was shown 
by organic extracts of A. auriculata and E. africanus (Salie et al., 1996). The 
antimicrobial activity of the genus Helichrysum has been extensively studied and other 
examples of active species in this genus are mentioned below. 
Members of the genus Helichrysum are widely used in Southern African traditional 
medicine. Helichrysum is one of the largest genus in the family Asteraceae, consisting 
of approximately 500-600 species. About 244-250 of these species occur in South 
Africa. Plants from this genus are very popular in traditional medicine for their use in 
invoking the goodwill of the ancestors, to induce trances and the aerial parts of several 
species that are used for these purposes are commercially available. Examples of these 
plants are H. griseum Sond, H. herbaceum (Adrews) Sweet, H. epapposum Bolus and 
H. natalitium DC. Helichrysum plants are also used to treat respiratory and gastro-
intestinal disorders, eye conditions, pain and inflammation, menstrual pains, 




rheumatism and headache. Leaves are often applied as a wound dressing and these 
plants are also used to fumigate huts and as bedding to repel insects (Afolayan and 
Meyer, 1997; Arnold et al., 2002; Hutchings et al., 1996; Lourens et al., 2008; 
Mathekga et al., 2000; Watt and Breyer-Brandwijk, 1962). 
Several research groups have extensively studied the antimicrobial activity of 
Helichrysum species and most crude extracts usually exhibited higher activity against 
Gram-positive organisms than Gram-negative species. Antibacterial compounds, which 
are commonly flavonoids, have been isolated from some species. The active compound 
isolated from H. aureonitens was galangin (3,5,7-trihydroxyflavone) (2.31).  
In a study conducted by Afolayan and Meyer (1997), galangin showed antibacterial 
activity against four Gram-positive bacteria (three Bacillus species and Micrococcus 
kristinae) and one Gram-negative species (Enterobacter cloaceae). Galangin (2.31) also 
exhibited activity against several bacteria and fungi, for instance, six β-lactam-sensitive 
and resistant strains of Staphylococcus aureus, sixteen strains of 4-quinolone-resistant 
strains of the bacterium, and Aspergillus tamari. In another study, galangin 
demonstrated antiviral activity against Herpes simplex virus type 1 and Coxsackie virus 





The active principle from H. odoratissimum was identified as 3-O-methylquercetin. 
This compound has antibacterial activity against a wide variety of microorganisms, 
including Salmonella typhimurium (Gram-negative, MIC = 50 µg/mL), Staphylococcus 
aureus (Gram-positive species, MIC = 6.25 µg/mL) and the fungi (e.g. Candida 
albicans, MIC = 12.5 µg/mL) (Van Puyvelde et al., 1989). Pinocembrin chalcone (2.32) 
was isolated from H. trilineatum, while pinocembrin (2.33) was obtained as an artefact 
during the isolation process from this plant. Both these compounds exhibited anti-
staphylococcal activity (Bremner and Meyer, 1998). Another flavonoid, 5,7-




dibenzyloxyflavanone was isolated from H. gymnocomum and it showed activity 
against a diverse group of Gram-positive and Gram-negative bacteria as well as a yeast 






2.33                 
Interesting antibacterial activity was observed for two chalcones (2.34 and 2.35) 
isolated from H. melanacme. 2',4′,6′-trihydroxy-3′-prenylchalcone (2.34) and 1-(3,4-
dihydro-3,5,7-trihydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-3-phenyl-(E)-2-propen-
1-one (2.35) inhibited growth of a drug-sensitive H37Rv strain of Mycobacterium 
tuberculosis with a MIC of 0.05 mg/mL. The crude extract together with the isolated 
chalcones were also evaluated for antiviral activity against the influenza A virus. The 
chalcones 2.34 and 2.35 showed lower activity than the crude extract, but the activity 







2.35          
Compounds other than flavonoids with antimicrobial activity have also been isolated 
from Helichrysum species. Linoleic and oleic acid were obtained from H. pedunculatum 
and they showed antibacterial activity against S. aureus and Micrococcus kristinae 
(MIC = 1.0 mg/mL) (Dilika et al., 2000). The active compound (kaurenoic acid) from 
H. kraussii inhibited growth of E. coli, Bacillus cereus, B. subtilis, S. aureus and 
Serratia marcescens. A prenylated butyrylphloroglucinol (2.36) (MIC = 100 µg/mL) 
was also isolated from H. kraussii and it showed activity against similar bacteria as 




kaurenoic acid (2.37) as well as B. pumilis and Micrococcus kristinae (Bremner and 








2.37            
From the crude extract of H. caespititium, two phloroglucinols (caespitin 2.38 and 2.39) 
with antimicrobial activity were isolated. Caespitin (2.38) inhibited growth of S. aureus, 
Streptococcus pygenes, Cryptococcus neoformans, Trichophyton rubrum, Trichophyton 
mentagrophytes and Microsporum canis (Mathekga et al., 2000). 2-Methyl-4-[2′,4′,6′-
trihydroxy-3′-(2-methylpropanoyl)-phenyl]but-2-enyl acetate (caespitate) (2.39) was 
active against several microorganisms, including Bacillus cereus, B. pumilis, B. 
substilis, Microsporum kristinae and S. aureus (Mathekga et al., 2000). At a 
concentration of 0.5-1.0 µg/mL, the antifungal activity of caespitate (2.39) was 
observed against Aspergillus flavus, A. niger, Cladosporium cladosporioides, C. 
cucumerinum, C. sphaerospermum and Phytophtora capsici (Lourens et al., 2008; 










     
In summary, Asteraceae plants are used extensively in ethnomedicines worldwide and 
many of the uses are associated with the treatment of infectious diseases, for instance, 
many genera are used to treat respiratory disorders and wounds. The chemical 
compositions of many genera in the family have been studied, and a wide variety of 
compounds have been isolated. This is not surprising since this family has a large 




morphological diversity of genera. The most common groups of compounds identified 
in this family include flavonoids, sesquiterpenes, diterpenes and acylated 
phloroglucinols. The biological/ pharmacological activities of the plant extracts and the 
compounds isolated from Asteraceae species have up to now not received enough 
attention. In this chapter, we intend to report on the isolation and structural elucidations 
of the compounds isolated from Elytropappus rhinocerotis.    
 




The genus Elytropappus Cass. (Asteraceae, tribe Gnaphaliea) derives its name from the 
Greek words elytron (sheath) and pappos (fluff) which is appropriate considering the 
fluffy feathery appearance of the top part of the seeds displayed by several species in 
this genus.  This genus was first described by Cassini in 1816 based on Gnaphalium 
hispidum (recently known as Elytropappus hispidus). A comprehensive taxonomical 
study on Elytropappus was later carried out by Levyn in 1935. Her findings led to the 
grouping of the eight Elytropappus species into three groups (Group 1: E. cyathiformis 
and E. hispidus; Group 2: E. longifolius, E. gnaphaloids, E. scaber and E. glandulosus; 
Group 3: E. rhinocerotis and E. adpressus) (Levyns, 1926, 1935). 
 
Koekemoer re-assessed the taxonomy of Elytropappus to establish the rank of its formal 
and informal grouping. In this study Koekemoer divided Elytropappus into three 
genera. The species which were previously in Group 2, together with Stoebe intricata, 
were grouped under a new genus Mytovernic, and Group 3 species (E. rhinocerotis and 
E. adpressus) were grouped under a new genus Dicerothamnus (Koekemoer, 2002). 
However, the proposed reclassification has not yet been published in a scientific 
journal; therefore, we will refer to Elytropappus in this thesis as a single genus.  
 




All Elytropappus species are endemic to South Africa, particularly they are common in 
Cederberg (part of Cape floristic region). With the exception of E. rhinocerotis, 
Elytropappus species are not well known and there is no literature about their medicinal 
or ecological uses. E. rhinocerotis (Fig. 2.1), commonly known as “renosterbos or 
rhinoceros bush” is a bush-shrub of 1-2 m in height with small grayish-green leaves and 
tiny flower heads. During the shedding of the seeds, the brown chaffy bracts around 
each flower head open up, giving the plant a brownish fluffy appearance (Dorchin and 
Gullan, 2007; Levyns, 1935; Pool et al., 2009). 
 
Figure 2.1: Habitat and aerial parts of E. rhinocerotis 
(Photo: http://botany.cz/cs/dicerothamnus-rhinocerotis/) 
 
 “Renosterbos” is a dominant plant in Renosterveld. This vegetation, which is believed 
to have derived its name from “Renosterbos”, was first described by Sparrman (a 
distinguished South African traveler) in 1775. “Renosterbos” is also found as far north 
as the Namaqualand and Richtersveld, the great escarpment around Molteno, and it also 
extends to the southern parts of Eastern Cape to East London. This plant tolerates both 
snow and fire and is abundant in heavily grazed areas as it is unpalatable to livestock 
(Proksch et al., 1982). As a result, farmers consider “renosterbos” as a major weed and 
a lot of research has been done on the eradication strategies and its biocontrol 
(Koekemoer, 2002).  
 




2.4.2 Traditional uses 
 
In traditional medicine, the powdered young tips and branches of E. rhinocerotis are 
used to treat colic, wind and diarrhoea in children. Adults take the infusions of the twigs 
(in brandy or wine) to treat indigestion, dyspepsia, gastric ulcers and stomach cancer. 
These infusions are also used as a tonic drink to improve appetite. E. rhinocerotis 
became popular for its use in the treatment of influenza and fever in the flu epidemic of 
1918 (Hutchings et al., 1996; Thring and Weitz, 2006; Watt and Breyer-Brandwijk, 
1962). 
 
2.4.3  Phytochemistry and biological activities 
 
Dekker et al. (1988) isolated a new labdane diterpene, rhinocerotinoic acid (2.40) from 
the aerial parts of E. rhinocerotis. This compound exhibited anti-inflammatory activity 
in both non-adrenalectomised and adrenalectomised rats. Gray et al. (2003) tried to 
isolate rhinocerotinoic acid from E. rhinocerotis but could not obtain this compound. 
Studies on the chemical composition of the leaf resin indicated that the methoxylated 
flavones, cirsimaritin (2.41), hispidulin (2.42), eupafolin (2.43) and quercetin (2.44) 
were the major products (Proksch et al., 1982).  
Benzoic acid (2.45), its derivatives [hydroxybenzoic acid (2.46), protocatechuic acid 
(2.47) and veratric acid (2.48)], as well as cinnamic acid derivatives [p-coumaric acid 
(2.49), ferulic acid (2.50) and sinapic acid (2.51)] were reported as minor products from 
the leaf resin of E. rhinocerotis (Proksch et al., 1982). However, it is unclear whether 
compounds 2.41-2.48 are produced by E. rhinocerotis or by the insects that use this 
plant as a habitat. To date, three species of gall-inducing Diptera (Spathulina peringueyi 
Bezzi and two species belonging to the Cecidomyiidae family) are reported to reside 
within E. rhinocerotis (Dorchin and Gullan, 2007). Cardiac glycosides, saponins and 
tannins were detected from the crude sample of E. rhinocerotis (Scott et al., 2004). 




However, these observations were based on colour reactions and the results should be 
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Knowles (2005) reported that the extracts of E. rhinocerotis showed antifungal 
properties against Botrytis cinerea, a fungal pathogen causing grey mould rot on a large 
number of economically and horticulturally important crops. This activity was more 
effective when the extracts were combined with synthetic fungicides. The methanol 
extract of the aerial parts showed moderate antimicrobial activity against S. aureus. A 
zone inhibition of 13 mm was observed compared to 9 mm (no activity) and 27 mm for 
ciprofloxacin (control) (Knowles, 2005). 
The above discussion demonstrates that the phytochemistry of E. rhinocerotis is not 
well understood. Even though some compounds were reported to occur in this plant, 
further studies are required to confirm their occurrence and to isolate new compounds. 




Herewith we report further phytochemical investigation of the aerial parts of E. 
rhinocerotis. The biological activities of the isolated compounds will also be evaluated. 
We will also report on the variation in the chemical composition of E. rhinocerotis 
plants collected in different locations. 
 
2.5 Results and discussion 
2.5.1 Introduction 
 
The leaves and branches of E. rhinocerotis were collected on farm Weltevreded in 
Sneeuberg, Murraysburg, Western Cape. After air drying and milling, the aerial plant 
material was extracted with dichloromethane (DCM) - methanol (MeOH) (1:1). This 
extract was fractionated by silica gel chromatography to afford 6,7-dimethoxycoumarin 
(2.52), 5,7,4'-trihydroxyflavone (2.53), 5,7-dihydroxy-4'-methoxyflavone (2.54), 5,7-
dihydroxy-6,4'-dimethoxyflavone (2.55), kaempferol 3-methyl ether (2.56), (+)-13-epi-
labdanolic acid (2.57), (+)-labdanolic acid (2.62), (+)-labdanolic acid methyl ester 
(2.64) and (+)-labdanediol (2.66). Although other compounds have been isolated from 
E. rhinocerotis (Proksch et al., 1982), the isolation of compounds 2.52-2.57, 2.62, 2.64 
and 2.66 from this species has not yet been reported. In the next section, the structural 
determination of these compounds is discussed.   
 











Compound 2.52 was fluorescing violet on TLC under UV light and showed a strong 
UV absorption peaks at λmax 228 and 343 nm (Fig. 2.2). These observations suggested 
the presence of a coumarin chromophore in compound 2.52 (Hammoda et al., 2008; 
Steck and Bailey, 1969). The structure of 2.52 was further characterised by MS and 




NMR data. A pseudo-molecular ion peak at m/z 229.0482 [M+Na]+, which is in 
agreement with a molecular formula of C11H10O4, was observed in the HRMS spectrum.  
 
Figure 2.2: UV/Vis absorption spectrum of compound 2.52 
 
The appearance of two singlets integrating for three protons each at δH 3.91 and 3.94 in 
the 1H NMR spectrum (Plate 1a) indicated the presence of two methoxy groups. The 
aromatic protons appearing as singlets at δH 6.83 (H-5) and 6.85 (H-8) are para to each 
other, and this suggested that the methoxy groups on the aromatic ring are in ortho 
positions (C-6 and C-7). The two doublets observed at δH 6.28 and 7.61 in 1H NMR 
spectrum were assigned to H-3 (J = 9.5 Hz) and H-4 (J = 9.5 Hz) respectively. In the 
13C NMR spectrum (Plate 1b), ten signals corresponding to eleven carbons (the two 
OCH3 carbon signals have the same chemical shift) were observed.  
The DEPT NMR spectrum (Plate 1d) displayed six protonated carbons. The upfield 
signal at δC 56.4 in the 13C and DEPT NMR spectra was assigned to the two methoxy 
carbons. The remaining four protonated carbon signals in the DEPT NMR spectrum 
were assigned to the methine carbons (C-3, C-4, C-5, and C-8). Four oxygen-linked 
non-protonated carbons were observed at δC 161.4 (C, C-2), 152.9 (C, C-7), 150.1 (C, 
C-8a) and 146.4 (C, C-6). The 1H, 13C NMR and the mass spectroscopy data led to the 
assignment of compound 2.52 as 6,7-dimethoxycoumarin.  




Further structural confirmation was achieved by analysing the HMBC spectrum (Plate 
1f). Correlations were observed between the aromatic singlets (H-5 and H-8) and the 
methoxy bearing carbons (C-6 and C-7) (Plate 1f and Fig. 2.3). A correlation between 
H-4 and the carbonyl carbon (C-2) also confirmed the proposed structural connection 
(Fig. 2.3). The experimental NMR data of compound 2.52 was in agreement with 












Figure 2.3: Key HMBC correlations in compound 2.52 
 
Scoparone (2.52) was previously isolated from several species in the Asteraceae family, 
such as Artemisia tridentate (Imamura et al., 1977), Haplopappus foliosus (Urzua, 
2004) and Artemisia capillaris (Jang et al., 2006). Coumarins (including 6,7-
dimethoxycoumarin) have been reported to exhibit antibacterial and antifungal activity 
against S. aureus, S. agalactiae, S. uberis, S. dysgalactiae, E. coli and Salmonella 
(Céspedes et al., 2006). Other activities of scoparone (2.52) include vasodilation, 
immunosuppression, radio-protection and anticoagulation activity (Gakuba, 2010).    
 
 















Compound 2.53 appeared as a brown spot on TLC under UV light and showed up as a 
bright yellow spot after treating the TLC with p-anisaldehyde/ H2SO4 stain followed by 
heating. The UV absorption spectrum (Fig. 2.4) of this compound showed λmax at 267 
and 338 nm, which is in agreement with the reported values for flavones (Rijke et al., 
2006). A pseudo-molecular ion peak at m/z 269.0454 [M-H]- observed in the HRMS 
spectrum is in agreement with a molecular formula of C15H10O5.   
 
Figure 2.4: UV/Vis absorption spectrum of compound 2.53 
 
In the 1H NMR spectrum (Plate 2a) of compound 2.53, two meta-coupled doublets were 
observed at δH 6.18 (1H, d, J = 2.0 Hz, H-6) and 6.42 (1H, d, J = 2.0 Hz, H-8). This 
indicated the presence of a tetra-substituted A-ring of a flavone. A deshielded singlet 
appearing at δH 6.56 was assigned to H-3 of ring C. Two ortho-coupled signals, each 
integrating to two protons was observed at δH 6.92 (2H, d, J = 8.8 Hz, H-3', 5') and 7.84 
(2H, d, J = 8.8 Hz, H-2', 6'), suggesting that the B-ring of the flavone was di-substituted 
at para positions.   




In the 13C NMR spectrum (Plate 2b), 15 signals were observed. The DEPT 135 
spectrum (Plate 2d) revealed that the structure contained 7 methine carbons (of which 
two were overlapping) and 8 non-protonated carbons. A deshielded carbon signal at δC 
183.7 was assigned to the carbonyl carbon (C-4). The other oxygen-linked carbons 
appeared at δC 166.1 (C, C-5), 165.8 (C, C-2), 162.9 (C, C-4', C-8a) and 159.6 (C, C-7). 
In the HMBC spectrum (Plate 2f), correlations were observed between H-3, C-2, C-4, 
C-1', C-4a and C-8a; H-6, C-5, C-7 and C-4a; H-2'/6', C-2, C-1' and C-4'; as well as 
between H-3'/5', C-4' and C-2. Some of these correlations are shown in Figure 2.5. 
Based on the spectral information obtained from NMR, mass, UV/Vis absorption 
spectra and comparison with literature values (Ersoz et al., 2002), compound 2.53 was 













Figure 2.5: Key HMBC correlations in compound 2.53 
 
Asteraceae plants are well-known for producing a wealth of flavonoids. These plants 
have been reported to produce nearly all types of known flavonoids. Amongst the 
flavonoids featuring a six-membered C-ring, flavanones, flavones and flavonols are the 
most common groups. The most widely occurring substitution pattern displayed by 
flavones in this family is 5,7,4'-trioxygenation (apigenin type) and 5,7,3',4'-
tetraoxygenation (luteolin type). The occurrence of apigenin (2.53) and its glycosidic 
derivatives have been reported in a large number of Asteraceae species and was 
identified in at least one species in 118 genera out of over 430 genera in this family 
(Bohm and Stuessy, 2001).  




Some genera that are reported to contain of apigenin (2.53) belong to the same tribe 
(Gnaphalieae) as Elytropappus. Example of these genera are Cassina, Ozothamnus, 
Odixia, and Gnaphalium (Wollenweber et al., 2005; Wollenweber et al., 1997b; 
Wollenweber et al., 2008; Zheng et al., 2013). As mentioned earlier, this is the first 
report on the occurrence of apigenin (2.53) in E. rhinocerotis. Previously isolated 
flavones (2.41-2.43) from this plant displayed 5,6,7,4'-tetraoxygenation substitution 
pattern (scutellarein type), which is slightly different to the apigenin substitution (5,7,4'-
trioxygenation) (Bohm and Stuessy, 2001).   
Flavonoids have a potential as chemoprevention and chemotherapeutic agents. The 
inhibition of malignant human cancer cells was shown to be through mechanisms such 
as cell cycle arrest, induction of apoptosis, reversal of multi-drug resistance, 
antiproliferation, antioxidant, inhibition of angiogenesis and inhibition of telomerase 
activity (Lindenmeyer et al., 2001; Ramos, 2007; Ren et al., 2003). Apigenin was also 
reported to regulate diabetes mellitus, thyroid dysfunction and lipid peroxidation (Panda 
and Kar, 2007). 
 






Similarly to compound 2.53, compound 2.54 stained bright yellow on TLC treated with 
p-anisaldehyde/ H2SO4 stain followed by heating. This was indicative of the presence of 
a flavonoid moiety in this compound. The UV absorption spectrum (Fig. 2.6) supported 
the presence of a flavone structure as it showed absorption peaks at λmax 268 and 333 
nm (Rijke et al., 2006). In the HRMS spectrum, a pseudo-molecular ion peak at m/z 
283.0609 [M-H]-, in agreement with the molecular formula of C16H12O5, was observed.   





Figure 2.6: UV/Vis absorption spectrum of compound 2.54 
 
The 1H (Plate 3a) and 13C (Plate 3b) NMR spectra of compound 2.54 were similar to 
those of compound 2.53. The only difference between these spectra was the presence of 
the methoxy singlet at δH 3.92 and δC 55.1 in the 1H (Plate 3a) and 13C (Plate 3b) NMR 
spectra of compound 2.54. The position of this methoxy group was determined by 
analysing the HMBC NMR spectrum (Plate 3f). A HMBC correlation (Fig. 2.7) was 
observed between the methoxy proton signal and C-4' (δC 162.8), which suggested that 
the methoxy was attached to C-4'. The structure of compound 2.54 was assigned as 5,7-
dihydroxy-4'-methoxyflavone (also known as acacetin or 4-O-methyl apigenin) and the 
experimental NMR data was in agreement with the reported data for this compound 











Figure 2.7: Some HMBC correlations in compound 2.54 
 




The isolation of acacetin (2.54) is reported for first time from E. rhinocerotis but this 
compound is common in other Asteraceae plants. Acacetin (2.54) was isolated from 
Blainvillea rhomboidea (Gomes et al., 2010), Centaurea furfuracea (Fakhfakh et al., 
2005), Microglossa pyrifolia (Kohler et al., 2002), some species in the genus Arnica 
(Merfort, 1984; Schmidt and Willuhn, 2000), several Artemisia species (Valant-
Vetschera and Wollenweber, 1995) and some Baccharis species (Wollenweber et al., 
1986a). 2.54 were also isolated from a Korean medicinal plant, Dendranthema 
zawadskii var. latilobum Kitamura, where it showed antimicrobial activity against 
Candida species with an inhibition zone of 9-12 mm. This compound also showed 
moderate anticancer activity against human lung carcinoma (A549), skin melanoma 
(B16F1) and mouse melanoma (SK-MI-2) with an IC50 of > 40 µg/mL (Rahman and 
Moon, 2007).  
 







Compound 2.55 was identified as a flavone based on the colour of its spot on TLC and 
the UV absorption spectrum pattern. The compound stained yellow on TLC treated with 
p-anisaldehyde stain and the λmax at 274 and 333 nm was obtained from the UV 
spectrum (Fig. 2.8). A pseudo-molecular ion peak at m/z 313.0714 [M-H]- observed in 
the HRMS spectrum is in agreement with the molecular formula (C17H14O6).   





Figure 2.8: UV/Vis absorption spectrum of compound 2.55 
 
Two methoxy signals were observed in the 1H and 13C NMR spectra (Plate 4a & Plate 
4b) at δH 3.89/ δC 55.5 and 4.04/ δC 60.8. The correlation between the methoxy protons 
at δH 3.89 and the C-4' carbon in the HMBC spectrum (Plate 4f) confirmed that the 
methoxy is attached to C-4'. The HMBC spectrum also showed that the second methoxy 
was attached to C-6. The 6-OMe experiences steric hindrance from the two ortho 
substituents which affects the aryl-O-bond and causes the methoxy group to adopt an 
out-of-plane conformation. This conformation results in an inefficient electron 
conjugation between the lone-pair of the methoxy oxygen and the aromatic ring which 
decreases electron density at the methoxy group and the ring carbons in the ortho and 
para positions to the methoxy group (Agrawal, 1989). This explains the observed 
downfield shift of the 6-OMe and C-5 signals in the 1H and 13C NMR spectra.   
The combination of 1H, 13C NMR, UV/Vis absorption and mass spectral data led to the 
assignment of compound 2.55 as 5,7-dihydroxy-6,4'-dimethoxyflavone. The proposed 
structure was further confirmed by HMBC correlations observed between 5-OH signal, 
the methoxy bearing carbon (C-6) and C-4a; H-3, C-2 and C-1' and between H-8, C-7 
and C-6 (Plate 4f, Fig. 2.9).  

















Figure 2.9: Important HMBC correlations in compound 2.55 
 
5,7-Dihydroxy-6,4'-dimethoxyflavone (2.55), commonly known as pectolinarigenin, is 
isolated for the first time from E. rhinocerotis. The substitution pattern (5,6,7,4') shown 
by this compound is similar to the pattern displayed by flavones 2.41-2.43 which were 
previously isolated from E. rhinocerotis (Proksch et al., 1982). Pectolinarigenin (2.55) 
was isolated from several Asteraceae species, including some members of the genus 
Artemisia (Valant-Vetschera and Wollenweber, 1995), Erigeron breviscapus (Vant.) 
Hand.-Mazz. (Zhang et al., 2000), Heterotheca latifolia (Rojo et al., 2004), Arnica 
species (Merfort, 1984; Schmidt and Willuhn, 2000), Tanacetum macrophyllum Willd 
(Ivancheva and Stancheva, 1997), Baccharis species and Brickellia californica (Torrey 
& Gray) A. (Wollenweber et al., 1997a; Wollenweber et al., 1986b). 
Watanabe et al. (2014) reported on the isolation and phytotoxicity of pectolinarigenin 
(2.55) from Onopordum acanthium L. (Watanabe et al., 2014). 2.55 was also isolated 
from Cirsium chanroenicum and it showed in vitro and in vivo anti-inflammatory and 
anti-analgesic activities (Lim et al., 2008). Pectolinarigenin (2.55) prevented hepatic 
injury induced by D-galactosamine (GalN) in rats (Yoo et al., 2008).  
 
 











Compound 2.56 showed a yellow spot on TLC which intensified to a brown colour after 
spraying the TLC with anisaldehyde in concentrated H2SO4. This compound showed 
strong UV absorption peaks at λmax 266 and 350 nm, which is in agreement with the 
reported values for flavonols (Fig. 2.10) (Moiseev et al., 2011). A pseudo-molecular ion 
peak at m/z 299.0721 [M-H]- was obtained from the LRMS spectrum. Two ortho-
coupled doublets (integrating to 2H each) were observed in 1H NMR spectrum (Plate 
5a) at δH 6.95 and 8.00. These indicated the presence of an AA'XX' system of a 1,4 
disubstituted aromatic ring. Two more doublets (integrating to 1 proton each) were 
observed at δH 6.23 (J = 2.0 Hz) and 6.44 (J = 2.0 Hz). These were meta-coupled and 
were assigned to the two protons of tetra-substituted A-ring of a flavone.  
 
Figure 2.10: UV/Vis absorption spectrum of compound 2.56 
 
A methoxy signal appeared at δH 3.79/ δC 60.6 in 1H and 13C NMR spectrum (Plate 5b). 
This signal is in a deshielded position when compared to the methoxy of 5,7-dihydroxy-
4'-methoxyflavone (2.54). This deshielding suggested that the methoxy group is in a 
sterically congested environment, which disturbs conjugation between the methoxy 
oxygen lone pairs and the C-ring. As a result, the methoxy group is in a less electron 
dense environment and therefore deshielded. An HMBC correlation (Plate 5f) was 
observed between the methoxy protons and carbon signal at δC 138.1. This carbon was 




assigned as C-3 since no proton showed a cross peak to this carbon in the HSQC 
spectrum (Plate 5e). Also, C-3 is more deshielded in this compound when compared to 
compound 2.53-2.55. This further indicated that C-3 was a non-protonated carbon in 
compound 2.56. Some important HMBC correlations within compound 2.56 are shown 
in Figure 2.11. The structure of compound 2.56 was assigned as kaempferol 3-methyl 
ether since the experimental NMR data was in agreement with the reported values 
















Figure 2.11: HMBC correlation in compound 2.56 
 
The occurrence of kaempferol 3-methyl ether (isokaempferide) (2.56) is reported for the 
first time from the extracts of E. rhinocerotis. A closely related flavonol (quercetin, 
2.44) was previously isolated from E. rhinocerotis. Isokaempferide (2.56) was 
previously isolated from several Asteraceae species such as Cirsium palustre (L.) Scop. 
(Nazaruk, 2009), some Centaurea species (Flamini et al., 2001; Forgo et al., 2012), 
Chrysothamnus nauseosus (Pallas) Britton ssp. alhicaulis (Nutt.) Hall & Clements, 
Grindelia species, Ericam eria linearifolia (DC.) Urb. & J. Wussow (Wollenweber et 
al., 1997a), Pulicaria dysenterica. (L.) Bernh, Senecio viscosa L. (Wollenweber et al., 
1997b) and Helichrysum italicum (Wollenweber et al., 2005). Robin, et al. (1998) 
isolated isokaempferide (2.56) from Psiadia dentate and this compound showed 
antipoliovirus activity (Robin et al., 1998).  
 















2.57                         
The 13C NMR spectrum (Plate 6b) of compound 2.57 showed 20 signals. This 
suggested that compound 2.57 might be a diterpene. Furthermore, a high resolution 
mass spectrum for this compound showed a pseudo-molecular ion peak at m/z 324.2839 
[M-H]- which is in agreement with the molecular formula of C20H36O3. A non-
protonated carbon signal observed at δC 177.9 in 13C NMR spectrum is characteristic of 
a carboxylic acid carbonyl carbon. An HMBC (Plate 6f) correlation is observed 
between this carboxylic acid signal and the two doublets of doublets appearing at δH 
2.14 (1H, J = 14.7, 7.9 Hz) and 2.39 (1H, J = 14.7, 6.4 Hz) in the 1H NMR spectrum 
(Plate 6a). The 1H-13C correlations in the HSQC spectrum (Plate 6e) revealed that these 
doublets of doublets were due to the protons on the same carbon. This led to the 
assignment of these doublets of doublets as 14-CH2 protons. An HMBC correlation was 
observed between 14-CH2 protons and a methyl carbon signal at δH 0.98. This methyl 
carbon was then assigned as 16-CH3. A 1H-1H correlation was observed in the COSY 
spectrum (Plate 6c) between the 16-CH3 and a multiplet at δH 1.98, which led to the 
assignment of this multiplet as the C-13 methine signal.  
Four methyl signals were observed at δH 1.15 (3H, s)/ δC 23.9, 0.84 (3H, s)/ δC 33.4, 
0.78 (3H, s)/ δC 21.5 and 0.78 (3H, s)/ δC 15.4 in the 1H and 13C NMR spectra. This is 
characteristic of a labdane-type skeleton. Two methine signals at δH 0.91 (1H, m, J = 
11.9, 1.9 Hz)/ δC 56.1 and δH 1.02 (1H, m)/ δC 61.8 were assigned to H-5 and H-9 
respectively. The methylene signals in this compound were overlapping in the range δH 
0.91 - 1.98 in the 1H NMR spectrum. Long range 1H/13C correlations were observed 
between 16-Me, C-13 and C-14); Me-17, C-7, C-8, and C-9; Me-20, C-1, C-5 and C-9; 
H-5, C-4, C-9, C-10, C-18, C-19 and C-20; as well as between H-9, C-1, C-8, C-11 and 
C-20 (Fig. 2.12). 














Figure 2.12: Important HMBC correlations in compound 2.57 
 
Compound 2.57 showed a specific rotation of +7° which was the same as the reported 
value for (+)-8α-hydroxylabdan-15-oic acid (Ramirez et al., 1998). The relative 
configuration at C-5, C-8, C-9 and C-10 was determined by analysis of the NOESY 
spectrum (Plate 6g and Fig. 2.13). Strong NOE correlations between Me-17, H-11 and 
Me-20 suggested that these groups were in the “same plane” and therefore have an all 
cis-configuration (Waibel et al., 1992). In addition, the Me-20 signal resonated upfield 
compared to the other methyl signals (Me-18 and Me-19). This also confirmed the cis-













Figure 2.13: NOE correlations observed for compound 2.57 
 
Based on the NMR data, 2.57, was assigned as labdanolic acid or its 13-epimer, but it 
was not possible to assign the relative configuration of C-13 or the absolute 
configuration of the compound. As will be discussed later, the differences between the 
NMR data for labdanolic acid and 13-epi-labdanolic acid are minimal and it not 
possible to distinguish between these two compounds using NMR spectroscopy. 




Therefore, it was envisaged that an X-ray crystal structure analysis of compound 2.57 
was necessary to determine the configuration of C-13. The absolute configuration at C-
13 was previously determined for (-)-labdanolic acid (2.58), a compound which is 
structurally close to the isolated compound 2.57. (-)-Labdanolic (2.58) was first isolated 
from Cistus ladanifer L. (Cistaceae) in 1956 (Cocker et al., 1956). The structure of 2.58 
was determined by chemical degradation and comparison with the specific rotation of 
sclareol (2.59) and manool (2.60), but the C-13 configuration was not determined 
(Cocker and Halsall, 1956). Subsequent studies showed the configuration at C-13 of 
labdanolic acid to be (R) (Bory and Lederer, 1957). This assignment was based on the 
assumption that no intramolecular hydrogen bonding existed in this molecule, but this 
was soon challenged as results from other studies showed evidence of intramolecular 








2.60    
Overton and Renfrew (1967) studied the absolute configuration at C-13 of (-)-
labdanolic acid and eperuic acid. In that study, the tricyclic hydroxy-esters of labdanolic 
acid and eperuic acid were synthesized and the NOE correlations of these esters was 
analysed. The configuration at C-13 was determined to be (R) for both acids (Overton 
and Renfrew, 1967). Bjamer et al. (1968) investigated the C-13 configuration of 2.58 by 
X-ray crystallography, where p-bromophenacyl esters of (-)-labdanolic acid and eperuic 
acid were synthesized and analysed. The results obtained in that study confirmed the 
absolute configuration at C-13 to be (S) for both (-)-labdanolic acid and eperuic acid 
(Bjamer et al., 1968). It is clear from the above discussion that there were controversial 
arguments used to establish the C-13 absolute configuration of labdanolic acid.  
Recently, García-Sánchez et al. (2014) investigated the stereochemical assignment of 
labdane diterpenes isolated from Ageratina jacotepecana (Asteraceae) using vibrational 
circular dichroism (VCD) measurements. In this study, (+)-13-epi-labdanolic acid was 




amongst the isolated compounds and its C-13 absolute configuration was confirmed as 
(R). This was based on the results reported by Bjamer et al (1968) for (-)-labdanolic 
acid (2.58) (García-Sánchez et al., 2014). 
In our study, the X-ray crystal data will be compared with the literature data for (-)-
labdanolic acid (2.58) and (+)-13-epi-labdanolic acid. In an effort to obtain crystals 
suitable for X-ray crystal structure analysis, the p-bromophenacyl ester of (+)-13-epi-
labdanolic acid was synthesised and the results obtained are discussed in the following 
section. 
 
2.5.8 Synthesis of the p-bromophenacyl ester of (+)-13-epi-
















(+)-13-epi-Labdanolic acid (2.57) was treated with p-bromophenacyl bromide and 
triethylamine in N,N-dimethylformamide at 70 °C. After separation with column 
chromatography using hexane-ethyl acetate (8:2), the desired p-bromophenacyl ester 
was obtained as a white solid which recrystallized from CHCl3-Hex (1:1) to afford 
well-formed monoclinic crystals, space group P21. This space group indicated that there 
is no centre of inversion in the crystal. While two molecules are observed in the unit 
cell (Fig. 2.14), these are not mirror images of each other. Therefore, compound 2.61 
crystallized as enantiopure crystals. The absolute configuration was determined by 
studying the anomalous dispersion effect. As the structure contains a relatively heavy 
bromine atom and a high intensity Cu radiation was used for data collection, the 
dispersion effects became significant and absolute configuration was determined. 





Figure 2.14: The unit cell of compound 2.61. 
A single molecule of the asymmetric unit of compound 2.61 is shown in Figure 2.15. 
The X-ray structure shows the absolute configurations to be 5S, 8R, 9R, 10S and 13R. 
These carbons are labelled as C-12, C-9, C-25 and C-13 respectively in Figure 2.15. 
The observed orientation of Me-17 and Me-20 in this X-ray structure of 2.61 is in 
agreement with the NOE correlation observed between these methyl groups in the 
isolated compound 2.57 (Plate 6g & Fig. 2.13). The length of the two C=O bonds 
averages to 1.206 Å while that of C-O bond averages to 1.445 Å. These values are in 
agreement with the values reported in literature for the average bond lengths of C=O 
and C-O bonds (Sutton, 1965). In addition, the C-Br bond measured to 1.885 Å, which 
is in agreement with the literature value of 1.85 ± 0.01 Å (Bjamer et al., 1968; Sutton, 
1965). 
 
Figure 2.15: A partially labelled thermal ellipsoid plot of compound 2.61 showing 50% 
probability surfaces. All hydrogen atoms are shown as small spheres of arbitrary radius. 
 




As stated above, the analysis of the X-ray crystal structure led to the assignment of C-
13 absolute configuration as (R). Noteworthy, the X-ray crystal structure demonstrated 
the presence of intramolecular hydrogen bonding within compound 2.61 (Fig. 2.16). 
Therefore, compound 2.61 was assigned as the p-bromophenacyl ester of (+)-13-epi-
labdanolic acid and the isolated natural product (2.57) was assigned as (+)-(5S, 8R, 9R, 
10S, 13R)-8-hydroxylabdan-15-oic acid, also known as (+)-13-epi-labdanolic acid. The 
X-ray crystal structure of an ester of (-)-labdanolic has been reported (Bjamer et al., 
1968), but this is the first report of the X-ray crystal structure of epi-labdanolic acid or 
ester derivative of either enantiomers. 
 
Figure 2.16: Hydrogen-bonded chains adopted by compound 2.61 running parallel to 
the b-axis. Hydrogen bonds between the molecules are shown in blue lines and red lines 
represent all bonds to atoms participating in hydrogen bonding. 
 
To the best of our knowledge, this is a first report of the isolation of (+)-13-epi-
labdanolic acid (2.57) from E. rhinocerotis. Compound 2.57 was previously isolated 
from some Asteraceae species such as Espeletiopsis muiska Cuatr (Cuatr) (Ramírez et 
al., 2000; Ramirez et al., 1998), Stevia lucida Lagasca (Amaro-Luis and Hung, 1988), 
and Ageratina jocotepecana (discussed earlier) (García-Sánchez et al., 2014). (+)-13-
epi-Labdanolic acid (2.57) was obtained from the oxidation of (-)-13-epi-labdan-8α,15-
diol which was isolated from Oxylobus glanduliferus (Amaro and Adrian, 1982; García-




Sánchez et al., 2014). (+)-13-epi-Labdanolic acid (2.57) was also isolated from some 
species in the genus Cistus (Cistaceae) (Venditti et al., 2014).  
(+)-13-epi-Labdanolic acid (2.57) showed moderate antibacterial activity against 
Bacillus subtilis (MIC 1.56 mg/mL) and Staphylococcus aureus (MIC 2.34 mg/mL) 
(García-Sánchez et al., 2014). Labdane-type diterpenes (other than compound 2.57) 
occur abundantly in nature and in the family Asteraceae and have been shown to exhibit 
a broad spectrum of biological activities, including, antibacterial, antifungal and 
cytotoxicity (Chinou, 2005; García-Sánchez et al., 2014). 
 











In the assignment of the structure of compound 2.62 it was observed that the 1H (Plate 
8a), 13C (Plate 8b) and HRMS spectra were closely related to those of compound 2.57. 
Slight differences in the chemical shifts were observed in the 1H NMR spectral data 
(Plates 6a and 8a, and Table 2.1) at H-11 (1.25 / 1.40 in 2.57 and 1.32 / 1.32 in 2.62), 
H-12 (0.91 / 1.61 in 2.57 and 1.32 / 1.48 in 2.62), H-13 (1.98 in 2.62 and 1.93 in 2.62), 
H-14 (2.14 / 2.39 in 2.57 and 2.20 / 2.35 in 2.62). These differences in chemical shifts 
were not observed in the 13C NMR spectra (Plate 6b and 8b). Similarly to (+)-13-epi-
labdanolic acid (2.57), NOE correlations (Plate 8f and Fig. 2.12) were observed 
between the methyl signals in positions 17, 18, and 20, which indicated that these 
methyl groups were in the same plane. Although compound 2.57 and 2.62 had almost 
the same NMR spectra, their Rf values were different on TLC.  
Compounds 2.57 and 2.62 showed pink spots on a TLC plate when treated with 
anisaldehyde/ H2SO4 stain and heated. Compound 2.57 showed an Rf value of 0.4 while 
the Rf value of compound 2.62 was 0.2 when using DCM-EtOAc (1:1). This separation 
on TLC revealed that compound 2.57 and 2.62 were diastereomers. A specific rotation 




of (+7°) was obtained for compound 2.62 and this is same as the value obtained for 
2.57.  
The NOE data (Fig. 2.12) showed that the relative configuration of C-5, 8, 9 and 10 of 
2.57 and 2.62 were the same and thus the difference between the structures of these two 
compounds had to the configuration of C-13. Therefore, the structure of 2.62 was 
assigned as labdanolic acid. The specific rotation of 2.62 (+7°) is opposite to that 
reported for (-)-labdanolic acid (2.58) which proved that 2.62 is the enantiomer of 2.58. 
The relative configuration at C-13 in diterpene 2.62 was suggested to be (R) based on 
the observed positive specific rotation (+7°) which is similar to the specific rotation for 
13-epi-labdanolic acid (2.57). There is only one chromophore in both 2.57 and 2.62. It 
is clear that the specific rotation of these compounds is influenced by the C-13 
stereocentre in close proximity to this chromophore rather than the configuration of the 
























Table 2.1: 1H and 13C NMR data (400 MHz, CDCl3) of compounds 2.57 and 2.62. 
Position δC (2.57) δH (2.57) δC (2.62) δH (2.62) 
1 39.8 (CH2) 1.40 (6H, m) 39.7 (CH2) 0.93 (1H, m,) 
1.63 (4H, m) 
2 18.4  (CH2) 1.40 (6H, m) 
 
1.61 (4H, m) 
18.4  (CH2) 1.42 (2H, m) 
 
1.56 (1H, dt, 13.5, 
3.2) 
3 41.9 (CH2) 1.15 (4H, s) 
 
1.40 (6H, m) 
41.9 (CH2) 1.15 (4H, s) 
 
1.38 (4H, m) 
4       33.2 (C)  33.2 (C)  
5 56.1 (CH) 0.91 (2H, m, 
11.9, 1.9) 
56.1 (CH) 0.89 (1H, m,) 
6 20.5 (CH2) 1.25 (3H, m) 
 
1.61 (4H, m) 
20.5 (CH2) 1.63 (4H, m) 
 
1.26 (7H, m) 
7 44.3 (CH2) 
 
1.40 eq (6H, m) 




1.38 (4H, m) 
1.86 (1H, dt, 12.3, 
2.8) 
8 74.7 (C)  74.6 (C)  
9 61.8 (CH) 1.02 (1H, m) 62.2 (CH) 1.02 (1H, m, 3.85) 
10 39.1 (C)  39.1 (C)  
11 21.9 (CH2) 1.25 (3H, m) 
1.40 (6H, m) 
22.9 (CH2) 1.32 (4H, m) 
 
12 39.6 (CH2) 0.91 (2H, m, 
11.9, 1.9) 
1.61 (4H, m) 
40.6 (CH2) 1.32 (4H, m) 
1.48 (2H, m) 
 
13 30.8 (CH) 1.98 (1H, m) 31.2 (CH) 1.93 (1H, m) 
14 40.9 (CH2) 2.14 (1H, dd, 
14.7, 7.9 ) 
 
2.39 (1H, 14.7, 
6.4) 




14.8, 5.9)                                                                                                                   
15 177.9 (C)  177.0 (C)  
16 19.9 (CH3) 0.98 (3H, d, 6.8) 19.9 (CH3) 0.99 (3H, d, 6.7)  
17 23.9  (CH3) 1.15 (4H, s) 24.0  (CH3) 1.15 (4H, s) 
18 33.4 (CH3) 0.84 (3H, s) 33.4 (CH3) 0.86 (3H, s) 
19 21.5 (CH3) 0.78 (6H, s) 21.5 (CH3) 0.79 (6H, s) 
20 15.4  (CH3) 0.78 (6H, s) 15.4  (CH3) 0.79 (6H, s) 
 





















(+)-Labdanolic acid (2.62) was treated with p-bromophenacyl bromide and 
triethylamine in DMF at 70 °C. The product was purified by a chromatotron using hex-
EtOAc (8:2) to furnish a white solid of p-bromophenacyl ester of (+)-labdanolic acid. 
Recrystallization of this ester from CHCl3-Hex (1:1) afforded white needle-like 
crystals. Unfortunately, we could not obtain suitable crystals for X-ray crystal structure 
analysis. The structure was therefore analysed using NMR and HRMS spectral data. 
Two singlets were observed in the 1H NMR spectrum (Plate 9a) at δH 5.26 (1H, s) and 
5.29 (1H, s). A 1H/13C short range correlation was observed (Plate 9e) between these 
singlets and a deshielded methylene carbon signal at δC 65.6 and these protons were 
assigned as H-21 methylene protons.  
Two sets of aromatic protons appeared at δH 7.63 (2H, d, J = 8.5 Hz) and 7.77 (1H, d, J 
= 8.5 Hz) in 1H NMR spectrum (Plate 9a). This was indicative of the presence of a 1,4-
disubstituted aromatic ring system. The remaining signals in 1H NMR spectrum were 
closely similar to those observed for compound 2.63. 26 Signals were obtained from 
13C NMR spectrum (Plate 9b). Two carbonyl carbon signals at δC 172.6 and 191.6 were 
present. The first signal (172.6 ppm) suggested the presence of an ester group in this 
compound, while the second signal (191.6 ppm) represented a ketone carbonyl carbon. 
Four aromatic signals existed at δC 129.1 (C, C-23), 129.3 (CH, C-25, 27), 132.2 (CH, 
C-24, 28) and 132.9 (C, C-26) in 13C NMR spectrum, this was in agreement with the 
proposed structure. Other signals observed in 13C NMR spectrum were similar to those 
discussed for compound 2.62.  
To assist with the determination of the relative and absolute configuration of the 
compounds 2.57 and 2.62, the electronic circular dichroism (ECD) spectra of both the 
phenacyl ester derivatives of these two compounds were run. However, no absorptions 




were observed in the spectra. It is clear that free rotation in the side chain containing the 
chromophore prevent ECD to be useful in determining the absolute configuration of 
these compounds. 
 















A compound (2.64) with pseudo-molecular ion peak at m/z 361.2633 [M+Na]+, which 
is in agreement with a molecular formula of C21H38O3, was isolated. Most of the signals 
in the 1H and 13C NMR (Plates 10a and 10b) spectra of this compound were similar to 
those of 13-epi-labdanolic acid (2.57). But, this compound was different to compound 
2.57 as the carboxylic acid signal at 177 ppm in 13C NMR spectrum (Plate 10b) was not 
observed. Instead, a shielded signal was observed at δC 173.9 in 13C NMR spectrum, 
which is characteristic of an ester carbonyl carbon. In addition, a methoxy signal was 
observed at δH 3.61 and δC 51.3 in 1H and 13C NMR spectra respectively. Further 
comparison between the experimental and literature data, suggested that compound 2.64 
was the methyl ester derivative of (+)-epi-labdanolic acid.  
The assignment of the relative configuration of compound 2.64 was achieved by 
analysing NOE correlations and by comparison of signals in 1H and 13C NMR spectra 
with those of  both (+)-epi-labdanolic acid (2.57) and (+)-labdanolic acid (2.62). NOE 
correlations were observed between Me-17, Me-18 and Me-20 (Fig. 2.18). 1H NMR 
spectra of compound 2.57, 2.62 and 2.64 were overlapped to observe differences 
between these compounds. Compound 2.64 was observed to be similar to (+)-13-epi-
labdanolic acid (2.57). Therefore, the relative configuration in compound 2.64 was 
predicted as 9R, 10S, 13R, 17R. 




Several steps in our extraction process involved the use of methanol. It is possible that 
the (+)-labdanolic acid methyl ester (2.64) that was isolated was an artefact formed 












Figure 2.18: NOE correlations observed for compound 2.64 
 
The C-13 epimer of 2.64 [(-)-labdanolic acid methyl ester (2.65)] was prepared by the 
oxidation of (-)-labdanediol with Jones reagent to give the carboxylic acid derivative 
which was subsequently methylated with an excess of MeSiCHN2 (Girón et al., 2010). 
(-)-Labdanolic acid methyl ester (2.65) showed in vitro anti-inflammatory effects when 
tested on lipopolysaccharide (LPS)-treated RAW 264 macrophages and it exhibited in 
vivo anti-inflammatory activity when tested in mice. The potency showed by compound 
2.65 was similar to that of the commonly used anti-inflammatory drug, indomethacin, 
which indicated the potential of using this compound for the design of new anti-




















Another labdanolic acid derivative (2.66) was isolated from the aerial parts of E. 
rhinocerotis. A majority of signals in 1H and 13C NMR spectra (Plate 11a and 11b) of 
this compound (2.66) were similar to labdanolic acids 2.57 and 2.62. A remarkable 
difference between compound 2.66 and the labdanolic acids 2.57 and 2.62 was the 
existence of a deshielded methylene signal at δH 3.7 in 1H NMR spectrum of compound 
2.66. This downfield shift of this methylene signal suggested that this methylene was 
oxygen-linked, and thus was assigned as H-15. After comparison of the 1H and 13C 
NMR data with the literature data, compound 2.66 was confirmed to be (+)-labdanediol. 
The experimental specific rotation (+12°) of compound 2.66 was also in agreement with 
the literature value for labdanediol (+10°) (Dawson et al., 1966). 
The occurrence of (+)-labdanediol (2.66) is reported for the first time from the family 
Asteraceae. (-)-Labdanediol (2.67) was previously isolated from one Asteraceae specie, 
Oxylobus glanduliferus (Amaro and Adrian, 1982). Recently, Girón et al (2010) used   
(-)-labdanediol as a starting material in the preparation of several derivatives, including 
(-)-labdanolic acid (2.58) and (-)-labdanolic acid methyl ester (2.65). The results 
obtained in this study showed that (-)-labdanediol (2.67) together with some 
derivatives, are potent inhibitors of LPS-induced NO and PGE2 production in 
macrophage cells and showed anti-inflammatory activity in mice (Cuadrado et al., 








There are also several reports about the anti-inflammatory properties of labdane 
diterpenes (De Las Heras et al., 1999; Girón et al., 2008; Matsuda et al., 2002; Shen et 
al., 2002). (-)-Labdanediol (2.67) was also isolated as a major constituent from Cistus 
ladaniferus L. and was converted to 12-nor-ambreinolide which is a precursor of 




The occurrence of flavonoids 2.52-2.56 are reported for the first time from E. 
rhinocerotis, however, other flavonoids were isolated from this species (Proksch et al., 
1982). The labdane diterpenoids 2.57, 2.62, 2.64 and 2.66 are not common in the 
Asteraceae family, but other labdane-type diterpenoids occur abundantly in this family. 
The biological activities of the isolated flavones and diterpenes were obtained from 
literature and these activities were compared with the traditional uses of this plant. The 
reported anticancer activity of E. rhinocerotis crude extracts may be attributed to the 
flavonoids found in this plant. While we isolated four substituted flavones, various 
flavonoids were present in small quantities in the ethyl acetate extract of this plant (Fig. 
2.15). 
The previously isolated labdane diterpene (rhinocerotinoic acid), which showed anti-
inflammatory properties (Dekker et al., 1988) was not isolated nor detected in the E. 
rhinocerotis extracts used in this study. However, the 13-C epimers of the isolated 
labdane diterpenes 2.57, 2.62, 2.64 and 2.66 showed anti-inflammatory activities (Girón 
et al., 2010). This suggests that this plant may be a useful source of natural diterpenes 
with anti-inflammatory properties. E. rhinocerotis is one of the plants that have been 
reported to be used in South Africa during the 1918 influenza pandemic. From the 
constituents present in this plant it is most likely that the anti-inflammatory effect of the 
plant extracts might have played a role in its use. 
 








Several studies have shown variations in the chemical profiles of the same plant 
collected in different geographic areas. These variations are normally associated with 
climatic changes, and the differences in the genetic type of the species (Dong et al., 
2003). It is therefore important to evaluate the chemical profiles of species collected in 
different geographic locations before making a general statement on the composition 
and biological activities of the plants. Reversed-phase high performance liquid 
chromatography coupled to photodiode array detection/electrospray or atmospheric 
pressure ionization mass spectrometry (HPLC-PDA/ESI-MS/APCI-MS) has been used 
as a rapid and powerful tool to define the chemical profiles of complex raw extracts 
from plants without isolating and cleaning-up their individual constituents (Ferreres et 
al., 2011). The type of compounds present in the plant extracts are determined by 
comparing their retention times with those of standard samples run under the same 
conditions. Additionally, the UV/Vis absorption profile and the data obtained from the 
mass spectra of the unknown compounds are compared with those reported in literature 
for various groups of compounds.  
Therefore, the aim of this study was to use HPLC-PDA/ESI-MS/APCI-MS in the 
analysis of the chemical variations in E. rhinocerotis collected from different locations 
(location 1, 2 and 3) in a farm in Weltevrede, Western Cape. The phytochemistry of the 
sample collected from location 1 was studied in this research and the results were 
discussed in Section 2.6. The flavonoids 2.52-2.56 isolated from this extract were used 
as reference compounds. The HPLC method which separated these flavonoids was 
developed and this method was used to analyze the three crude extracts (collected from 
location 1, 2, and 3). 
 




2.6.2 Analysis of E. rhinocerotis collected from location 1 on 
farm Weltevreded.  
 
The aerial parts of E. rhinocerotis were collected from location 1 on farm Weltevreded, 
Sneeuberg, Murraysburg (Western Cape). After drying, crushing, and extraction with 
DCM-MeOH (1:1), the crude extract was fractionated using column chromatography to 
obtain EtOAc extract. The crude EtOAc extract was further purified on silica gel as 
described in Section 2.6 and the pure compounds were assayed using HPLC-PDA. 
Compounds 2.52-2.56 (0.1 mg each) were redissolved in methanol and were analyzed 
by reverse phase HPLC using gradient elution method with MeOH/1% AcOH in H2O. 
The most polar coumarin 2.52 eluted at 7.445 minutes followed by apigenin (2.53) at 
16.635 min from HPLC (Fig. 2.19 A & B). As expected, 5,7-dihydroxy-4'-
methoxyflavone (2.54) and 5,7-dihydroxy-6,4'-dimethoxyflavone (2.55) were retained 
for a longer time in the column and they eluted at 31.338 and 31.290 min, respectively 
(Fig. 2.19 C & D). This is because the methyl ether substituents (-OMe) in compound 
2.54 and 2.55 are more non-polar than the hydroxy (-OH) substituents in apigenin 
(2.53).  
A Phenomenex Luna C18 (2) column (250 x 4.60 mm, 5µ) was blocked while we were 
in the process of analyzing kaempferol 3-methyl ether (2.56). Compound 2.56 was then 
analyzed using Phenomenex kinetex C18 column (100 x 4.60 mm, 2.6µ). Kaempferol 
3-methyl ether eluted at 10.298 min (Fig. 2.19 E) and this peak showed the same 
UV/Vis absorption spectrum to the peak at 17.771 min in the crude E. rhinocerotis 
sample. The structural characterization of compounds 2.52-2.56 was confirmed by 
comparing their UV/Vis absorption spectra (Fig. 2.19) with literature, as well as 
analyzing their NMR and HRMS spectral data (discussed in Section 2.5). 
The second step was to analyse the E. rhinocerotis crude extract from location 1 using 
HPLC-PDA under the same conditions as the pure analytes to determine its chemical 
composition. Figure 2.20 shows the HPLC chromatogram of the crude extract and the 
isolated flavonoids 2.52-2.56 is labelled. The HPLC method used to analyse this sample 
separated all the reference analytes, therefore, this method was used to analyse the other 
E. rhinocerotis plants using HPLC-PDA/MS.  









Figure 2.19: HPLC chromatogram and UV/Vis absorption spectra of flavonoids 2.52-
2.56 from E. rhinocerotis (location 1). 
 





Figure 2.20: HPLC-PDA chromatogram of E. rhinocerotis collected from location 1 on 
farm Weltevreded. 
 
The E. rhinocerotis extract from location 1 was further analysed by HPLC-ESI-MS and 
APCI-MS to identify and characterise the structures of both the UV/Vis absorbing and 
UV/Vis non-absorbing compounds. Flavonoids 2.52-2.56 were identified in the APCI-
MS(-) and ESI-MS(+) spectra (Fig. 2.21 B & C). (+)-13-Epi-labdanolic acid (2.57), (+)-
labdanolic acid (2.62) were identified from the APCI-MS(-) mode (Fig. 2.21 B), while 
labdanolic acid methyl ester (2.64) was identified from APCI-MS(+) (Fig. 2.21 A). (+)-
Labdanediol (2.66) was not identified in the crude extract, which may be due to the 
very small amounts of this compound relative to the other compounds in the crude 
extract.  
 
Figure 2.21: HPLC-LCMS chromatogram of the aerial parts of E. rhinocerotis 
collected from location 1 on farm Weltevreded. 





Figure 2.22: HPLC-LCMS chromatogram of the aerial parts of E. rhinocerotis 
collected from location 1 on farm Weltevreded. 
 
2.6.3 Analysis of E. rhinocerotis collected from location 2 on 
farm Weltevreded.  
 
E. rhinocerotis was collected in a different location (location 2) on farm Weltevreded. 
Leaves were separated from branches, washed with water, dried, and each extracted 
with DCM-MeOH (1:1). The crude extracts were analysed by HPLC-PDA/ESI-MS and 
APCI-MS. From the leaves, apigenin (2.53), 5,7-dihydroxy-4'-methoxyflavone (2.54) 
and kaempferol 3-methyl ether (2.56), were identified from the APCI-MS(-) and ESI-
MS(-) chromatograms (Fig. 2.22 B & C). In addition, 13-epi-labdanolic acid (2.57), (+)-
labdanolic acid (2.62) and (+)-labdanolic acid methyl ester (2.64) were also observed 
from the APCI-MS(-) and ESI-MS(+) spectra (Fig. 2.22 B & D). 5,7-Dihydroxy-6,4'-
dimethoxyflavone (2.55) and (+)-labdanediol (2.66) were not observed in the LCMS 
spectra. It is possible that this plant does not produce compounds 2.55 and 2.66 or the 
concentrations of these compounds are too small relative to the other compounds 
present. 
 






Figure 2.23: HPLC-PDA/LCMS chromatogram of the leaves of E. rhinocerotis 
collected from location 2 on farm Weltevreded. 
 
From the branches, pseudo-molecular ion peaks in agreement with the molecular 
masses of flavones 5,7-dihydroxy-4'-methoxyflavone (2.54), 5,7-dihydroxy-6,4'-
dimethoxyflavone (2.55) and kaempferol-3-methyl ether (2.56) were identified from the 
APCI-MS(-) (Fig. 2.23 B). Interestingly, no peaks corresponded to labdanolic acid and 
its derivatives (2.57, 2.62, 2.64 and 2.66). These results show that there are a lot of 












Figure 2.24: HPLC-PDA/LCMS chromatogram of the branches of E. rhinocerotis 
collected from location 2 on farm Weltevreded. 
 
2.6.4 Analysis of E. rhinocerotis collected from location 3 on 
farm Weltevreded. 
 
E. rhinocerotis plant was collected from location 3 on farm Weltevreded. Leaves were 
separated from branches and the dried plant material was extracted with DCM-MeOH 
(1:1). The crude extracts were also analysed by HPLC-PDA/ESI-MS/APCI-MS. From 
the UV/Vis absorption chromatogram, compounds 2.52-2.56 were identified (Fig. 2.24 
A). The pseudo-molecular ion peaks corresponding to the molecular masses of 
compounds 2.53-2.56 was observed in the APCI-MS(-) (Fig. 2.24 B). Scoparone (2.52) 
co-eluted with an unidentified compound at 11.01 min from the HPLC column. 
Compound 2.52 showed a pseudo-molecular ion peak at m/z 229.0422, while 
compound (x) showed a peak at m/z 261.0707 in the ESI-MS(+) mode (Fig. 2.24 D). 
13-Epi-labdanolic acid (2.57) and (+)-labdanolic acid (2.62) were also observed from 
the APCI-MS(-) spectrum (Fig. 2.24 B). Labdanolic acid methyl ester (2.64) and 
labdanediol (2.66) were not identified in this extract. Five of the seven identified 
compounds in this extract (2.53, 2.54, 2.55, 2.57 and 2.62) were also detected from E. 




rhinocerotis extract collected from location 2. This showed very close similarities in the 




Figure 2.25: HPLC-PDA/LCMS chromatogram of the leaves of E. rhinocerotis 
collected from location 3 on farm Weltevreded. 
 
The crude extract of the branches from location 3 was assayed by HPCL-LCMS and the 
molecular masses and retention times in agreement with 5,7-dihydroxy-4'-
methoxyflavone (2.54), 13-epi-labdanolic (2.57), (+)-labdanolic acid (2.62) and 
labdanediol (2.66) were observed in the LC-MS spectra (Fig. 2.25 B & C). The 
chemical composition of this sample was very different to that of branches from the E. 
rhinocerotis collected in location 2. The only common compound between these 
samples was dihydroxy-4'-methoxyflavone (2.54). In general, this sample (branches 
from location 3) was dominated by the labdanolic acids (2.57, 2.62 and 2.66) while only 
flavonoids could be detected from the location 2 sample.  
 
 






Figure 2.26: HPLC-PDA/LCMS chromatogram of the branches of E. rhinocerotis 
collected from location 3 on farm Weltevreded. 
 
In summary, slight variations in the chemical profiles were observed between the leaves 
and branches of the same plant. Minor variations were also observed in the constituents 
of leaves from different plants (collected in different locations). The chemical 
constituents of the branches collected from different locations were significantly 
different. Basically, the sample from location 2 was rich in flavonoids [5,7-dihydroxy-
4'-methoxyflavone (2.54), 5,7-dihydroxy-6,4'-dimethoxyflavone (2.55) and kaempferol-
3-methyl ether (2.56)] while that from location 3 was dominated by the labdanolic acid 
derivatives [13-epi-labdanolic (2.57), (+)-labdanolic acid (2.62) and labdanediol 
(2.66)]. However, the overall chemical profiles of the aerial parts (leaves and branches) 
of E. rhinocerotis plants collected in locations 1, 2 and 3 were similar. The observed 
variation in the chemical constituents of the branches collected from different locations 
was not unexpected. The exposure to different environmental conditions (light, 
temperature and humidity) and the age of the plant might have influenced the chemical 
profiles. E. rhinocerotis was reported to support a rich fauna of insects, including, three 
species of gall-inducing Diptera (Spathulina peringueyi Bezzi and two species 
belonging to the Cecidomyiidae family (Dorchin and Gullan, 2007). It is therefore 
possible that some chemical constituents in this plant are produced by these species. 
This might cause variations in the chemical profiles if different species (producing 
different compounds) occur in the plants collected from different locations. 






We developed a HPLC-PDA/MS method for the analysis of E. rhinocerotis extracts. 
The chromatographic results obtained from the leaves collected in different locations 
farm Weltevreded in the Western Cape indicated minor variation in the chemical 
profiles of these extracts, while significance variations were observed in the 
composition of the branches. The overall chemical composition of the aerial parts 
(leaves and branches) of the E. rhinocerotis extracts collected from the three different 
locations was similar. Since the present study focused on plants collected during the 
same season, further investigation is required to evaluate the impact of seasonal change 




2.8.1 Instrumentation and chemicals 
 
Thin-layer chromatography (TLC) plates (Kieselgel 60 F254, 0.25 mm) were used for 
the inspection of compounds in the crude extracts and the purified fractions. 
Visualization was achieved by placing the TLC plate under UV radiation (254 or 365 
nm) or by staining with p-anisaldehyde/H2SO4 and heating. The p-anisaldehyde stain 
was prepared by cooling methanol (85 mL) in ice, followed by addition of p-
anisaldehyde (0.5 mL), sulfuric acid (4 mL) and glacial acetic acid (10 mL). After 
vigorous shaking, this solution was stored in the refrigerator. Columns packed with 
silica gel 60 and centrifugal chromatography (Chromatotron™ model 7924, Harrison 
Research) were used for the purification of the extracts. The circular plates used on the 
Chromatotron were coated with preparative silica gel to a thickness of 1, 2 or 4 mm.  
1H and 13C NMR spectra were recorded on either a Bruker Avance III 500 or Bruker 
Avance III 400 at frequencies of 500 MHz/ 400 MHz (1H) and 100 MHz/ 125 MHz 
(13C) using either a 5 mm BBOZ probe or a 5 mm TBIZ probe. All protons and carbons 




chemical shifts are quoted relative to the relevant solvent signal (e.g. CD3OD: 1H, 3.33 
ppm, 13C, 49.0 ppm; CDCl3: 1H, 7.26 ppm, 13C, 77.0 ppm; acetone-d6: 1H, 2.05 ppm, 
13C, 29.9 ppm). Proton-proton coupling constants are reported in Hertz. All experiments 
were conducted at 30 °C unless specified otherwise.  
HPLC-PDA analysis was performed on a Shimadzu HPLC consisting of a controller, 
solvent supply unit, photodiode-array detector and an autosampler, using either a 
Phenomenex Luna C18 (2) column (250 x 4.60 mm, 5 µ) or a Phenomenex Kinetex 
C18 column (100 x 4.60 mm, 2.6 µ) operated at 40 °C. The mobile phase consisted of 
two solvents, 1% acetic acid (A) and methanol (B). Elution was started with 30% of B 
and using a linear gradient to obtain 90% at 20 min, 100% at 25 min, and returning to 
30% at 30 minutes. The injection volume was 4.00 uL and the flow rate was 0.400 
µL/min. UV detection for all peaks was from 210-450 nm, and the chromatograms were 
recorded at 340 nm. UPLC-PDA/LCMS analysis was carried out on the ACQUITY 
UPLC system consisting of a binary pump, photodiode-array detector, autosampler, and 
a Waters BEH C18 column (2.1 x 100 mm, 1.7µm) operated at 25 °C. Mass spectra 
data were collected on a time-of-flight Waters LCT Premier mass spectrometer using 
electrospray ionization (ESI) or atmospheric pressure chemical ionisation (APCI) in the 
positive or negative mode. Optical rotation was determined using an ADP 440+ model 
polarimeter manufactured by Bellingham and Stanley.  
X-ray diffraction data were recorded on a Bruker Apex Duo diffractometer equipped 
with an Oxford Instruments Cryojet operating at 100(2) K. The data was collected with 
copper radiation (λ=1.5418Å) at a crystal-to-detector distance of 50 mm using omega 
and phi scans with exposures taken at 30 W X-ray power and 0.50° frame widths. The 
data was reduced with the programme SAINT using outlier rejection, scan speed 
scaling, as well as standard Lorentz and polarisation correction factors. Direct methods 
(SHELXS-97 and WinGX) were used to solve the structures. All non-hydrogen atoms 
were located in the E-map and refined anisotropically with SHELXL-97. Hydrogen 
atoms were included as idealised contributors in the least squares process. All diagrams 
were generated using Mercury 2.2. 
 




2.8.2 Plant material 
 
For bulk extraction, the aerial parts (leaves and branches) of Elytropappus rhinocerotis 
were collected from farm Weltevreded in Sneeuberg (Murraysburg, Western Cape, GPS 
coordinates 32.1182 S, 24.0095E) in December 2008. The plant was identified by Mrs. 
Alison Young from the University of KwaZulu-Natal Botanical Gardens, voucher 
specimen (van Heerden 3) deposited in the Bews Herbarium, University of KwaZulu-
Natal (Pietermaritzburg). For analytical studies, three plants about one kilometre from 
each other were collected from the same farm (location 1, 2, and 3). The voucher 
specimens (van Heerden 3) were deposited in the Bews Herbarium, University of 
KwaZulu-Natal (Pietermaritzburg). 
2.8.3 Extraction and isolation 
 
The aerial parts of E. rhinocerotis were air dried, ground into a powder (1.9 kg) and 
then extracted with a mixture of methanol (MeOH)-dichloromethane (DCM) (1:1) at 
room temperature for 48 hours. This yielded 189 g of crude extract. 19 g of this extract 
was redissolved in acetone and subjected to a short silica gel column chromatography. 
Successive elution of this column with hexanes (Hex)-ethyl acetate (EtOAc) (10:0, 9:1, 
7:3, 3:7, 5:5 and 0:10) and finally washing with methanol resulted in four  fractions (A-
D) with the masses of 10.009 g, 6.837 g, 1.9601 g and 3.251g, respectively. Fraction A 
was purified on a column chromatography using Hex-EtOAc (7:3) to afford five 
fractions (A1-A5). Further purification of fraction A3 using Hex-EtOAc (7:3) resulted 
in three fractions (A3.1-A3.3). Fraction A3.1 was further subjected to column 
chromatography using Hex-EtOAc (8:2) to afford compound 2.56 (0.12 g). Separation 
of fraction A3.3 on a column with DCM-EtOAc (8:2) yielded six fractions (A3.3.1-
A3.3.6). Fraction A3.3.6 (4.02 g) was further purified on a chromatotron using DCM: 
EtOAc (1:1) to afford labdanolic acid methyl ester (2.64) (45 mg), labdanediol (2.66) (5 
mg), (+)-13-epi-labdanolic acid (2.57) (250 mg) and (+)-labdanolic (2.62) (135 mg). 
Fraction B was further separated by column chromatography using Hex-EtOAc (4:6). 
This resulted into four fractions (B1-B4). Further separation of fraction B2 on a column 




using DCM-MeOH (9.5:0.5) yielded seven fractions (B2.1-B2.7). Purification of 
fraction B2.3 using Hex-EtOAc (4:6) afforded 2.52 (14 mg). Separation of fraction 
B2.4 by column chromatography eluting with Hex-EtOAc (1:1) resulted in the isolation 
of 2.53 (2 mg) and 2.55 (5 mg). When fractions B2.5 and B2.6 were re-dissolved in 
methanol, a light yellow precipitate of compound 2.54 (12 mg) was obtained.  
The purified compounds were subjected to HPLC to confirm their purity and to 
characterise their structures. The structures of isolated compounds were further 
characterised using NMR and mass spectrometry and the compounds were identified as 
6,7-dimethoxycoumarin (2.52) (Céspedes et al., 2006), 5,7,4'-trihydroxyflavone (2.53) 
(Ersoz et al., 2002), 5,7-dihydroxy-4'-methoxyflavone (2.54), 5,7-dihydroxy-6,4'-
dimethoxyflavone (2.55) (Soon-Ho et al., 2003), kaempferol-3-methyl ether (2.56) 
(Forgo et al., 2012; Gao et al., 2011), (+)-13-epi-labdanolic acid (2.57), (+)-labdanolic 
(2.62), (+)-labdanolic acid methyl ester (2.64) and (+)-labdanediol (2.66) (Cocker and 
Halsall, 1956; Ramirez et al., 1998). 
 
2.8.4 Physical data of isolated compounds 
 
6,7-Dimethoxycoumarin (2.52) was isolated as off-white crystals.1H NMR (400 MHz, 
CDCl3): δH 3.91 (3H, s, 6-OMe), 3.94 (3H, s, 7-OMe), 6.28 (1H, d, J = 9.5, H-3), 6.83 
(1H, s, H-5), 6.85 (1H, s, H-8), 7.61 (1H, d, J = 9.5, H-4) (Plate 1a); 13C NMR (100 
MHz, CDCl3): δC 56.4 (CH3, 6-OCH3), 56.4 (CH3, 7-OCH3), 108.0 (CH, C-8),  
100.1(CH, C-5), 111.4 (C, C-4a), 113.9 (CH, C-3), 143.2 (CH, C-4), 146.4 (C, C-6), 
150.1 (C, C-8a), 152.9 (C, C-7), 161.4 (C, C-2) (Plate 1b); HPLC: tR 9.445, λmax 228 
and 343 nm; HRMS(+), m/z 229.0482 [M+Na]+ (calc. for  C11H10O4Na: 229.0477)  
5,7,4'-Trihydroxyflavone (2.53) was isolated as a yellow powder. 1H NMR (400 MHz, 
CD3OD): δH  6.18 (1H, d , J = 2.0, H-6), 6.42 (1H, d, J = 2.0, H-8), 6.56 (1H, s, H-3), 
6.92 (2H, d, J  =  8.8, H-3',5'), 7.84 (2H, d, J = 8.8, H-2',6') (Plate 2a); 13C NMR (125 
MHz, CD3OD), Plate 2b: δC 95.4 (CH, C-8), 100.7 (CH, C-6), 103.7 (CH, C-3), 104.9 
(C, C-4a), 117.1 (CH, C-3',5'), 123.3 (C, C-1'),  129.4 (CH, C-2',6'), 159.6 (C, C-7), 
160.8 (C, C-8a), 162.9 (C, C-4'), 165.8 (C, C-2), 166.1 (C, C-5), 183.7 (C, C-4) (Plate 




2b); HPLC: tR 16.734, λmax 267 and 338 nm; HR-ESIMS(-), m/z 269.0454 [M-H]- (calc. 
for  C15H9O5: 269.0450) . 
5,7-Dihydroxy-4'-methoxyflavone (2.54) was isolated as a yellow powder. 1H NMR 
(400 MHz, Acetone-d6): δH 3.92 (3H,s, 4'-OMe), 6.26 (1H, d , J= 1.7, H-6), 6.54 (1H, d, 
J= 1.7, H-8), 6.66 (1H, s, H-3), 7.13 (2H, d,  J = 8.8, H-3', 5'), 8.02 (2H, d, J = 8.8, H-2', 
6'), 12.98 (5-OH) (Plate 3a); 13C NMR (125 MHz, Acetone-d6): δC 55.1 (CH3, 4'-OMe), 
93.9 (C, C-8), 99.0 (CH, C-6), 103.7 (CH, C-3), 114.5 (CH, C-3',5'), 123.5 (C, C-1'), 
128.2 (CH, C-2',6'), 157.9 (C, C-8a),  162.5 (C, C-5), 162.8 (C, C-4’), 163.8 (C, C-2), 
164.7 (C, C-7), 182.1 (C, C-4) (Plate 3b); HPLC: tR  31.290, λmax 268 and 333 nm; HR-
ESIMS(-), m/z 283.0609 [M-H]- (calc. for C16H11O5: 283.0606). 
5,7-Dihydroxy-6,4'-dimethoxyflavone (2.55) was isolated as a green solid. 1H NMR 
(400 MHz, CDCl3): δH 3.89 (3H, s, 4'-OMe), 4.04 (3H,s, 6-OMe), 6.56 (1H, s, H-3), 
6.58 (1H, s, H-8), 7.01 (2H, d , J = 9.0, H-3',5'), 7.83 (2H, d, J = 9.0, H-2', 6'), 13.09 
(1H, s, 5-OH) (Plate 4a); 13C NMR (125 MHz, CDCl3): δC 55.5 (CH3, 4'-OMe), 60.8 
(CH3, 6-OMe), 93.3 (CH, C-8), 103.8 (CH, C-3), 105.7 (C, C-4a), 114.5 (CH, C-3', 5'), 
123.6 (C, C-1'), 128.0 (CH, C-2', 6'), 130.3 (C, C-6), 152.1 (C, C-8a), 153.1 (C, C-5), 
154.9 (C, C-7), 162.6 (C, C-4'), 164.1 (C, C-2), 182.9 (C, C-4) (Plate 4b); HPLC: tR 
31.290, λmax 274 and 333 nm;  HR-ESIMS(-), m/z 313.0714 [M-H]- (calc. for  
C17H13O6: 313.0712) . 
Kaempferol 3-methyl ether (2.56) was isolated as yellow crystals. 1H NMR (400 
MHz, CD3OD): δH 3.79 (3H, s, 3-OMe), 6.23 (1H, d, J = 2.0, H-6), 6.44 (1H, d, J = 2.0, 
H-8), 6.95 (2H, d, J = 8.8, H-3', 5'), 8.00 (2H, d, J = 8.8, H-2', 6') (Plate 5a); 13C NMR 
(125 MHz, CD3OD): δC 60.6 (CH3, 3-OMe), 94.2 (CH, C-8), 98.5 (CH, C-6), 104.5 (C, 
C-4a), 115.2 (CH, C-3', 5'), 121.2 (C, C-1'), 130.0 (CH, C-2', 6'), 138.1 (CH, C-3),  
156.7 (C, C-8a), 157.1 (C, C-2), 160.3 (C, C-4'), 161.7 (C, C-5),  164.5 (C, C-7), 178.6 
(C, C-4) (Plate 5b); HPLC: tR 17.771, λmax 266 and 350 nm; LRMS(-), m/z 299.0721 
[M-H]- (calc. for  C16H12O6: 300.2629). 
13-Epi-labdanolic acid (2.57) was isolated as an off-white solid.  1H and 13C NMR data 
(Table 2.1, Plate 6a and 6b); mp 66-69 °C (lit. 68 °C); [α]D30 +7 (c 1.0, CHCl3) (lit., +5) 




(Ramirez et al., 1998), HR-ESIMS(-), m/z 323.2582 [M-H]- (calc. for C20H35O3: 
323.2586) 
(+)-labdanolic acid (2.62) was isolated as an off-white solid; 1H and 13C NMR data 
(Table 2.1, Plate 8a and 8b); mp 67 °C (lit. 68 °C); [α]D30 +7.3 (c 2.2, CHCl3) (lit., +5) 
(Ramirez et al., 1998) , HR-ESIMS(-), m/z 323.2582 [M-H]- (calc. for C20H35O3: 
323.2586). 
Compound 2.64, light brown solid, was identified as (+)-labdanolic acid methyl 
ester; 1H NMR (400 MHz, CDCl3): δH  0.76 (6H, s, 19 and 20-OMe),  0.84 (3H, s, 18-
OMe), 0.88 (2H, m, H-1, H-5), 0.92 (3H, d, J = 6.7, 16-OMe),  0.99 (1H, t, J = 3.5, H-
9), 1.11 (4H, s, H-3, H-17), 1.38 (6H, m, H-2, H-3, H-7, H-11, H-12), 1.59 (3H, s, H-1, 
H-2, H-6), 1.83 (1H, dt, J = 12.0, 2.9, H-7), 1.92 (1H, m, H-13), 2.09 (1H, dd, J = 14.6, 
8.0, H-14), 2.33 (1H, dd, J = 14.6, 6.1, H-14) (Plate 10a); 13C NMR (125 MHz, CDCl3): 
δC 15.4 (CH3, 20-OMe), 18.5 (CH2, C-2), 19.9 (CH3, 16-OMe), 20.5 (CH2, C-6),  21.4 
(CH3, 19-OMe), 22.4 (CH2, C-11), 23.9  (CH3, 17-OMe), 31.1 (CH, C-13), 33.2 (C, C-
4), 33.4 (CH3, 18-OMe), 39.1 (C, C-10), 39.7 (CH2, C-1), 40.3 (CH2, C-12), 41.2 (CH2, 
C-14), 41.9 (CH2, C-3), 44.4 (CH2, C-7), 56.1 (CH, C-5), 61.9 (CH, C-9), 74.1 (C, C-8), 
173.9 (C, C-15) (Plate 10b); mp 71-73 °C (lit. 72-74 °C); [α]D28 + 9.5 (c 16.4), CHCl3) 
(lit., [α]D22 +10, c 2.03) (Henrick et al., 1964) LRMS(+), m/z 361.2633 [M+Na]+ (calc. 
for C21H38O3Na: 361.5246). 
Compound 2.66 was identified as (+)-labdanediol; 1H NMR (400 MHz, CDCl3): δH 
(6H, s, 19, 20-OMe), 0.86 (3H, s, 18-OMe), 0.92 (5H, d, J = 6.8, H-1a, 5, 16-OMe), 
1.03 (1H, t, J = 3.7, H-9), 1.15 (4H, s, H-3a, 17-OMe), 1.26 (4H, s, H-6a, H-11a), 1.38 
(6H, m, H-2a, 3, 7a, 11b, H-14), 1.61 (9H, m, H-1b, 2b, 6b, 12, H-13), 1.85 (1H, dt, J = 
12.3, 3.0, H-7b), 3.68 (2H, m, H-15) (Plate 11a); 13C NMR (125 MHz, CDCl3): δC 15.4 
(CH3, 20-OMe), 18.5 (CH2, C-2), 20.0 (CH3, 16-OMe), 20.6 (CH2, C-6), 21.5 (CH3, 19-
OMe), 22.3 (CH2, C-11), 24.1 (17-OMe), 30.1 (CH, C-13), 33.2 (C, C-4), 33.4 (CH3, 
18-OMe), 39.2 (C, C-10), 39.3 (CH2, C-12), 39.8 (CH2, C-1), 40.5 (CH2, C-14), 42.0 
(CH2, C-3), 44.6 (CH2, C-7), 56.2 (CH, C-5), 61.3 (CH2, C-15), 61.9 (CH, C-9), 74.4 
(C, C-7) (Plate 11b),  [α]D28 +12 (c 0.4), CHCl3) (lit., [α]D22 +10, c 2.03) (Dawson et al., 
1966); HR-ESIMS(-), m/z 307.2798 [M-H]- (calc. for  C20H37O2: 307.2794) . 




2.8.5 Synthesis of p-bromophenacyl ester of (+)-13-epi-
labdanolic acid (2.61) 
 
A mixture of 13-epi-labdanolic acid (176 mg, 0.544 mmol), p-bromophenacyl bromide 
(151 mg, 0.544 mmol) and triethylamine (0.114 mL) was stirred in N,N-
dimethylformamide (5 mL) at 70 °C for 4 hours. The resulting mixture was extracted 
with diethyl ether and washed with HCl (0.1 M). The main product was purified by 
column chromatography using Hex-EtOAc (8:2) to yield an off-white sticky white solid 
of p-bromophenacyl ester of 13-epi-labdanolic acid (0.271 mmol, 49%). 
Recrystallization of this ester (2.61) from chloroform-hexane (1:1) afforded white 
needle-like crystals. 
1H NMR (400MHz, CDCl3): δH  0.79 (6H, s, 19, 20-OMe),  0.86 (3H, s, 18-OMe), 0.92 
(2H, m, H-1a, H-5), 1.02 (4H, m, J = 6.8, H-9, 16-OMe), 1.15 (4H, s, H-3a, H-17), 1.26 
(3H, m, H-6a, 11a), 1.41 (6H, m, H-2a, H-3b, H-7a, H-11b, H-12), 1.64 (3H, m, H-1b, 
H-2b, H-6b), 1.86 (1H, dt, J = 12.2, 3.1, H-7), 2.05 (1H, m, H-13), 2.27 (1H, dd, J = 
14.9, 7.9, H-14a), 2.55 (1H, dd, J = 14.9, 6.2, H-14), 5.27 (1H, s, H-21a), 5.28 (1H, s, 
H-21b), 7.63 (2H, d, J25,24 = 8.5, H-25, 27), 7.77 (1H, d, J = 8.5, H-24, 28) (Plate 7a) ; 
13C NMR (100 MHz, CDCl3): δC 15.5 (CH3, 20-OMe), 18.5 (CH2, C-2), 19.9 (CH3, 16-
OMe), 20.6 (CH2, C-6),  21.5 (CH3, 19-OMe), 22.1 (CH2, C-11), 23.9  (CH3, 17-OMe), 
30.9 (CH, C-13), 33.2 (C, C-4), 33.4 (CH3, 18-OMe), 39.1 (C, C-10), 39.7 (CH2, C-1), 
40.0 (CH2, C-12), 40.8 (CH2, C-14), 41.9 (CH2, C-3), 44.5 (CH2, C-7), 56.1 (CH, C-5), 
62.0 (CH, C-9), 65.6 (CH2, C-21), 74.2 (C, C-8), 129.1 (C, C-23), 129.3 (CH, C-25, 
27), 132.2 (CH, C-24, 28), 132.9 (C, C-26), 172.8 (C, C-15), 191.5 (C, C-22) (Plate 7b); 
HR-ESIMS(+), m/z 543.2076 [M+Na]+ (calc. for C28H41O4NaBr: 543.2086) 
Crystal Data 
Formula C28H41BrO4 
Cell setting Monoclinic 
Space group P21 
Mr (g/mol) 521.18 




a/Å   8.0014 (2) 
b/Å   10.9459 (3) 
c/Å   15.2268 (3) 
α/°  90.00 
β/°   97.9420 (10) 
γ/°  90.00 
T/K  100 
Z  2 
V/Å3  1320.81 
 
2.8.6 Synthesis of p-bromophenacyl ester of (+)-labdanolic acid 
(2.63) 
 
The mixture of (+)-labdanolic acid (54 mg, 0.166 mmol), p-bromophenacyl bromide 
(46.3 mg, 0.166 mmol) and triethylamine (0.0347 mL) was stirred in N,N-
dimethylformamide (5 mL) at 70 °C for 4 hours.  The mixture was extracted with 
diethyl ether and washed with HCl (0.1 M). The main product was purified by a 
chromatotron using Hex-EtOAc (8:2) to obtain an off-white sticky white solid of p-
bromophenacyl ester of (+)-labdanolic acid (27.4 mg, 32%). Recrystallization of this 
ester (2.63) from CHCl3-Hex (1:1) afforded white needle-like crystals. 
1H NMR (400 MHz, CDCl3): δH 0.79 (6H, s, 19, 20-OMe), 0.86 (3H, s, 18-OMe), 0.92 
(2H, m, H-1a, H-5), 1.02 (4H, m, J = 6.8, H-9, 16-OMe), 1.15 (4H, s, H-3a, H-17), 1.26 
(3H, m, H-6a, 11a), 1.41 (6H, m, H-2a, H-3b, H-7a, H-11b, H-12), 1.59 (3H, m, H-1b, 
H-6b), 1.86 (1H, dt, J = 12.2, 3.1, H-7), 2.01 (1H, m, H-13), 2.34 (1H, dd, J = 14.7, 7.3, 
H-14a), 2.46 (1H, dd, J = 14.7, 6.2, H-14), 5.26 (1H, s, H-21a), 5.29 (1H, s, H-21b), 
7.63 (2H, d, J  = 8.5, H-25, 27), 7.77 (1H, d, J = 8.5, H-24, 28) (Plate 9a); 13C NMR 




(100 MHz, CDCl3): δC 15.5 (CH3, 20-OMe), 18.5 (CH2, C-2), 19.9 (CH3, 16-OMe), 
20.5 (CH2, C-6), 21.5 (CH3, 19-OMe), 22.9 (CH2, C-11), 23.9 (CH3, 17-OMe), 31.5 
(CH, C-13), 33.2 (C, C-4), 33.4 (CH3, 18-OMe), 39.7 (C, C-1), 40.6 (CH2, C-10), 41.3 
(CH2, C-12), 42.0 (CH2, C-14), 44.3 (CH2, C-3), 53.4 (CH2, C-7), 56.1 (CH, C-5), 62.5 
(CH, C-9), 65.6 (CH2, C-21), 74.2 (C, C-8), 129.1 (C, C-23), 129.3 (CH, C-25, 27), 
132.2 (CH, C-24, 28), 132.9 (C, C-26), 172.6 (C, C-15), 191.6 (C, C-22) (Plate 9b); 






















The onset of labour process during pregnancy has been reported as the main cause of 
maternal and perinatal deaths in developed countries. It is reported that 28% of the 4 
million annual neonatal deaths are due to pre-term births. On the other hand, delayed 
labour processes are also associated with some neonatal deaths. Therefore, in some 
cases, induction of labour is required. These are cases such as post-term pregnancy, lack 
of progress, oligohydramnios and suspected intrauterine growth restriction, where drugs 
with uterotonic properties are normally used.  
Uterotonic drugs are involved in the modulation of uterine muscle contractions at 
labour, resulting in uterine stimulation. These drugs are divided into three 
pharmacological groups, namely, ergot alkaloids, oxytocins and prostaglandins (Gruber 
and O’Brien, 2011). Ergot alkaloids were the first drugs to be used for their uterotonic 
properties. The first alkaloid with contractile activity was described in 1582 from the 
fungus Claviceps purpurea (commonly known as secale cornutum).  
Unfortunately ergot alkaloids were always associated with maternal and fetal deaths. As 
a result, the use of secale cornutum was halted in 1828. After this, various alkaloids 
were described, the most important being ergometrine (3.1) and methylergometrine 
(3.2) (den Hertog et al., 2001). Ergometrine was isolated from Claviceps purpurea by 
Dudley and Moir in 1932 and was described to be uterine specific and showed less 
vasospatic properties (Vigneaud et al., 1953). Even though these alkaloids were useful 
in the prevention of post-partum haemorrhage, their use was limited by severe side 
effects such as hypertension, nausea, vomiting and maternal death. Ergot alkaloids were 
unstable when exposed to heat, light and humidity, and this further restricted their use 
(de Groot et al., 1998; den Hertog et al., 2001; Van Dongen and de Groot, 1995).
















3.2         
Oxytocin, an endogenous mammalian cyclopeptide discovered by Sir Henry Dale in 1909, 
was confirmed to have uterine contractility and milk-ejecting activities. Dale (1909) also 
concluded that oxytocin was a hormone of the hypothalamus originating from the posterior 
pituitary gland (Dale, 1909; Wathes and Swann, 1982). Later (1953), oxytocin was 
described as a polypeptide, and an octapeptide 3.3 with the hormonal activity of oxytocin 
was synthesised (du Vigneaud et al., 1953; Vigneaud et al., 1953). The octapeptide 
oxytocin (3.3) is used as a WHO standard drug for prevention of post-partum haemorrhage 
(PPH) (den Hertog et al., 2001).  In humans, oxytocin and the closely related vasopressin, 
act on four cognate receptors (oxytocin and three vasopressin receptors). These all belong 
to the family of G protein-coupled receptors (GPCR). GPCR are the most promising targets 
for a drug with about 30% of all marketed drugs acting on them (Gruber and O’Brien, 
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Prostaglandins have been used to augment labour and cervix ripening since the 1960’s. 
Prostaglandins are members of the eicosanoid family of compounds naturally produced by 
the uterus, fetal membrane and placenta. The concentration of these compounds increases 
during the onset of labour and their direct involvement in the parturient process at term and 
preterm labour has been studied (Keelan et al., 2003; Mitchell et al., 1995). Synthetic 
prostaglandins play an important role in the ripening of cervix and labour initiation during 
childbirth. Dinoprostone (3.4) and misoprostol (3.5) (Cytotec®) are the two most 
commonly used and commercially available prostaglandin analogues. Dinoprostone, which 
can be obtained as a vaginal insert (Cervidil®) and a cervical gel (Prepidil®), is approved by 
the FDA for cervical ripening and induction of labour. Dinoprostone has been less popular 
in low resource settings as a result of its high costs and special storage conditions 













3.5                          
 Misoprostol (3.5) is approved by the FDA for the treatment and prevention of 
gastrointestinal and peptic ulcers; however it is used off-label for the facilitation of cervix 
ripening and stimulation of labour in obstetric and gynaecological procedures. This drug 
has gained popularity as an uterotonic agent since it is cheap, heat stable, and orally active.  
It has been discovered recently that the optimal dosage for misoprostol is 25 mg and that 
the oral administration route reduces risks of uterine hyperstimulation when compared to 
the vaginal route. Kundodyiwa et al. (2009) reported that even the 25 mg optimal dosage 
results into a 6% hyperstimulation rate (Bracken et al., 2014; Hofmeyr et al., 2009; 
Kundodyiwa et al., 2009; Shetty et al., 2001a).   
It is clear from the above discussion that the available uterotonic drugs may lack potency 
and  selectivity, and therefore result to harmful side effects to the mother and the baby 
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(Attah et al., 2012; Gruber and O’Brien, 2011). Traditional plants have been used for many 
years by local communities to induce or enhance the labour process during child birth. 
Their uses are well documented in countries such as Argentina, China, Indonesia, Mexico, 
Ethiopia, South Africa, northern America and central Europe (Attah et al., 2012; Gruber 
and O’Brien, 2011). In South Africa, approximately 80% of pregnant women from Zulu 
and Xhosa populations use traditional medicines (Gruber and O’Brien, 2011; Lindsey et 
al., 1998; Varga and Veale, 1997). The chemical profiles as well as toxic effects of many 
oxytocic plants have been reported.  
 
3.2 Non-South African oxytocic plants 
 
Herbal remedies used for pregnancy related ailments are becoming increasingly popular 
amongst various cultures worldwide. For most populations, this interest in traditional 
medicine is due to their accessibility and affordability. The majority of African people rely 
on these remedies because of cultural beliefs, superstitions, circumstantial constraints or a 
combination of these (Kaido et al., 1997). Some examples of oxytocic plants used in 
various regions around the world, including Southeast Asia, China, Mexico, North 
America, Honduras, India, Congo, Nigeria, and Uganda are presented below.  
People of low socioeconomic status in the countries in the Southeast Asia region still rely 
on traditional medicine for their health care needs. Women most frequently use herbal 
medicines for various health issues, including birth-related ailments, menstrual related 
disorders, and post-natal issues (post-partum bleeding, lactation increase or decrease). In a 
recent review, Leonurus japonicas and Ricinus communis received over 20 species-use 
reports from the Southeast Asia countries for their induction of labour (de Boer and 
Cotingting, 2014).  
L. japonicas (Lamiaceae) is also traditionally used to treat haemorrhage disorders, and the 
leaves extracts were found to be analgesic and anti-inflammatory (Wang et al., 2009), 
reduce PGF2-α and PGE2 concentrations and increase levels of progesterone (Jin et al., 
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2003). Other species related to L. japonicas, for instance L. artemisia and L. heterophyllus 
(known as Yi-Mu-Cao), have also been used for hundreds of years in Chinese traditional 
medicine for the initiation and enhancement of labour (Chen and Kwan, 2001). The 
uterotonic activity of these Leonurus herbs was attributed to an alkaloid (leonurine, 4-
guanidino-n-butyl syringate) (3.6) isolated from the fresh and dried leaves extracts (Kong 
et al., 1976). Together with uterotonic action, Leonurus herbs exhibit anti-apoptotic, anti-
oxidant, anti-inflammatory, anti-platelet aggregation effects, inhibitory action on pulsating 
myocardial cells and vasorelaxant activity (Chen and Kwan, 2001; Liu et al., 2012; Sun et 










Ricinus communis (Euphorbiaceae) is used to ease delivery and reduce labour pains, induce 
labour, expel the placenta, and help the mother recover from the birthing process. Castor 
oil, derived from the seeds of this plant, increases contractions on isolated human 
myometrium (O'Sullivan et al., 2010), and induced labour and cervical ripening in pregnant 
rats (Gao et al., 1999; Gao et al., 1998). It is reported that a castor oil metabolite (ricinoleic 






Women from Mexico use Montanoa tomentosa (Asteraceae) for its contraceptive effect 
and to facilitate labour and child birth. Twenty different compounds have been isolated 
from M. tomentosa, but of particular interest are the three uterotonic tetracyclic diterpenes 
[kaurenoic acid (3.8), grandiflorenic acid (3.9) and monoginoic acid (3.10)] isolated from 
the roots (Villa-Ruano et al., 2009). Kaurenoic and grandifloric acids were also isolated 
from the leaves of M. tomentosa (Villa-Ruano et al., 2009) and from various other plants 
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such as Aspilia mossambicensis (Asteraceae) (Page et al., 1992). Aspilia species in 
Tanzania are consumed by wild chimpanzees. Interestingly, they are more frequently 
consumed by female chimpanzees compared to males, which may be explained by the 






3.8 R = H




              
Medicinal herbs are used by pregnant women in North America to tone the uterus, prevent 
miscarriage and to induce labour. Some common tonic herbs used are Rubus idaeus 
(raspberry leaf) (Rosaceae), Mitchella repens (partridge berry) (Rubiaceae) and Urtica 
dioica (stinging nettle) (Urticaceae) (Westfall, 2001). The highly nutritious tea prepared 
from fresh raspberry leaves is taken for toning the uterus and this tea is also known to 
prevent miscarriage. The active compound was isolated from the leaves in 1941 and was 
characterised as an alkaloid (fragarine). Other compounds identified from raspberry 
(tannins, polypeptides and flavonoids) have been linked to the astringent, stimulant and 
soothing properties of this plant (Burn and Withell, 1941; Westfall, 2001; Whitehouse, 
1941).  
Caulophyllum thalictroides (blue cohosh) (Berberidaceae) became popular in North 
America around 1800 for inducing labour as well as stimulating menstrual flow. This plant 
is still popular today in western and African American folk medicine and is commercially 
available as tinctures or tablets. Several alkaloids and saponins have been isolated from C. 
thalictroides (El Tahir, 1991; Flom et al., 1967; Power and Salway, 1913; Rader and 
Pawar, 2013). In a recent study that focused on the quantification of major alkaloids and 
saponins in a blue cohosh dietary supplement, magnoflorine (3.11), baptifoline (3.12), 
anagyrine (3.13), N-methylcytisine (3.14), leonticin D (3.15), cauloside G (3.16) and 
cauloside D (3.17) were identified as major constituents (Rader and Pawar, 2013). 
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Magnoflorine (3.11) stimulated contractions on isolated rat uterus and isolated guinea pig 













3.12  R= OH












 R1                  R2              R3 
3.15    α-L-Ara                                    α-L-Rha (1      4)-β-D-Glc (1        4) - β-D-Glc         OH 
3.16    β-D-Glc(1        2)- α-L-Ara-    α-L-Rh (1      4)-β-D-Glc(1       4)- β-D-Glc                        H 
3.17    α-L-Ara       α-L-Rha (1      4)-β-D-Glc (1        4) - β-D-Glc         OH 
 
Ticktin et al. (2005) conducted a survey on the use of medicinal plants for various 
complications during childbirth by Honduras midwives. Citrus aurantifolia (lime tree) 
(Rutaceae) was by far the most frequently mentioned plant out of the sixteen plants used to 
accelerate contractions during labour. The root decoction from the lime tree is taken orally 
(one-half cup) during labour and this plant is also used for its uterotonic activity by the 
Arunachal Pradesh tribe (India) and Kenyah Leppo’Ke tribe (Indonesia) (Ticktin and Dalle, 
2005).  
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Oldenlandia affinis DC (Rubiaceae) have been used for its oxytocic effects since the 
1960’s by Lulua women (Kasai in Congo), as well as women from the Central African 
Republic. Dried leaves from this plant are used to prepare tea, which is sipped and applied 
to the vagina during labour to facilitate delivery. Gran (1973) isolated two polypeptides 
(kalata B1 and B2) from the leaves of O. affinis. In this study, the major peptide (kalata B1) 
(Fig. 3.1) was found to induce in vitro uterine muscle contractions on isolated rat, rabbit 
and human uteri strips. Recently, kalata B1, B2 and B7 were re-isolated from O. affinis and 
their uterotonic activities were confirmed (Gran et al., 2008; Gruber and O’Brien, 2011).    
 
Figure 3.1: Three-dimensional structure of cyclotides kalata B1 (Saether et al., 1995) 
Kalata B1 sequencing : Cyclo(L-arginyl-L-asparaginylglycyl-L-leucyl-L-prolyl-L-valyl-
L-cysteinylglycyl-L-a-glutamyl-L-threonyl-L-cysteinyl-L-valylglycylglycyl-L-threonyl-L-
cysteinyl-L-asparaginyl-L-threonyl-L-prolylglycyl-L-cysteinyl-L-threonyl-L-cysteinyl-L-
seryl-L-tryptophyl-L-prolyl-L-valyl-L-cysteinyl-L- threonyl), cyclic(7-21 ), (11-23), (16-
28)-tris(disulfide). 
 
A majority of Nigerians in rural areas still rely on the use of traditional herbs to tone the 
uterus muscle, induce labour, in the removal of placenta and the management of post-
partum haemorrhage. Attah et al. (2012) recently analysed the in vitro uterine contractility 
of nine plant species used in Nigerian traditional medicine. All tested plant extracts elicited 
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a significant increase in the uterine smooth muscle cell contractility; however, the highest 
increase was observed for Commelina africana (Commelinaceae), Sida corymbosa 
(Malvaceae) and Vernonia amygdalina (Asteraceae) (Attah et al., 2012). C. africana and S. 
corymbosa are also used in Tanzanian traditional medicine for abortion, and their 
uterotonic activities were reported by Nikolajsen and co-workers (Nikolajsen et al., 2011).  
Bullough and Leary (1982) documented the first report on the use of V. amygdalina leaf 
extract to induce uterine motility and prevent post-partum haemorrhage by Malawian 
women. Further reports proving the oxytocic property of the aqueous extracts were 
provided by Kamatenesi-Mugisha (2004), Kamatenesi-Mugisha et al. (2005), and recently 
by Ijeh et al. (2011). In the former study, the contractility effect of the leaf extract was 
observed on rabbit jejunum, while there was an increase in the rat uterine motility. The 
latter study was conducted on guinea pig and an increase in the uterine smooth muscle 
contractions amplitudes was similar to that of ergometrine. However, uterine contraction 
amplitudes observed when mammary isolated uterus was used, were lower than 
ergometrine (Bullough and Leary, 1982; Ijeh and Ejike, 2011; Kamatenesi-Mugisha, 2004; 
Kamatenesi-Mugisha et al., 2005). 
Approximately 90% of the Ugandan population, with the highest portion being women and 
children, rely on traditional medicine for day-to-day health care needs. Medicinal plants 
used to increase uterine contractions are commonly used, and about seventy-five uterotonic 
plants used in the Busheyi and Kasese districts of Western Uganda have recently been 
documented (Kamatenesi-Mugisha et al., 2007). Some of the plants cited in this survey 
have the potential to contain potent compounds, since they are used also in other parts of 
Uganda and other countries to induce labour. For example, Bidens pilosa (Asteraceae) (one 
of the plants cited in this survey) is also used in Rwanda and its methanol extract showed 
weak stimulating effect on the guinea pig uterine contractions (Chagnon, 1984). Another 
plant used in both Uganda and Rwanda is Tetradenia riparia (Iboza) (Lamiaceae). Goto et 
al. (1957) reported that the water-methanol extract from T. riparia caused a weak 
stimulation of the guinea pig uterus and ileum smooth muscle contractions (Goto et al., 
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1957). The use of Erlangea cordifolia (Asteraceae) to augment labour during childbirth is 
reported in Uganda, as well as in Kenya (Kamatenesi-Mugisha et al., 2007; Mugo, 1977).   
 
3.3 South African oxytocic plants 
 
Veale et al. (1992) conducted a literature survey on the ethnic background, traditional uses 
and potential toxicity of traditional herbal remedies used by South African (SA) women as 
antenatal medication or to induce labour. Findings from this study revealed that around 57 
plants are used during pregnancy and childbirth in SA (Veale et al., 1992).  The Zulu and 
Xhosa traditional healers prepare an aqueous root extract decoction using a combination of 
a minimum of four oxytocic plants. This herbal drink, commonly known as isihlambezo is 
reported to be used by ca. 80% of Zulu and Xhosa women and is orally taken in the last 
trimester of pregnancy. Isihlambezo is taken to ensure good health of the mother and the 
foetus, preventing long and complicated labour, and is believed to protect the baby against 
evil spirits (Varga and Veale, 1997; Veale et al., 1998).  
Some herbal remedies (imbelekisane, inembe and imbiza) also used in Zulu and Xhosa 
cultures are closely related to and have been confused with isihlambezo. Imbelekisane is 
orally or administered as an enema in cases of prolonged and difficult labor. Inembe is 
normally taken as an arbortifacient, and its ingredients include Triumfetta rhomboidea 
(Jacq.) (Malvaceae), Gunnera perpensa L. (Gunneraceae), Rhoicissus tridentata subsp. 
cunefolia (Vitaceae) and Cyphostemma natalitium (Szyszyl.) J.v.d. Merwe (Vitaceae). A 
herbal medicine administered as a drink, emetic, or vaginal douche, with laxative effects is 
named Imbiza. Imbiza is believed to cleanse the uterus thus preparing it to accept the fetus 
(Varga and Veale, 1997; Veale et al., 1998).  
The combination of plants used in the preparation of isihlambezo varies from village and 
from person to person, however, some plants are quoted more than others (Varga and 
Veale, 1997). Some of the most commonly cited species together with the isolated 
uterotonic compounds and their mode of actions are shown in Table 3.1. Although the 
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plants listed here have been thoroughly studied for their biological activities, the activity of 
other frequently used plants such as Scadoxus puniceus (Amaryllidaceae), Crinum sp. 
(Amaryllidaceae), Typha capensis (Typhaceae) and Vernonia neocorymbosa Hilliard 
(Asteraceae) are not yet fully understood. The active principles of most of these plants have 
not been identified.  Examples of isolated uterotonic compounds are shown in Figure 3.2. 
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Uterotonic activity on isolated rat 
uterus and ileum, extract possess 
agonistic activity of uterus 
muscarinic receptors and promoted 
prostaglandin synthesis 
(Kaido et al., 
1997; Veale 
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Z-venusol (3.26) Extract stimulated direct contractile 
response of the uterus smooth 
muscle, pure venusol showed no 
effect but after its removal, the tissue 
experienced a state of spontaneous 
contractility 
(Kaido et al., 
1997; Khan 
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 Uterus and ileum showed direct 
contractile response which may be 
due to the activation of muscarinic 
receptors and cyclooxygenase 






























3.23 R = H





























Figure 3.2: Structures of uterotonic compounds isolated from some oxytocic plants. 
Structures shown are of linoleic acid (3.18), 5-hydroxymethyl-2-furancarboxaldehyde 
(3.19), oleanolic acid (3.20), 3-epi-oleanolic acid (3.21), β-sitosterol (3.22), combretastatin 
B-1 (3.23), 2'-O-β-D-glucopyranoside of combretastatin B-1 (3.24), 2'-O-β-D-
glucopyranoside of combretastatin A-1 (3.25), Z-venusol (3.26) and coniferaldehyde 
(3.27). 
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The aqueous extract of the leaves from Agapanthus africanus showed uterotonic effects on 
both isolated rat uterus and ileum, and the mode of action of this extract is well understood 
(Kaido et al., 1997). Pure active principles have not yet been reported, but some 
compounds isolated from this plant are yuccagenin (3.28), sapogenin agapanthagenin 
(3.29), 7-dehydroagapanthagenin (3.30), 8(14)-dehydroagapanthagenin (3.31) and 9(1l)-
































Asclepias fructicosa leaves and stem extracts are very rich in steroidal glycosides. Several 
of the isolated glycosides are of the pregnane and cardenolide types. Examples of major 
glycosides from leaves are uscharin (3.33), 3'-epigomphoside 3'-acetate (3.34), and 3'-
epiafroside 3'-acetate (3.35). Afroside (3.36) was isolated as a major constituent from the 
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stem of A. fructicosa (Cheung et al., 1983). Another type of glycosides isolated from this 
plant is the megastigmane glycosides. (6S,9R)-Roseoside (3.37) and ascleposide A (3.38) 















                   
Besides uterotonic activity, Clivia miniata was reported as one of the most active antiviral 
plants in the Amaryllidaceae family. The alkaloid lycorine (3.39), isolated as a major 
compound from the polar fractions of leaves or roots showed antiviral activity against 
semliki forest, herpes simplex and poliomyelitis viruses (Ieven et al., 1982). Another major 
alkaloid, clivimine (3.40), together with clivonine (3.41) and cliviamartine (3.42) were also 
isolated. Alkaloids 3.40-3.42 did not show any antiviral effects, and have not been linked to 

















































































































           
Apart from Z-venusol; small quantities of succinic acid, lactic acid, 1,1'-biphenyl-4,4'-
diacetic acid, methyl lespedezate (3.43), ellagic acid (3.44), the trimethyl ether of ellagic 
acid glucoside (3.45), p-hydroxybenzaldehyde and β-sitosterol (3.22) were isolated from 
the dry rhizomes of Gunnera perpensa (Brookes and Dutton, 2007; Khan et al., 2004). 
Brookes and Dutton (2007) also partially characterized two uteroactive phenolic glycosides 
(named A and B) from G. perpensa extracts. These glycosides showed greater uterotonic 
activity than the water and methanol extracts by increasing the response of the uterus to 
acetylcholine over a full range of concentrations tested. G. perpensa is also used for the 














3.44 R = H
3.45 R = -D-glc                         
 
In a phytochemical investigation of Combretum kraussii, four pure uteroactive compounds 
(Table 3.1), as well as combretastatin A-1, ellagic acid (3.44) and trimethyl ethers of 
ellagic acid (3.45) were isolated. Two uteroactive phenolic glycosides were also partially 
characterized from the root extracts. These glycosides exhibited the highest uteroactivity 
when compared to the other compounds isolated from this plant (Brookes et al., 1999). 
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The phytochemistry of Pentanisia prunelloides has not been extensively studied, and only 
two compounds have been isolated from this plant. (-)-Epicatechin was obtained from the 
polar extract, while palmitic acid was identified as a major constituent of the non-polar 
extract.  Recent quantification studies showed that there is 2.29 µg (-)-epicatechin)/g of dry 
MeOH extract and 0.26 µg/g dry aqueous extract of P. prunelloides (Mpofu et al., 2014; 
Yff et al., 2002). 
  
Brookes et al. (2006) studied the phytochemistry of Rhoicissus tridentata. A hydrogel 
polymer of glucose, which stimulated uterine muscle contractions from low to maximal 
concentrations of acetylcholine, was partially characterised. The uteroactive oleanolic acid 
(3.20) was purified from the chloroform extract of the roots and branches in this study. 
Compound 3.20 was also isolated from Ekebergia capensis and Grewia occidentalis (Table 
3.1). β-Sitosterol (3.22) and its glucoside, sitosterolin, were also isolated and they showed 
slight oestrogenic activity causing an increase in the uterine muscle contractility at low 
acetylcholine concentrations. The uterine response was inhibited at maximum 
concentrations of acetylcholine (Brookes and Katsoulis, 2006). 
An investigation of the hexane extract of the rhizomes of Typha capensis led to the 
isolation of two new compounds, typhaphthalide (3.46) and typharine (3.47), as well as 
sitosterol, afzelechin, epiafzelechin, (+)-catechin and (-)-epicatechin (Shode et al., 2002). 
Some of the compounds (afzelechin and epiafzelechin) isolated from T. capensis 
demonstrated antibacterial activities in previous studies, but the uteroactive principles are 
not known (Masoko et al., 2008; Xie and Dixon, 2005).  









3.46 3.47  
In the Tswana population, traditional remedies used in pregnancy are known as kgaba. 
Similarly to isihlambezo, kgaba is taken from the last three months to protect against evil 
and harm, to hastened prolonged labour, and to augment labour when overdue. In a study 
carried out by Kooi (2006), several traditional healers from Mogwase district, North West 
Province revealed that about 18 plants are used in the preparation of kgaba and one of the 
most frequently used is R. tridentata (known as kgaba etona in this region). Some other 
items, for instance, ostrich eggshell, baboon urine and mud of wasp, have been reported to 
stimulate labour amongst Tswana population. Plants with uterotonic activity are sometimes 
mixed with these items, and these plants are burnt and their ashes used with blessed water 
in churches (Van der Kooi and Theobald, 2006). 
 
3.3.1 Toxicity of some South African oxytocic plants 
 
Humans have known for a long time that some plants are toxic. They would use these 
poisonous plants for hunting, war, rituals, murder, suicide, abortions and euthanasia. Some 
research groups who have focused on identifying the toxic principles in plants, have also 
shown that most of the toxic chemicals tend to have medicinal properties at lower 
concentrations. In South Africa, the toxicity of some plants used in isihlambezo preparation 
has been investigated. Yuccagenin and agapanthagenin isolated from the rhizomes of 
Agapanthus africanus caused gastrointestinal track and kidney problems (Ndhlala et al., 
2013).  
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Cardiac glycosides, such as those isolated from Asclepias fructicosa (Apocynaceae), are 
known for their toxic effects on gastro-intestinal, respiratory and nervous system resulting 
to neuromuscular disorders and death (due to cardiotoxic effects) (Kellerman et al., 1988). 
A recent review has been published covering the ethnopharmacology and toxicology of 
Amaryllidaceae alkaloids. It was concluded in this review that although several interesting 
biological activities are shown by Amaryllidaceae plants, they must be used cautiously 
because of the toxicity of their alkaloids. Members of this family used during pregnancy 
and which have shown potential toxicity are Clivia miniata, Scadoxus puniceus, and 
Crinum bulbispermum (Nair and van Staden, 2013; Ndhlala et al., 2013).  
Brookes et al. (2003) studied the cytotoxicity of the aqueous extracts from R. tridentata, G. 
perpensa and C. kraussii using human fibroblast, monkey vero, and human hepatoma cells. 
R. tridentata extracts had been previously associated with a number of deaths as a result of 
central nervous system depression and respiratory failure (Brookes and Smith, 2003). Some 
species from Combretaceae are considered as toxic. In Zimbabwe, 5 women died after the 
vaginal insertion of powdered root material from C. erythrophyllum, while C. kraussii 
butanol extracts showed toxicity to brine shrimps (Rogers and Verotta, 1996).   
Brookes (2003) found that the threshold (concentration at which 100% cells survived) for 
zero monkey vero and human cell death was 250 µg/mL (G. perpensa), 67 µg/mL (C. 
kraussii) and 8 µg/mL when R. tridentata was used. The blood stream concentration of 
these extracts were then estimated (taking dilutions into account) to be 4.6 µg/mL for G. 
perpensa, 8.9 µg/mL for C. kraussii and 6.1 µg/mL for R. tridentata. It was then concluded 
that the three extracts used in this study were not toxic at cellular level since all the 
estimated cell concentrations were below the thresholds for zero cell death (Brookes and 
Smith, 2003). However, traditional healers must be cautions with the dosage of R. 
tridentata as this plant showed the lowest threshold. There are some claims that R. 
tridentata may result into uterine hyperstimulation. Proanthocyanidins, which are found in 
higher concentrations in summer than winter, have been associated with hyperstimulation. 
The concentration of these polyphenolic compounds is also reported to vary from one 
CHAPTER 3: The Phytochemistry of Rhoicissus tridentata 
91 
 
location to the next (Brookes and Katsoulis, 2006). Therefore, dosage is an important factor 
to consider when this plant is used.  
It is clear from the above discussion that plants are used worldwide for pregnancy-related 
disorders. But, the phytochemistry of most of these plants has not yet been studied. 
Moreover, there are several claims concerning the toxicity of these medicinal plants. To 
minimise the toxicity risks of isihlambezo (or any other herbal remedy), correct 
identification of the species, knowledge of the chemical constituents of the plant, as well as 
proper dosages must be taken into account. Therefore, more research is needed to study the 
phytochemistry of oxytocic plants. In this research we focused on a South African 
indigenous oxytocic plant, Rhoicissus tridentata. 
 
3.4 Genus Rhoicissus 
3.4.1 Introduction 
 
The genus Rhoicissus Planch. consists of around 12 to 22 species distributed in the 
Afrotropical zone of Africa, south of Sahara desert, southern and eastern parts of Arabian 
Peninsula, Madagascar, south-western Pakistan and the Islands of western Indian Ocean 
(Chen and Manchester, 2007). The distribution of Rhoicissus species is shown in Figure 
3.3. Rhoicissus belongs to the family Vitaceae. Vitaceae, also known as the grape family, is 
amongst the smallest flowering plant families with about 14 genera and 900 species. The 
largest genera in this family are Cissus L. and Cyphostemma (Planch.) Alston, with ca. half 
of the species belonging to these genera (Chen and Manchester, 2007; Soejima and Wen, 
2006).  
Rhoicissus is one of the smallest genera in the family (Nalule et al., 2012; Nie et al., 2010; 
Soejima and Wen, 2006). As mentioned above, Rhoicissus occur naturally in South Africa. 
Other genera of natural origin in South Africa are Ampelocissus, Catratia, Cissus and 
Cyphostemma. Ampelopsis, Parthenocissus and Vitis, are cultivated in South Africa. In 
CHAPTER 3: The Phytochemistry of Rhoicissus tridentata 
92 
 
addition to South Africa, Vitaceae plants are found in the tropical regions of Asia, 
Australia, neotropics, Pacific Islands and other African countries. Vitis, Parthenocissus and 
Ampelopsis normally occur in the temperate regions (Chen and Manchester, 2007; Naude, 
2012; Nie et al., 2010; Soejima and Wen, 2006). 
 
Figure 3.3: Distribution of Rhoicissus. 
(Map: http://www.discoverlife.org/mp/20q?search=Rhoicissus) 
Rhoicissus species, together with other Vitaceae members, are mostly twining vines, but 
small trees and shrubs also exist. Other characteristic features are (a) the alternating simple 
or compound leaves, which are often palmately or stipulate lobed, veined or course teeth, 
(b) tendrils (modified shoots or inflorescences sometimes ending in disk like suckers) 
opposite the leaves, (c) small unisexual, bisexual or actinomorphic flowers growing as 
determinate or indeterminate inflorescences and (d) a berry fruit (Chen and Manchester, 
2007; Gerrath et al., 2004; Naude, 2012; Nie et al., 2010; Soejima and Wen, 2006). 
There are no reports on the economic significance of Rhoicissus plants, however members 
of the sister genera, Vitis and Parthenocissus, are of high economic value worldwide. 
Examples of the economically important species are Vitis vinifera, Parthenocissus 
quinquefolia and P. tricuspidata. Table grapes are obtained from V. vinifera (wine grape) 
and these are used to produce raisins and wine. Wine grape, together with its hybrids, are 
nowadays cultivated in more than 8 million hectares of land worldwide and annually 
produce over 200 million litres of wine (Soejima and Wen, 2006; Tröndle et al., 2010). P. 
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quinquefolia (Virginia creeper) and P. tricuspidata (Boston ivy) are used as landscape 
ornaments worldwide (Brickell, 2008; Thornbush, 2012).  
Vitaceae plants have been used in various traditional medicine systems for centuries for 
diseases such as cancer, skin disease, bone fracture, wounds, eye diseases, gonorrhoea, 
syphilis, menstrual ailments, liver disorders, abdominal pains, stomachaches, headache, 
diarrhoea, fever, vomiting, typhoid, nausea and malaria (Kanwal, 2011; Khan et al., 2015; 
Patel et al., 2013; Pathomwichaiwat et al., 2015; Tröndle et al., 2010). This family is also 
well known for treating gynaecological disorders. Examples of plants used for these 
disorders are Ampelocissus latifolia (used to prevent miscarriages and reduce bleeding 
during menopause) (Rao, 2010) and several species from the genera Cyphostemma and 
Rhoicissus (commonly used to facilitate delivery during pregnancy) (Lin et al., 1999).  
In the following sections, we will focus on the genus Rhoicissus, its local uses, reported 
biological activities and phytochemistry. Included in this chapter are also the results from 
the phytochemical study of Rhoicissus tridentata 
 
3.4.2 Local uses 
 
As mentioned earlier, Rhoicissus species are popular in traditional medicine for their use in 
treating gynaecological and obstetrics complaints. R. tridentata (L. f.) Wild & Drum subsp. 
cuneifolia (Eckl. & Zeyh.) N.R. Urton, R. digitata (L. f) Gilg & Brandt and R. tomentosa 
(Lam.) Wild & Drum are all used to prevent long and complicated labour during child-birth 
(Brookes and Katsoulis, 2006; Hutchings et al., 1996; Lin et al., 1999). These three plants, 
as well as R. rhomboidea (E. Mey ex Haru.) Planch, are all named isinwazi/ umthwazi 
(isiZulu). The oxytocic properties of R. tridentata and R. digitata have been confirmed by 
in vitro biological tests (discussed below); however, the use of R. tomentosa has not been 
supported by scientific data. This ambiguity in naming creates confusion during plant 
identification, and thus uncertainty about the medicinal properties of the collected species 
(Hutchings et al., 1996; Lin et al., 1999). 
CHAPTER 3: The Phytochemistry of Rhoicissus tridentata 
94 
 
Aqueous extract of the root of R. digitata have been cited by lay people of Maputaland 
(KwaZulu-Natal, SA) to be used in combination with other species, for example, Bridelia 
cathartica, Commiphora neglecta, Crotalaria monteiroi, Garcinia livingstonei, Grewia 
occidentalis and Ochna natalitia for treating dysmenorrhea, menorrhagia, oligomenorrhoea 
and infertility. This combination of plants is also used to prevent premature birth, and to 
cleanse blood after pregnancy (de Wet and Ngubane, 2014). R. tomentosa is used as an 
antihelmintic for calves (Hutchings et al., 1996). 
R. revoilli (Planch) root decoctions are used in lactation for both human and cows to 
increase milk production. Depending on the preparation method, leaves of this plant are 
used to treat various ailments in African communities. Crushed leaves are externally 
rubbed to infected skin to hasten wound and ringworm healing (Arwa et al., 2008). 
Aqueous decoctions prepared from crushed leaves are orally taken to treat intestinal worms 
such as hookworms (Omino and Kokwaro, 1993). Decoctions are also externally applied to 
boils to ripen them and thus promote faster healing (Arwa et al., 2008).   
 
3.4.3 Biological activities and phytochemistry 
 
Some Zulu medicinal plants belonging to the Vitaceae family were screened for anti-
inflammatory and antimicrobial activities (Lin et al., 1999). A total of twenty-nine crude 
extracts were evaluated but only five showed significant inhibition of prostaglandin 
synthesis. With the exception of Cyphostemma natalitium, the other four active species (R. 
digitata, R. rhomboidea, R. tomentosa, and R. tridentata) all belong to the genus 
Rhoicissus. R. digitata and R. rhomboidea extracts showed the highest activity, but these 
plants are not used as anti-inflammatory agents in traditional medicine. In addition, these 
extracts exhibited the highest antifungal activity against Candida albicans (Lin et al., 
1999). Antifungal activity reported for R. tridentata against C. albanicans and 
Saccharomyces cerevisiae was confirmed in a recent study conducted in Tanzania (Hamza 
et al., 2006).  
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Lin et al. (1999) also investigated the antimicrobial activities of the twenty-nine extracts, 
and it was found that all extracts showed some degree of antimicrobial activity. Gram-
positive microorganisms were better inhibited than Gram-negative bacteria. R. rhomboidea 
was one of the plants showing the highest inhibition against different microorganisms (Lin 
et al., 1999). In another study aimed at screening fourteen medicinal plants used by the 
Venda community for infectious diseases (such as diarrhoea and fever), antibacterial 
activities for root/ tubers methanol extracts of R. tridentata were confirmed (Samie et al., 
2005). 
Opoku et al. (2002) investigated the antioxidant activities of four Rhoicissus species 
(Rhoicissus digitata, R. tridentata, R. rhomboidea and R. tomentosa). The methanol 
extracts of the roots, stems and leaves were all tested for: (a) free radical scavenging 
activity using 1,1'-diphenyl-2-picryhydrazyl free radical, (b) effect on the generation of free 
radicals by xanthine oxidase, (c) effect on DNA sugar damage and (d) Fe2+ chelating 
activity. R. tridentata and R. rhomboidea showed more than 50% antioxidant activity, 
which was comparable to the activities observed for the commercial antioxidants BHA 
(42%), BHT (50%) and Vitamin E (63%). In Contrast, R. digitata and R. tomentosa 
extracts only exhibited pro-oxidative properties at very high concentrations (Atawodi, 
2005; Opoku et al., 2002). 
Naidoo et al. (2006) further studied the antioxidant properties of the leaves, stem bark and 
roots acetone extracts of R. tridentata.  In this study the stem bark acetone extract showed 
the highest antioxidant activity. Compounds associated with this activity were catechin, 
epicatechin, gallic acid, epigallocatechin gallate and other unidentified proanthocyanidins 
(Naidoo et al., 2006). In a recent study the antioxidant property of the root methanol extract 
of R. tridentata has been confirmed (Steenkamp et al., 2013). 
Opoku et al. (2000) screened twenty-seven Zulu medicinal plants for antineoplastic 
activities against HepG2 cell lines and R. tridentata, R. tomentosa, R. rhomboidea and R. 
digitata were amongst the investigated plants. The aqueous root extract of R. tridentata 
exhibited the highest inhibition of proliferation (96%) compared to the other crude extracts. 
Methanol extract of R. tridentata also showed stronger inhibitory activity, with 87% 
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inhibition of proliferation. Results from this study also showed that all the Rhoicissus 
species, together with other plants tested, have potential antineoplastic activities (Opoku et 
al., 2000). 
The methanol root and leaves extracts of R. revoilli were studied to confirm their 
antimicrobial activity. The root extract was more active than the leaves against three 
microorganisms (Gram-positive bacteria Streptococcus pryogenes, Gram-negative 
Salmonella typhi and a fungal pathogen Aspergillus niger). Although the active compounds 
responsible for antimicrobial activity were not isolated and characterized, the 
phytochemical screening of the active fractions led to the identification of saponins, 
flavonoids, ketones, anthraquinones, carbohydrates and alkaloids. In addition to these types 
of compounds, aldehydes were detected in the leave extract (Arwa et al., 2008).  
In a study conducted by Schou et al. (2010), the water extract of R. digitata root and the 
methanol extract of the leaves, increased the acetylcholine-mediated contractions of rat 
uterine smooth muscle. The MeOH extract of the root inhibited uterine contractility. In 
additional to providing a rationale for the use of this plant during pregnancy in traditional 
medicine, results from this study also showed that instead of using the roots, traditional 
healers can use the leaves (which also showed similar activity to the roots) (Schou et al., 
2010). 
 
3.5 Rhoicissus tridentata 
3.5.1 Introduction 
 
Rhoicissus tridentata (L.F.) Wild & Drum subsp. cuneifolia (Eckl. & Zehr.), N.R. Urton, 
commonly known as wild grape and Isinwazi or Umthwazi (isiZulu) is a shrubby creeper in 
the genus Rhoicissus (Vitaceae). This plant is characterised by trifoliate leaves with wedge 
shaped leaflets, and greyish bark with a tubular root (Katsoulis et al., 2000). R. tridentata 
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plants occur throughout the Afrotropical zone (South Africa, south of Sahara desert, 
southern and eastern parts of Arabian Peninsula, Madagascar, and south-western Pakistan). 
 
Figure 3.4: Leaves and branches of R. tridentata 
(Photo:https://www.google.co.za/?gfe_rd=cr&ei=DsP1VPExjqnzB4uugIgF#q=rhoicissus+t
ridentata+subsp.+cuneifolia) 
Local communities in South Africa use R. tridentata during pregnancy to enhance the 
labour process. This plant is also used to prevent miscarriage and diarrhoea, treat 
abdominal pains and stomach disorders, swelling, menorrhagia, infertility, broken bones, 
cuts and wounds, epilepsy and to feed children in the absence of their mother (Hutchings et 
al., 1996; Lin et al., 1999; Veale et al., 1992). The Vhavenda men use R. tridentata to treat 
erectile dysfunction (Rakuambo et al., 2006). Aqueous decoctions and infusions are 
prepared form crushed dried leaves and roots and are administered orally or as enemas. 
 
3.5.2  Biological activities and phytochemistry 
 
The methanol and aqueous extracts of R. tridentata roots have shown antifungal, 
antibacterial, antioxidant and antineoplastic activities (described above). Further biological 
studies on the aqueous extract of the roots and lignotubers showed that this extract caused 
an increase in the contraction of isolated uterine smooth muscle/ileum. This contractility 
increase was confirmed to be due to the muscarinic receptor system and the production of 
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cyclooxygenase metabolites (Table 3.1) (Brookes and Katsoulis, 2006; Katsoulis et al., 
2000). It is noteworthy that some researchers have confirmed that the uterotonic activity of 
R. tridentata varies seasonally. It is reported that the lignotubers, followed by the stems 
were the most active plant part; however, this activity was 4-5 times higher for the extracts 
harvested in autumn and summer compared to those harvested in spring and winter 
(Katsoulis et al., 2002). 
Brookes and Katsoulis (2006) studied the phytochemistry of R. tridentata subsp. cuneifolia, 
and amongst the 20 compounds identified from the methanol and chloroform extracts, the 
uteroactive oleanolic acid (3.18) and slightly oestrogenic β-sitosterol (3.22) were isolated. 
Some proanthocyanidins monomers and dimers from the methanol root extract were 
identified by HPLC. These included catechin (3.48), gallocatechin (3.49), fisetinidol (3.50), 
mollisacacidin (3.51), epicatechin (3.52), epigallocatechin (3.53), epicatechin-3-gallate 
(3.54), procyanidin B3 (3.55), procyanidin B4 (3.56), fisetinidol-(4α→8) catechin (3.57), 
fisetinidol-(4β→8) catechin (3.58) and gallic acid.  
Another major component of the methanol extract was an unidentified uteroactive sugar 
fraction (Brookes and Katsoulis, 2006). From the non-polar root extract of R. tridentata, 
the triterpenoids, 20(29)-lupen-3-one (3.59), 20-epi-ψ-taraxastananol (3.60) and γ-sitosterol 
(which is similar to β-sitosterol (3.22), but with a 24S configuration), were identified by 
gas chromatography-mass spectrometry (GC-MS). The young branches afforded 
























































































                    
 
The in vitro anti-oxidative properties of R. tridentata motivated Opoku et al. (2007) to 
evaluate in vivo hepatoprotective effects of this plant. The free radical intermediates 
(malondialdehyde and 4-hydroxy-2-nonenal) produced by carbon tetrachloride (CCl4) 
initiated acute liver injury in rats, and the change in the concentrations of serum enzymes 
[e.g. aspartate transaminase (ALT) and serum alanine transaminase (ASP)] was a useful 
factor in determining the extent of hepatic damage. Other variables assayed included the 
effect on the concentration of glucose-6-phosphatase and changes in the levels of lipid 
peroxidase (LPO). Results obtained in this study demonstrated a decrease in the 
concentrations of ALT, ASP and LPO, while the glucose-6-phosphatase concentration 
increased as a result of the administration of R. tridentata extract to the CCl4 intoxicated 
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rats. These results were an indicator of the hepatoprotective property of R. tridentata 
(Opoku et al., 2007).     
R. tridentata was one of the 24 plants mentioned by traditional healers in Limpopo 
province to be used in the treatment of TB. However, when R. tridentata extracts were 
tested for their antimycobacterial activity against Mycobacterium tuberculosis H37Ra, MTB 
resistant strain, ripifampicin, ethambutol and streptomycin, no significant activity was 
observed at concentrations ≤100 µg/mL (Green et al., 2010).  
Results obtained from the in vitro bioassays on the chloroform and ethanol extracts 
confirmed the erectile dysfunction activity as these extracts caused relaxation of rabbit 
corpus cavenosal smooth muscle. Significantly higher percentage relaxation was observed 
at the extract concentration of 13.0 mg/mL instead of 6.5 mg/mL. These results suggest 
that R. tridentata extracts contain promising future candidate for treating erectile 
dysfunction (Rakuambo et al., 2006).  
Nalule et al. (2012) and Tuwangye and Olila (2006) demonstrated the in vitro ascaricidal 
activity of ethanol and water root extract of R. tridentata against adult nematodes. The 
inhibition of adult worm motility increased with increasing extract concentration and 
incubation. The death of treated worms in this study was attributed to starvation as a result 
of paralysis. Several active principles previously isolated from R. tridentata, including 
sitosterol, sitosterolin and proanthocyanidins, were associated with the paralysis (Brookes 
and Katsoulis, 2006; Nalule et al., 2012; Nalule, 2011; Tuwangye and Olila, 2006). 
The biological activities of both the polar and non-polar extracts from the roots and 
lignotubers of R. tridentata have been extensively studied. However, the phytochemistry of 
this plant has received limited attention. A number of compounds have been identified by 
Brookes, et al. (2006), but their identification relied on the GC-MS and HPLC results and 
no compounds were isolated from the root polar extract (which is the extract used by 
traditional healers for the preparation of the uterotonic herbal drink).  In the following 
section (Section 3.6), we will discuss the phytochemistry of the polar extracts from R. 
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tridentata root. In addition, the uterotonic activity of the isolated compounds will be 
evaluated in vitro. 
 
3.6 Results and discussion: Isolation and structural elucidation 
of compounds from R. tridentata 
3.6.1 Introduction 
 
Rhoicissus tridentata subsp. cuneifolia (leaves, branches and root) were collected from 
Silverglen nursery in Durban. A second batch of the roots was collected from the vendors 
in the Warwick Triangle in Durban. After washing under running water, the plant material 
was separated and dried in an oven at 30 °C. Each plant part was crushed and extracted 
with DCM (48 hours) and subsequently with MeOH (48 hours). Bioassay guided 
fractionation of the acetone fraction of the methanol extract of the root led to the isolation 
of quercetrin (3.61), morin 3-O-α-L-rhamnopyranoside (3.62), catechin (3.63), trans-
resveratrol glucoside (3.64) and an inseparable mixture of arjunolic acid (3.65) and asiatic 
acid (3.66) were isolated. β-Sitosterol (3.22) was the major compound in the DCM fraction 
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Compound 3.61 appeared as a yellow band on TLC with an Rf value of 0.62 (7:3 
DCM-MeOH), which turned orange after treating the TLC plate with anisaldehyde 
stain followed by heating. The UV/Vis spectrum (Fig. 3.5) revealed the maximal UV 
wavelengths (λmax) of 257 and 352 nm, which is in agreement with the UV spectrum of 
a flavonol (Mabry et al., 1970). In the ESI(+)-HRMS spectrum, a pseudo-molecular 
ion peak observed at m/z 471.3783 [M+Na]+ is in agreement with a molecular formula 
of C21H20O11. 
 
Figure 3.5: UV/Vis absorption spectrum of compound 3.61 
 
In the 1H NMR spectrum (Plate 12a), two meta-coupled aromatic protons were 
observed at δH 6.40 (d, J = 2.3 Hz) and 6.23 (d, J = 2.3 Hz). These are characteristic of 
flavonoids with oxygen substituents at positions 5 and 7. The 1H NMR spectrum also 
showed three signals corresponding to an ABX aromatic spin system at δH 6.94 (d, J = 8.2 
Hz), 7.33 (dd, J = 8.2, 2.3 Hz) and 7.36 (d, J = 2.3 Hz), which represented a 3',4' 
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substituted B-ring of a flavonoid derivative. The substitution pattern of ring B was 
confirmed by the downfield shift of H-2' and H-6' when compared to H-5'. 
The 1H and 13C NMR spectra both showed upfield signals at δH 0.92 (3H, d, J = 5.9 
Hz) and δC 17.7, respectively, which is diagnostic of the 6-methyl group of a rhamnose 
moiety. The anomeric proton signal of this moiety observed at δH 5.37 (d, J = 1.7 Hz) 
correlated in the HSQC NMR spectrum (Plate 12e) with a carbon resonating at δC 
103.6. The small coupling constant for H-1'' (J = 1.7 Hz) confirmed the α-
configuration of the anomeric proton (Lu and Foo, 1997). Other rhamnose protons 
were observed at δH 3.44 (1H, t, J = 5.9 Hz, H-5''), 4.24 (1H, m, H-2''), 3.77 (1H, dd, J = 
9.4, 3.4 Hz, H-3'') and 3.37 (1H, m, H-4'').  
In the 13C NMR spectrum (Plate 12b) of 3.61, a total of 21 carbons were present. A 
carbonyl carbon signal at δC 179.6 (C-4) and six oxygen-bonded carbons were observed at 
δC 166.0 (C, C-7), 163.4 (C, C-5), 159.3 (C, C-2), 158.6 (C, C-8a), 149.8 (C, C-3'), 
146.4 (C, C-4') and 136.2 (C, C-3). In combination with the 1H NMR data, it was 
concluded that compound 3.61 was 5,7,3',4'-tetrahydroxy-3-O-rhamnopyranoxy 
flavone, better known as quercetrin.  
The proposed structure was further confirmed by correlations observed in the HMBC 
spectrum (Plate 12f and Fig. 3.6). Correlations between H-8/H-6, C-8a, C-6 and C-4a 
established the presence of a benzopyran ring system. H-2' showed a long range 
correlation to C-2, which confirmed the substitution of the B-ring to C-2. HMBC 
spectrum also revealed a correlation between H-1'' and C-3. This proved that the sugar 
moiety was connected to C-3 of the flavonol. 





















Figure 3.6: Key HMBC correlations in compound 3.61 
 
The 1H and 13C NMR data of compound 3.61 was in agreement with the reported data 
for quercetrin (Lu and Foo, 1997). This is the first report of quercetrin (3.61) from the 
genus Rhoicissus. However, this compound has been identified in the family Vitaceae. 
It was isolated from the aqueous extract of the stems and leaves of Cissus 
quadrangularis L. (Sharp et al., 2007) and Cissus sicyoides L. (Beltrame et al., 2001). 
Quercetrin is also present in several species of the genus Vitis (Moore and Giannasi, 1994) 
and has been isolated from Leea indica (Joshi et al., 2013).  
Flavonoids and their glycosylated derivatives are known for their activity as antioxidants, 
anti-inflammatory and anticancer activity (Antunes-Ricardo et al., 2014; Veitch and 
Grayer, 2011). Moreover, quercetrin (3.61) have shown in vitro antiviral activity against 
the influenza A/NWS/33 (H1N1) virus and when high concentrations were used, it 
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Compound 3.62 was observed as a yellow spot on TLC, with an Rf value of 0.69 (7:3 
DCM-MeOH). Similarly to quercetrin (3.61), the UV/Vis absorption spectrum showed λmax 
at 257 and 352 nm, which is consistent with the UV spectrum of a flavonol (Mabry et 
al., 1970). A pseudo-molecular ion peak at m/z 471.3851 [M+Na]+ in agreement with the 
molecular formula, C21H20O11, was observed in the ESI(+)-HRMS spectrum. The 
presence of a tetra-substituted A-ring of a flavonol was confirmed by the two meta-
coupled aromatic protons observed at δH 6.22 (1H, d, J = 2.0 Hz) and 6.08 (1H, d, J = 
2.0) in the 1H NMR spectrum (Plate 13a). An ABX aromatic spin system was observed in 
the 1H NMR spectrum (Plate 12a) at δH 6.73 (d, J = 8.2 Hz, H-6'), 7.13 (1H, d, J = 2.0 Hz, 
H-3'), 7.21 (dd, J = 8.2 and 2.0 Hz, H-5'), which suggested the presence a 2',4'-substituted 
B-ring of a flavonol. The signal for H-5' proton was upfield compared to H-3' and 
therefore confirming the substitution pattern of the B-ring. An upfield signal at δH 0.92 
(d, J = 6.2 Hz) and δC 17.7 in the 1H NMR and 13C NMR spectra (Plates 13a and 13b), 
respectively, was indicative of the 6-methyl group of a rhamnose moiety. A doublet at 
δH 5.29 (1H, J = 1.7 Hz) in 1H NMR spectrum represented the anomeric proton (H-1'') 
signal of the rhamnose unit. The α-configuration of this proton was confirmed by small 
coupling constant for (J = 1.7 Hz) (Harborne, 1993; Lu and Foo, 1997).   
In the 13C NMR spectrum of compound 3.62, 21 carbon signals were present. A carbonyl 
carbon signal was observed at δC 178.8 (C, C-4), whereas six oxygen-bonded carbons 
resonated at δC 162.7 (C, C-7), 159.1 (C, C-5), 153.2 (C, C-2), 159.0 (C, C-8a), 156.7 (C, 
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C-4') and 159.9 (C, C-2'). The rhamnose carbons resonated at δC 72.1 (H-5''), 72.0 (H-2''), 
72.1 (H-3'') and 73.4 (H-4'').The 1H and 13C NMR data led to the assignment of the 
structure of 3.62 as morin 3-O-α-L-rhamnopyranoside.  
The connectivity of the above-mentioned system was established by 1H/13C correlations 
observed from the HMBC spectrum (Plate 13f and Fig. 3.7). The presence of the 
benzopyran ring system in 3.62 was confirmed by the observed long-range 1H/13C 
correlations between H-6/ H-8, C-4a and C-8a. An HMBC correlation between H-1'' and C-
3 implied that the sugar unit was connected to C-3 of the flavonol. The trisubstituted 
aromatic system was established to be linked to C-2 of the benzopyran moiety by the 
observed long range correlations between H-6'/H-5'/H-3' and C-2.  
The experimental NMR data of compound 3.62 was in agreement with the data reported in 
literature for morin 3-O-α-L-rhamnopyranoside (Lu and Foo, 1997; Yen et al., 2009). 
Morin 3-O-α-L-rhamnopyranoside (3.62) is isolated for the first time from the genus 
Rhoicissus. Compound 3.62 was reported to exhibit several biological activities, for 























Figure 3.7: HMBC correlations in compound 3.62 
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Compound 3.63 showed a pseudo-molecular ion peak at m/z 313.2611 [M+Na]+ which 
is in agreement with the molecular formula, C15H14O6. A λmax of 278 nm was observed 
in the UV/Vis absorption spectrum (Fig. 3.8) of compound 3.63, which is 
characteristic of catechin (Zu et al., 2006). The 1H NMR (Plate 14a) and 1H-1H COSY 
spectra (Plate 14c) of 3.63 showed the presence of an ABX aromatic spin system at δH  
6.79 (d, J = 8.2 Hz), 6.75 (dd, J = 8.2, 1.9 Hz ) and 6.86 (d, J = 1.9 Hz). The tetra-
substituted flavonoid derivative was shown by the two meta-coupled protons (H-8 and 
H-6) at δH 5.88 and 5.95 respectively. Two methine protons (H-2 and H-3) resonated at 
δH 4.59 (d, J = 7.3 Hz) and 3.99 (m). A 1H-1H COSY correlations were observed 
between H-2 and H-3, as well as between H-3 and the methylene protons (H-4) at δH 
2.53 (dd, J = 8.2 Hz, H-4β) and 2.86 (dd, J = 15.9, 5.6 Hz, H-4α). 
 
Figure 3.8: UV/Vis absorption spectrum of compound 3.63 
 
Fifteen signals were observed in the 13C NMR spectrum (Plate 14b) of compound 3.63, 
which corresponded to the proposed structure. The presence of 5 aromatic oxygen-
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bonded carbons in the proposed structure was confirmed by the signals at δC 146.2 (C, 
C-3'), 146.3 (C, C-4'), 156.9 (C, C-8a), 157.6 (C, C-5) and 157.8 (C, C-7). The signal 
at δC 28.5 in the DEPT-135 experiment (Plate 14d) was assigned to the methylene 
carbon (C-4). No signal was observed at δC 170-190 in 13C NMR spectrum. This 
confirmed the absence of a carbonyl carbon in this compound.  
HMBC correlations (Plate 14f and Fig. 3.9) were used to further confirm the 
connectivity of the proposed structure. HMBC correlations were observed between H-
2' and C-2; H-6' and C-2 which shows that the ABX ring system was connected to the 
pyran ring through C-2. The presence of the benzopyran ring system was confirmed by 
long range correlations between H-6, C-4a, C-5, and C-7; as well as between H-8, C-
4a, C-8a, C-5, and C-7 (Fig. 3.9).  
After comparison of the experimental spectroscopic data with the reported data, 
compound 3.63 was assigned as catechin (Davis et al., 1996). Catechin (3.63) was 
previously isolated from the roots of R. tridentata (Brookes and Katsoulis, 2006). 
Catechin (3.63) was also isolated from several species in the Vitaceae family, 
including Ampelopsis megalophylla Diels et. Gilg and Leea thorelii Gagnep. 

















Figure 3.9: HMBC correlations in compound 3.63 
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Compound 3.64 showed a maximal UV absorption at λmax 310 nm in the UV/Vis 
spectrum (Fig.3.10) and a molecular ion peak at m/z 413.1212 [M+Na]+ was observed 
in the ESI(+)-HRMS spectrum, which is in agreement with the molecular formula of 
C20H22O8. 
 
Figure 3.10: UV/Vis absorption spectrum of compound 3.64 
 
The 1H NMR spectrum (Plate 15a) of compound 3.64 showed two ortho-coupled 
doublets (integrating to two protons each) at δH 6.79 (d, J = 8.7 Hz) and 7.39 (d, J = 
8.7 Hz). These revealed the presence of an AA'XX' system of a 1,4-disubstituted 
aromatic ring. Three broad singlets/multiplets were observed at δH 6.47 (br.s), 6.64 (m, 
J = 1.6 Hz) and 6.80 (m, J = 1.6 Hz). These represented the three meta-coupled 
protons of the 1,3,5-trisubstituted aromatic ring. Two doublets with large coupling 
constants were observed at δH 6.87 (d, J = 16.3 Hz) and 7.04 (d, J = 16.3 Hz), 
suggesting the presence of a trans-olefin. A set of signals characteristic of glycosidic 
protons were observed between δH 3 and 5 in the 1H NMR spectrum. An anomeric 
proton signal appeared at δH 4.91 (d, J = 7.5 Hz, H-1'') and the other sugar protons 
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resonated at δH 3.95 (dd, J = 11.9, 2.3 Hz), 3.76 (dd, J = 11.9, 2.3 Hz) and 3.40-3.80 
(m). The methylene signals (δH 3.95 and 3.76) suggested that this sugar moiety was 
glucose. The large coupling constant (J = 7.5 Hz) for H-1'' was consistent with the β-
configuration of the glucosyl bond. 
Eighteen carbon signals were observed in the 13C NMR spectrum (Plate 15b) of 
compound 3.64. Three of these carbons were oxygen-bonded and they resonated at δC 
158.5 (C-4'), 159.6 (C-5) and 160.5 (C-3). The three methine carbons of the 1,3,5-
trisubstituted aromatic ring resonated at δC 104.1 (C-4), 107.1 (C-2) and 108.4 (C-6). 
These signals were more upfield in comparison to the methine signals of the 1,4-
disubstituted aromatic ring. The 1,3,5-trisubstituted aromatic ring is more electron-rich 
than the 1,4-disubstituted aromatic ring since it is attached to two electron-donating 
groups, the oxygen of the sugar and the hydroxy group.  
The olefinic carbon signals resonated downfield at δC 126.7 (C-7) and 130.0 (C-8), 
which indicated that these carbons were bonded to aromatic rings. The five glucosyl 
carbon signals were observed at δC 71.5 (CH, C-4''), 73.9 (CH, C-2''), 78.1 (CH, C-3''), 
78.3 (CH, C-5'') and 102.5 (CH, C-1''). The methylene signal (C-6'') appeared at δC 
62.6 in the 13C NMR spectrum. Based on the 1H and 13C NMR data, it was concluded 
that compound 3.64 was trans-resveratrol glucoside. 
The long-range 1H-13C correlations observed in the HMBC spectrum (Plate 15f) 
further confirmed the proposed structural connectivity in compound 3.64. The HMBC 
correlation observed between the anomeric proton (H-1'') and C-3 confirmed that the 
sugar unit was connected to the aromatic ring by C-3. Other important HMBC 
correlations observed in this compound are shown in Figure 3.11.  
 
 




















Figure 3.11: Important HMBC correlations in compound 3.64 
Our spectroscopic data for compound 3.64 was in agreement with the reported data for 
trans-resveratrol glucoside, commonly known as piceid (Ha et al., 2009; Teguo et al., 
1996). This is the first report on the isolation of trans-resveratrol glucoside from the 
genus Rhoicissus. However, the family Vitaceae is dominated by monomeric and 
oligomeric stilbenoids. The most well-known and studied stilbene in this family is 
resveratrol, especially E-resveratrol found in grapes and red wine from Vitis vinifera. 
Resveratrol and its derivatives have shown a variety of biological activities, namely, 
anti-inflammatory, anticarcinogenic, antiaging, antiviral, antioxidant, as well as 
cardioprotective and neuroprotective effects (Burns et al., 2002; Rivière et al., 2012). 
Piceid (3.64) has been associated with treating atherosclerosis as it was isolated from 
the two plants used to treat this condition in Asia (leaves of Eucalyptus and 
Polygonum cuspidatum roots) (Hillis, 1966; Teguo et al., 1996). Compound 3.64 was 
also isolated from the leaves of Veratrum grandifolium treated with cupric chloride, 
and it showed antifungal activity (Hanawa et al., 1992).  
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An inseparable mixture of an isomeric pair of triterpenoids (3.65 and 3.66) was isolated. It 
showed a pseudo-molecular ion peak at m/z 511.3399 [M+Na]+ in the HRESIMS spectrum 
which is in agreement with a molecular formula of C30H48O5. The percentage composition 
of asiatic acid and arjunolic acid in the mixture was determined to be 50:50% by NMR 
spectral data. The 1H NMR spectrum (Plate 16a) of 3.65 and 3.66 showed signals of 
olefinic protons at δH 5.26 (m, H-12). Oxygen-bearing methylene protons appeared at δH 
3.29 (d, J = 11.1 Hz, H-23) and 3.52 (d, J = 11.1 Hz, H-23), which is characteristic of both 
asiatic acid (3.65) and arjunolic acid (3.66). 1H NMR and 13C NMR spectra (Plate 16b) also 
showed two oxygen-bearing methine protons at δH 3.38/ δC 69.7 and δH 3.72/ δC 78.3. 
Cross peaks were observed in 1H-1H COSY spectrum (Plate 17c) between these signals, 
and thus were assigned as H-2 and H-3.  
Two set of six methyl signals were observed in the 1H and 13C NMR spectra. In one set, 
four methyl signals were singlets while two were doublets (Table 3.2), characteristic of the 
ursane-type triterpene (asiatic acid). In second set of methyl signals, all of them were 
singlets, suggesting oleanane-type skeleton (arjunolic acid). Of note, there was only a slight 
difference in the chemical shift for most methyl signals for compounds 3.65 and 3.66. A 
significant difference in δC values (>5 ppm) was observed for C-29 (Table 3.2). This was 
expected since C-29 is attached to a methine carbon (C-19) in compound 3.65, whereas it is 
attached to a tertiary carbon (C-20) in compound 3.66.  The signals highlighted in green in 
Table 3.2 also showed slight differences in chemical shifts.  
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The 1H and 13C NMR spectra also showed a doublet at δH 2.22/ δC 54.4 and a doublet of 
doublets at δH 2.87/ δC 42.8. These signals were assigned to H-18 in compound 3.65 (asiatic 
acid) and arjunolic acid (3.66), respectively. Other signals observed in the 1H and 13C NMR 
spectra are collated in Table 3.2. From the HMBC spectrum (Plate 16f), correlations were 
observed between H-23, C-24, C-4 and C-3; H-24, C-23, C-3, C-4 and C-5; H-26, C-7, C-
14, C-5; and H-25, C-10 and C-9. These correlations confirmed the proposed partial 
structure shown in Figure 3.12. Notably, the same HMBC correlations were observed for 
















Figure 3.12: HMBC correlations in a partial structure of compound 3.65 and 3.66 
 
From the other half of the structure, 1H/13C long-range correlations existed between H-12, 
C-18 and C-27; H-29, C-27 and C-18; and H-27 correlated to C-15, C-14 and C-13 (Fig. 















Figure 3.13: HMBC correlations in a partial structure of compound 3.65 
 
The experimental NMR data of compounds 3.65 and 3.66 was in agreement with the 
literature data of asiatic acid and arjunolic acid respectively (Aguirre et al., 2006). The 
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structures of asiatic acid (3.65) and arjunolic acid (3.66) are closely related and it was also 
observed by other researchers that a mixture of these compounds is inseparable by 
chromatographic methods (Bag et al., 2008). This is the first report on the isolation of both 
asiatic acid (3.65) and arjunolic acid (3.66) from the genus Rhoicissus. Asiatic acid was 
previously isolated from the aerial parts of Cissus repens (Vitaceae) (Wang et al., 2006). 
 
Table 3.2: 1H and 13C NMR spectroscopic data (CD3OD) of compounds 3.65 and 3.66  
 3.65  3.66  
Position δC δH (J in Hz) δC δH (J in Hz) 
1a 47.3 1.68, m 47.3 1.68, m 
1b  1.68, m  1.68, m 
2 69.7 3.72, m 69.7 3.72, m 
3 78.3 3.38, dd (9.6, 
1.7) 
78.3 3.38, dd (9.6, 
1.7) 
4 44.1  44.1  
5 47.8 3.32 47.8 3.32 
6a 19 1.44, m 19 1.44, m 
6b  1.44, m  1.44, m 
7a 33.7 1.54, m 33.6 1.54, m 
7b  1.75, m  1.75, m 
8 40.8  40.4  
9 48 1.29, m 48 1.29, m 
10 38.9  38.9  
11 23.9 1.11, m 24.1 1.96 
12 126.7 5.26, m 126.7 5.26, m 
13 138.6  138.6  
14 43  43  
15a 29.2 1.09, m 29.2 1.09, m 
15b  1.96, m  1.96, m 
16a 25.3 1.64, m 25.3 1.64, m 
16b  1.64, m  1.64, m 
17 48  48  
18 54.4 2.22, d (11.0) 42.8 2.87, dd (14.3, 
3.7) 
19a 40.4 0.98, m 47.9 0.92, m 
19b    1.96, m 
20 40.4 0.98, m 31.8  































Compound 3.22 showed a molecular ion peak at m/z 414.7067 [M-H]- in the LRMS 
spectrum, which is in agreement with the molecular formula of C29H50O. In the 1H and 
13C NMR spectra (Plates 17a and 17b), six upfield methyl signals were observed at δH 
0.68 (3H, s, Me-18)/ δC 11.9; δH 0.83 (9H, m, Me-26, Me-27, Me-29)/ δC 19.8, 19.4, 
11.9; δH 0.92 (4H, d, J = 6.5 Hz, Me-21, H-9)/ δC 18.8; and δH 1.00 (3H, s, Me-19)/ δC 
19.0. This is consistent with the 6 methyl groups in the structure of β-sitosterol. A 
 3.65 (continued) 3.66 (continued) 
Position δC δH (J in Hz) δC δH (J in Hz) 
21a 31.6 1.34 31.6 1.34 
21b  1.51  1.51 
22a 38.1 1.67, m 38.1 1.67, m 
22b  1.34, m  1.34, m 
23 66.4 3.52, d (11.1) 66.4 3.52, d (11.1) 
  3.29, d (11.1)  3.29, d (11.1) 
24 13.9 0.72, s 13.8 0.72, s 
25 17.8 1.07 17.5 1.06 
26 17.9 0.83 17.7 0.83 
27 24 1.15, s 26.5 1.20, s 
28 181.7  181.7  
29 17.6 0.92, d (6.4) 33.4 0.93, s 
30 23.7 0.96, m 23.8 0.96, s 
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doublet appeared downfield at δH 5.35/ δC 121.7 which was indicative of the vinyl 
proton (H-6). The H-3α proton resonated downfield as a multiplet at δH 3.51 in the 1H 
NMR experiment and C-3 at δC 71.8 in the 13C NMR experiment. In the 13C NMR 
spectrum, additional signals observed included 11 methylene, 7 methine and 3 
quaternary carbons. In combination with the 1H NMR data, it was concluded that 
compound 3.22 was β-sitosterol. 
The HMBC spectrum (Plate 17f) was used to confirm the structure of compound 3.22. 
Amongst the correlations observed in the HMBC spectrum were correlations between 
Me-18, C-13 at δC 42.3, C-14 at δC 56.8 and C-17 at δC 56.1; Me-27/29 and C-24 at δC 
45.9; as well as between H-4, C-2 at δC 31.7, C-5 at δC 140.8, C-6 at δC 121.7 and C-10 
at δC 36.5  (Fig. 3.14). Further confirmation of compound 3.22 as β-sitosterol was 
achieved by comparing the experimental NMR data of this compound with literature 
data (Ahmad et al., 2010). β-Sitosterol was previously isolated from the roots of R. 
tridentata and in the same study, it was evaluated for in vitro uterotonic activity using 


















Figure 3.14: HMBC correlations in compound 3.22 
 
β-Sitosterol was previously isolated from R. tridentata, as well as several other 
Vitaceae plants such as Ampelocissus latifolia (Brookes and Katsoulis, 2006; Raman et 
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al., 2014), Cissus quadrangularis, Tetrastigma erubescens Planch. (Dao et al., 2013) 
and Cissus sicyoides (Beltrame et al., 2002). This compound showed antibacterial 
activity against Bacillus subtilis with an MIC of 50 µg/mL and it has been isolated 
from numerous plants showing analgesic and anti-inflammatory activities (Nirmal et 
al., 2012; Sengupta et al., 2012). 
 







9 10 12 13
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Compound 3.18 was isolated from the non-polar fraction of the root methanol extract, with 
an Rf value of 0.8 (DCM-EtOAc, 8:2). The TLC plate treated with anisaldehyde stain and 
heated, showed compound 3.18 as a purple spot. A molecular ion peak at m/z 281.2538 
[M-H]- observed in the LREIMS spectrum was in agreement with the molecular formula of 
C18H32O2.  
In the 1H NMR spectrum (Plate 18a), four deshielded olefinic protons were observed at δH 
5.35 (4H, m, H-9, H-10, H-12, H-13). Cross peaks were observed in the 1H-1H COSY 
NMR spectrum (Plate 18c) between the olefin protons and a signal at δH  2.78 (2H, m, H-
11) and at δH  2.05 (4H, m, H-8 and H-14). A triplet appeared at δH 2.35 in the 1H NMR 
spectrum which is characteristic of C-2 protons in a fatty acid. These protons showed a 1H-
1H correlation to a multiplet at δH 1.63, which was readily assigned as H-3. The terminal 
methyl protons resonated at δH (0.89, t, J = 6.8), and a 1H-1H COSY spectrum revealed a 
connection between these protons and a methylene signal at δH (1.29, m, 14H).  
The 13C NMR spectrum (Plate 18b) showed the presence of 13 carbon signals, consisting 
of acid carbonyl carbon at δC 179.9, four olefin carbon signals at δC 127.9, 128.1, 130.0 and 
130.2, one methyl carbon at δC 14.0, and twelve methylene carbon signals at δC 22.6, 24.7, 
25.6, 27.2, 27.2, 29.0, 29.1, 29.1, 29.3, 29.6, 31.5 and 34.0. These spectral data suggested 
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that compound 3.18 was an unsaturated fatty acid, and after comparison with the literature 
data, the structure of this compound was determined as linoleic acid (Marwah et al., 2007).  
Linoleic acid (3.18) has never been reported from the genus Rhoicissus, however, this 
compound is present in several oxytocic plants. Linoleic acid (3.18) was isolated from the 
supercritical fluid extract of the roots of Clivia miniata L. and was found to induce the 




Investigation of the acetone fraction of R. tridentata root methanol extract using bioassay-
guided isolation technique afforded six compounds [quercetrin (3.61), morin 3-O-α-L-
rhamnopyranoside (3.62), catechin (3.63), trans-resveratrol glucoside (3.64) and an 
inseparable mixture of asiatic acid (3.65) and arjunolic acid (3.66)]. The non-polar (DCM) 
fraction of the root methanol extract was also investigated and two compounds [β-sitosterol 
(3.22) and linoleic acid (3.18)] were isolated.  
Except for β-sitosterol (3.22) and catechin (3.63), all isolated compounds are reported for 
the first time from R. tridentata; however these compounds are common in the family 
Vitaceae. We have not isolated any of the other compounds reported by Brookes et al. 
(2006) from the HPLC analysis of the methanol extract of the root of R. tridentata. The 
isolated compounds were assayed for their uterotonic activity to provide rationale for the 
use of this plant by local communities to facilitate labour during childbirth. Results 
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3.7 Results and discussion: Biological activity 
3.7.1 Introduction 
 
The uterotonic effects of the methanol extracts of the leaves and roots of R. tridentata, the 
root aqueous extract of Gunnera perpensa and the isolated pure compounds from R. 
tridentata were evaluated using uterine muscle strips obtained from stilboestrol-primed 
Sprague-Dawley rats. The uterine muscle contractility effect of the aqueous extract of the 
root of R. tridentata was previously reported, but in that study the polar compounds were 
not isolated (discussed in Section 3.5.2). In the present study, the uterotonic activity of R. 
tridentata crude polar extracts was re-investigated and the activity of the pure isolated 
compounds was also evaluated.  
Uterotonic assays were performed by Ms. S. Dube in the laboratory of Prof. C. T. 
Musabayane (School of Laboratory Medicine and Medical Science, University of 
KwaZulu-Natal, Westville). Ethical clearance for all experiments was obtained by Prof. 
Musabayane. Briefly, portions of the uterine muscle tissue were harvested from the 
stilboestrol-primed rats. The tissues were mounted in an organ bath containing a buffer 
solution at room temperature. A control experiment, in which the muscle strip was 
mounted in a drug-free buffer solution, was run for each experiment.  The crude extracts 
and pure compounds were dissolved in a small amount of DMSO and diluted with a buffer 
solution to give solutions of different concentrations. Each experiment was performed by 
subjecting the uterine tissue to a solution with a specific concentration and the uterine 
contractions were electronically recorded using a labograph. Results obtained are presented 
as a graph of % contractions versus sample concentration. Values in each plot are presented 
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3.7.2 Uteroactivity assays of the crude R. tridentata extracts 
 
The uterine muscle strips were subjected to various solutions of R. tridentata leaves, with 
concentrations ranging from 0.24 mg/mL to 62.08 mg/mL. The lower doses (0.24 mg/mL-
1.94 mg/mL) induced a gradual increase in both the force and the rate of uterine muscle 
contractility; however, these results were not significantly different compared to the control 
(Fig. 3.15). A statistically significant increase in the force of contractility was observed at a 
concentration of 3.88-62.08 mg/mL. The maximum response (80%) to the force of 
contractility was observed at 15.50 mg/mL and this force remained constant with 
increasing concentration (Fig. 3.15).  
The leaves extract also caused an increase in the rate of uterine muscle contractions, with a 
maximal response (30%) (Fig. 3.15). These results suggest that the leaves contain 
uteroactive agents and can be used as a replacement to the roots for the induction of labour 
during pregnancy. The uterotonic activity of the leaves of R. tridentata was previously 
reported by Brookes and Katsoulis (2006).   
 
 
Figure 3.15: Effects of R. tridentata leaves crude extract on the force and rate of uterine 
muscle contractility. 
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The root methanol extract directly stimulated a concentration dependent contraction of the 
uterus, with the maximal response (80%) at 15.50 mg/mL. The higher dose (62.08 mg/mL) 
of extract caused a significant decrease in the force of uterine contractions. An increase in 
the rate of uterine muscle contractions was observed after subjecting the tissue to the root 
methanol extract of R. tridentata, with a maximum of response of 20% at 15.50 mg/mL 
(Fig. 3.16).  
 
Figure 3.16: Effects of R. tridentata root crude extract on the force and rate of uterine 
muscle contractions. 
 
The methanol extract of the root of R. tridentata was separated using column 
chromatography to give the non-polar (DCM) fraction, acetone fraction and the very polar 
(methanol) fraction. The uterotonic activity of the acetone and methanol fractions was 
investigated. The acetone fraction caused an increase (75%) in the force of uterine 
contractility at a dose of 1.06 mg/mL (Fig. 3.17). On the other hand, a maximal response 
(60%) in the force of contractions was observed at a concentration of 4.0 mg/mL of the 
methanol fraction.  
The acetone and methanol fractions also caused an increase in the rate of uterine 
contractions. The highest change (35%) in contraction rate was exhibited by the acetone 
fraction at a dose of 2.13 mg/mL. The methanol fraction caused a maximal response of 
30% at a concentration of 4.0 mg/mL (Fig. 3.17). These results indicate that the very polar 
(methanol) fraction is less potent than the moderately polar fraction. In this research, the 
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phytochemistry of the acetone fraction from the methanol extract of the root of R. 
tridentata was studied (Section 3.6). The pure isolated compounds were assayed for 
uterotonic activity and the results are discussed in Section 3.7.3. Furthermore, the chemical 
composition of the methanol and DCM fractions from the methanol extract was also 
investigated. The major compounds (3.18 and 3.22) isolated from the DCM fraction were 
also assayed for uterotonic activity.  
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3.7.3 Uteroactivity assays of the isolated compounds 
 
The isolated compounds (quercetrin, morin 3-O-L-rhamnopyranoside, catechin, trans-
resveratrol glucoside, a mixture of asiatic and arjunolic acid and β-sitosterol) were 
evaluated for uteroactivity effects on isolated uterine muscle strips. An inseparable mixture 
of asiatic-arjunolic acid (3.65 and 3.66) stimulated the direct contractile response of the 
uterus. The maximum response in both the force and rate of contractions was observed at a 
concentration of 1.23 µg/mL and this response remained unchanged with higher sample 
concentrations (6.14 µg/mL) (Fig. 3.19). This is a first report on the uterotonic activity of 
asiatic acid (3.65) and arjunolic acid (3.66). 
Cumulative addition of β-sitosterol (3.22) (from 0.09 µg/mL to 57.10 µg/mL) to the organ 
bath, caused stimulation of uterine muscle contractility, with the highest response (40%) in 
the force of contractility observed at 57.1 µg/mL (Fig. 3.20). The rate of uterine 
contractility was increased by 20% at a dose of 11.4 µg/mL and the rate remained constant 
at higher concentrations (57.1 µg/mL). The contractility effect of β-sitosterol (3.22) on 
isolated uterine smooth muscle was previously investigated. Compound 3.22 was isolated 
(along with other uterotonic compounds) from Ekebergia capensis and it showed no in 
vitro uterotonic activity against both pregnant and non-pregnant guinea pig uterine smooth 
muscle in this study (Sewram et al., 2000). In another study, β-sitosterol (3.22) was isolated 
from R. tridentata and was reported to stimulate uterine contractions at higher 
concentrations of acetylcholine (Brookes and Katsoulis, 2006). The results obtained in the 
present study are in agreement with those reported by Brookes and Katsoulis (2006) since 
the maximal response in uterine contractions was observed at higher sample concentrations 
(Fig. 3.20).  




Figure 3.19: Effect of the mixture of asiatic acid and arjunolic acid on the force and rate of 
uterine muscle contractility.  
 
 
Figure 3.20: Effect of β-sitosterol on the force and rate of uterine muscle contractility. 
 
Interestingly, morin 3-O-α-L-rhamnopyranoside (3.62) and trans-resveratrol glucoside 
(3.64) caused a relaxation of the isolated uterine smooth muscle when added to the organ 
bath (Fig. 3.21 and Fig 3.22). Both the force and rate of uterine contractility were reduced 
below the control, which suggested that compound 3.62 and compound 3.64 had inhibitory 
effects on the uterine muscle contractility. These findings suggest that the R. tridentata 
extract possesses opposing activities (oxytocic and tocolytic). It is well known that 
biological activities of plant extracts depend on the preparation, composition and dosage. In 
traditional medicine, boiled aqueous root extract of R. tridentata are administered orally to 
treat different conditions; however, information about the dosage used in each case is not 
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well known. It is possible that this extract possesses oxytocic and tocolytic effects at 
different dosage.   
This is the first report of the relaxation effect of morin-3-O-α-L-rhamnopyranoside (3.62) 
and trans-resveratrol glucoside (3.64) on uterine muscle. The inhibitory effect shown by 
compound 3.64 is in agreement with the data reported in literature for resveratrol. 
Resveratrol showed inhibitory effects on non-pregnant rat uterine contractility. 
Specifically, this compound inhibited prostaglandin F2α, oxytocin, acetylcholine, carbachol 
and high K+ concentration-induced uterine contractions as well as Ca2+ channel activator 
(Hsia et al., 2011; Novakovic et al., 2013). The addition of quercetrin (3.61) and catechin 
(3.63) into the organ bath completely stopped the uterine muscle contractions. It was 
concluded that these compounds were cytotoxic to the uterine tissue cells. 
 
 
Figure 3.21: Effect of morin 3-O-α-L-rhamnopyranoside on the force and rate of uterine 
muscle contractility. 
 




Figure 3.22: Effect of trans-resveratrol glucoside on the force and rate of uterine muscle 
contractility. 
 
3.7.4 Uteroactivity assays of Gunnera perpensa 
 
The effect of aqueous root extract of Gunnera perpensa stimulated a direct contractile 
response on the isolated uterine muscle strips. The force of uterine muscle contractions 
gradually increased between the doses of 0.95 mg/mL to 7.76 mg/mL, with the maximal 
response observed at a concentration of 7.76 mg/mL. Concentration-dependant stimulation 
in the rate of uterine contractility was observed at 0.95 mg/mL to 3.88 mg/mL. The higher 
concentrations (7.76 mg/mL) inhibited the rate of uterine muscle contractions (Fig. 3.23).  
The observed uterotonic activity of G. perpensa is in agreement with the results reported in 
literature (Kaido et al., 1997; Khan et al., 2004). The results from the present study showed 
that the crude polar extract of G. perpensa was more active than the extract of R. 
tridentata. Lower concentrations of G. perpensa (7.76 mg/mL and 3.88 mg/mL) were 
required to stimulate maximal force and rate of uterine contractions when compared to the 
15.50 mg/mL required for the R. tridentata extract. The observed lower activity of the R. 
tridentata when compared to G. perpensa extract may be attributed to the occurrence of 
compounds with opposing effects (oxytocic and tocolytic) in this extract. The 
phytochemistry of G. perpensa was previously investigated and the isolation of pure 
compounds was not repeated in this study. 









The methanol root extract of R. tridentata stimulated a concentration-dependent 
contractility of the isolated uterine smooth muscle. However, the uterotonic activity of R. 
tridentata was lower than the activity of the aqueous extract of the root of G. perpensa (one 
of the six most frequently cited plants used to facilitate labour during childbirth). The 
acetone fraction obtained from the methanol extract of R. tridentata displayed efficacy at 
much lower doses than the methanol fraction and this fraction was further purified to yield 
compounds 3.61-3.66. Compounds 3.18 and 3.22 were obtained from the DCM fraction of 
the methanol extract. 
The uterotonic effects of the isolated compounds, with the exception of linoleic acid (3.18), 
were assayed. Linoleic acid (3.18) and β-sitosterol (3.22) were previously reported to 
exhibit uterotonic activity. The results from this study confirmed the uterotonic activity of 
β-sitosterol (3.22), with the highest response in the force and the rate of uterine 
contractions at higher doses. An inseparable mixture of asiatic and arjunolic acid (3.65 and 
3.66) elicited a muscle response at much lower doses compared to β-sitosterol (3.22), 
therefore it can be concluded that the mixture of asiatic-arjunolic acid (3.65 and 3.66) is the 
active principle responsible for the uterotonic properties of the methanol extract of the root 
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of R. tridentata. This is the first report on the uterotonic activity of the mixture of asiatic 
acid and arjunolic acid.  
Morin 3-O-α-L-rhamnopyranoside (3.62) and trans-resveratrol glucoside (3.64) caused a 
relaxation of the uterus, which is consistent with the use of this plant in early pregnancy for 
threatened abortion and for treating dysmenorrhea. It is speculated that this plant possesses 
the oxytocic and tocolytic activities at different doses, however, further studies are required 




3.9.1 General experimental procedure 
 
The general experimental procedure is discussed in Chapter 2 of this thesis. 
 
3.9.2 Plant material 
 
Plant material was collected from two sources: 
1. Rhoicissus tridentata subsp. cuneifolia (leaves, branches and root) was collected 
from Silverglen nursery, Durban in December 2012. The plant was identified by Mrs. 
Allyson Young from the University of KwaZulu-Natal Botanical Gardens and a 
voucher specimen (van Heerden 2) was deposited in the Bews Herbarium, University 
of KwaZulu-Natal (Pietermaritzburg). 
2. Rhoicissus tridentata subsp. cuneifolia (root) was collected from the vendors in the 
Warwick Triangle, Durban on the 26th of June 2013, and a voucher specimen (van 
Heerden 20) was deposited in the Bews Herbarium, University of KwaZulu-Natal 
(Pietermaritzburg). 
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3.9.3 Extraction of the leaves 
 
The dried leaves and branches (143.4 g) of R. tridentata (collected from Silverglen 
nursery) were extracted consecutively with dichloromethane (DCM), methanol (MeOH), 
and water at room temperature for 48 hours. After evaporating the solvent, 7.89 g MeOH 
extract, 2.89 g DCM extract and 4.02 g H2O extract were obtained. The HPLC 
chromatogram of the water and MeOH extract showed the same chemical profile, therefore 
these extracts were combined and analysed for uterotonic activity. 
 
3.9.4 Extraction and isolation of the roots 
 
The oven-dried (30 °C) roots and tubers of R. tridentata were milled into a brown 
powder (2.5 kg). This powder was extracted consecutively at room temperature with 
DCM and MeOH for 48 hours. After evaporating the solvents, DCM (13 g) and MeOH 
(72 g) extracts were obtained. The MeOH extract was fractionated by silica gel column 
chromatography into non-polar (DCM 2), intermediate polar (acetone) and very polar 
(MeOH 2) fractions. After evaporating the solvents, each fraction was submitted for 
uterotonic activity testing.  
DCM 2 fraction (0.90 g) was further purified on a Chromatotron with DCM: EtOAc 
(8:2) resulting in the isolation of 3 mg of compound 3.18 and 293 mg of compound 
3.22. The acetone fraction (9.96 g) was fractionated on silica gel column using DCM: 
EtOAc (1:1) into 5 fractions (A1-A5), where the last fraction was a methanol wash. 
Fraction A1 showed a similar chemical profile to DCM 2 fraction when analyzed with 
TLC [eluting with DCM: EtOAc (8:2)]. Fraction A2 was purified with a Chromatotron 
eluting with DCM: EtOAc (1:1) to afford 3.63 (2.0 mg) and a mixture of 3.65 and 3.66 
(26.7 mg). Purification of fraction A3 on a Chromatotron using DEE: MeOH (9:1) 
resulted in the isolation of 3.61 (21.8 mg) and 3.62 (13.6 mg). Purification of fraction 
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A4 on a Chromatotron with DCM: MeOH (8.5:1.5) afforded 61 mg of 3.64. The flow 
diagram for the isolation of compounds from R. tridentata roots is shown below. 
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3.9.5 Physical data of the isolated compounds 
 
Quercetrin (3.61) was isolated as a light yellow fine powder, mp 178-182 °C. 1H 
NMR (400 MHz, CD3OD) δH  0.96 (3H, d, 5.9, 5''-OMe), 3.44 (1H, dd, 5.9, 5.9, H-5''), 
4.24 (1H, m, H-2''), 3.77 (1H, dd, 9.4, 3.4, H-3''), 3.37 (1H, m, H-4''), 6.40 (1H, d, 2.3, H-
8), 6.23 (1H, d, 2.3, H-6), 5.37 (1H, d, 1.7, H-1''), 6.94 (1H, d, 8.2, H-5'), 7.33 (1H, dd, 
8.2, 2.26, H-6’), 7.36 (d, 2.3, H-2’) (Plate 12a); 13C NMR (125 MHz, CD3OD) δC 
179.7 (C, C-4), 166.0 (C, C-7), 163.4 (C, C-5), 159.3 (C, C-2), 158.6 (C, C-8a), 149.8 
(C, C-3'), 146.4 (C, C-4'), 136.2 (C, C-3), 123.0 (C, C-1'), 122.9 (CH, C-6'), 116.97 
(CH, C-2') 116.4 (CH, C-5'), 105.9 (C, C-4a), 103.6 (CH, C-1''), 99.9 (CH, C-6), 94.7 
(CH, C-8), 73.3 (CH, C-4''), 72.2 (CH, C-3''), 72.0 (CH, C-2''), 71.9 (CH, C-5''), 17.7 
(CH3, 5''-OMe) (Plate 12b). HRESIMS (positive ionization mode, m/z 471.3709 
[M+Na]+ (calculated for C21H20O11Na 471.3712); λmax 257 and 352 nm.  
Morin 3-O-α-L-rhamnopyranoside (3.62) was isolated as a light yellow fine powder, 
mp 271-276 °C. 1H NMR (400 MHz, CD3OD) δH  0.92 (3H, d, 6.2, 5''-OMe), 3.50 (1H, 
dd, 6.2, 6.03, H-5''), 4.25 (1H, m, H-2''), 3.83 (1H, dd, 9.6, 3.7, H-3''), 3.29 (1H, m, H-4''), 
6.22 (1H, d, 2.0, H-8), 6.08 (1H, d, 2.0, H-6), 5.29 (1H, d, 1.7, H-1''), 6.73 (d, 8.2, H-6'), 
7.13 (1H, d, 2.0, H-3'), 7.21 (dd, 8.2, 2.0, H-5') (Plate 13a); 13C NMR (125 MHz, 
CD3OD) δC 178.8 (C, C-4), 162.7 (C, C-7), 159.1 (C, C-5), 153.2 (C, C-2), 159.0 (C, 
C-8a), 121.9 (C, C-3'), 156.7 (C, C-4'), 135.3 (C, C-3), 121.1 (C, C-1'), 159.9 (C, C-
2'), 109.2 (CH, C-6') 109.5 (CH, C-5'), 103.8 (C, C-4a), 103.4 (CH, C-1''), 102.0 (CH, 
C-6), 96.5 (CH, C-8), 73.4 (CH, C-4''), 72.1 (CH, C-3''), 72.0 (CH, C-2''), 72.1 (CH, C-
5''), 17.7 (CH3, 5''-OMe) (Plate 13b). HRESIMS (positive ionization mode, m/z 
417.3710 [M+Na]+ (calculated for C21H20O11Na 417.3712); [α]D28 -22.1° (c 0.1), 
CH3OH) (lit., [α]D  -20.8, c 0.003) (Yen et al., 2009); λmax 257 and 352 nm 
Catechin (3.63) was isolated as a light brown solid, mp 175-177 °C. 1H NMR (400 
MHz, CD3OD): δH 2.53 (1H, dd, 8.2, H-4β), 2.86 (1H, dd, 15.9, 5.6, H-4α), 3.99 (1H, 
m, H-3), 4.59 (1H, d, 7.3, H-2), 5.88 (1H, d, 2.3, H-8), 5.95 (1H, d, 2.3, H-6), 6.75 
(1H, dd, 8.2, 1.9, H-6’), 6.79 (1H, d, 8.2, H-5’), 6.86 (1H, d, 1.9, H-2’) (Plate 14a); 13C 
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NMR (100 MHz, CD3OD) δC 28.5 (CH2, C-4), 68.8 (CH, C-3), 82.9 (CH, C-2), 95.5 
(CH, C-8), 96.3 (CH, C-6), 100.8 (C, C-4a), 115.3 (CH, C-2'), 116.1 (CH, C-5'), 120.0 
(CH, C-6'), 132.2 (C, C-1'), 146.2 (C, C-3'), 146.3 (C, C-4'), 156.9 (C, C-8a), 157.6 (C, 
C-5), 157.8 (C, C-7) (Plate 14b). HRESIMS (positive ionization mode, m/z 313.2611 
[M+Na]+ (calculated for C15H14O6Na 313.2620); λmax 278 nm 
Trans-resveratrol glucoside (3.64) was isolated as a brown solid, mp 223-225 °C. 1H 
NMR (500 MHz, CD3OD): δH 3.42-3.73 (11H, m, H-2'', H-3'', H-4'', and H-5''), 3.76 
(1H, dd, 11.9, 2.3, H-6b''), 3.95 (1H, dd, 11.9, 2.3, H-6a''), 4.91 (2H, d, 7.5, H-1''), 
6.47 (1H, m, H-4), 6.64 (1H, m, 1.70, H-6), 6.79 (2H, d, 8.7, H-3', 5'), 6.80 (1H, m, 
1.7, H-2), 6.87 (1H, d, 16.3, H-7), 7.04 (1H, d, 16.3, H-8), 7.39 (2H, d, 8.7, H-2', 6') 
(Plate 15a); 13C NMR (125 MHz, CD3OD) δC 62.6 (CH2, C-6''), 71.5 (CH, C-4''), 73.9 
(CH, C-2''), 78.1 (CH, C-3''), 78.3 (CH, C-5''), 102.5 (CH, C-1''), 104.1 (CH, C-4), 
107.1 (CH, C-2), 108.4 (CH, C-6), 116.5 (CH, C-3',5'), 126.7 (CH, C-7), 128.9 (CH, 
C-2', 6'), 130.0 (CH, C-8), 131.4 (C, C-1'), 141.4 (C, C-1), 158.5 (C, C-4'), 159.6 (C, 
C-5), 160.5 (C, C-3) (Plate 15b). LRESIMS (positive ionization mode, m/z 413.1199 
[M+Na]+ (calculated for C20H22O8Na 413.1212); λmax 310 nm 
Asiatic (3.65) and arjunolic (3.66) acid mixture was isolated as light yellow solid. 1H 
NMR (Plate 16a) and 13C NMR (Plate 16b) (125 MHz, CD3OD) data is shown in Table 
3.2. HRESIMS (positive ionization mode, m/z 511.3396 [M+Na]+ (calculated for 
C30H48O5Na 511.3399). 
β-sitosterol (3.22) was isolated as white crystals (recrystallized from methanol), mp 
139-140 °C. 1H NMR (400 MHz, CDCl3): δH 0.68 (3H, br.s, Me-18), 0.83 (10H, m, 
Me-26, Me-27 & Me-29, H-24), 0.92 (5H, d, 6.5, H-21 & H-9), 1.00 (4H, br.s, Me-19, 
H-17), 1.22 (14H, m, H-1, H-12, H-14, H-15, H-16, H-20, H-22, H-23 & H-28), 1.57 
(9H, m, H-8, H-11, H-15b, H-22b, H-25), 1.84 (3H, m, H-1b, H-2 & H-16b), 1.99 (2H, 
m, H-7 & H-12b), 2.22 (2H, m, H-4), 3.51 (1H, m, H-3), 5.35 (1H, d, 4.9, H-6) (Plate 
17a); 13C NMR (100 MHz, CDCl3) δC 11.7 (CH3, C-18), 11.9 (CH3, C-29), 18.8 (CH3, 
C-21), 19.0 (CH3, C-19), 19.4 (CH3, C-27), 19.8 (CH3, C-26), 21.1 (CH2, C-11), 23.1 
(CH2, C-28), 24.3 (CH2, C-15), 26.1 (CH2, C-23), 28.3 (CH2, C-16) , 29.2 (CH, C-25), 
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31.6 (CH2, C-2), 31.7 (CH, C-8), 31.9 (CH2, C-7), 33.9 (CH2, C-22), 36.2 (CH, C-20), 
36.5 (C, C-10), 37.3 (CH2, C-1), 39.8 (CH2, C-12), 42.33 (CH2, C-4), 42.34 (C, C-13), 
45.9 (CH, C-24), 50.2 (CH, C-9), 55.9 (CH, C-17), 56.8 (CH, C-14), 71.8 (CH, C-3), 
121.7 (CH, C-6), 140.8 (C, C-5) (Plate 17b). LRESIMS (negative ionization mode, m/z 
414.7067 [M-H]-. 
Linoleic acid (3.18) was isolated as off-white solid, 1H NMR (400 MHz, CDCl3): δH 0.89 
(3H, t, 6.8, H-18), 1.29 (14H, m, H-4, H-5, H-6, H-7, H-15, H-16, H-17), 1.63 (3H, m, H-
3), 2.04 (4H, m, H-8, H-14), 2.35 (3H, t, 7.4, H-2), 2.78 (2H, m, H-11), 5.35 (4H, m, H-9, 
H-10, H-12, H-13) (Plate 18a); 13C NMR (100 MHz, CDCl3): δC 179.9 (C, C-1), 130.2 
(CH, C-13), 130.0 (CH, C-9), 128.1 (CH, C-10), 127.9 (CH, C-12), 34.0 (CH2, C-2), 31.5 
(CH2, C-16), 29.6 (CH2, C-7), 29.3 (CH2, C-15), 29.1 (CH2, C-5), 29.1 (CH2, C-6), 29.0 
(CH2, C-4), 27.2 (CH2, C-8), 27.2 (CH2, C-14), 25.6 (CH2, C-11), 24.7 (CH2, C-3), 22.6 
(CH2, C-17), 14.0 (CH3, C-18) (Plate 18b). LRESIMS (negative ionization mode, m/z 
281.2530 [M-H]-. 
 
3.9.6 Uteroactivity assays 
 
Uterotonic activity assays were performed by Ms. S. Dube in the laboratory of Prof. C.T. 
Musabayane (School of Laboratory Medicine and Medical Sciences, University of 
KwaZulu-Natal, Westville, RSA). The protocol for these assays is reported in the MSc. 
thesis of Ms. Dube, which was submitted at UKZN in December 2014. 
After preparation of the leaves and roots aqueous crude extracts from our laboratory, 1.00 g 
of each extract was submitted for the assaying of uterotonic activity by Ms. Dube. Various 
amounts (depending on the yield) of the pure isolated compounds were also submitted for 
biological assays.  
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CHAPTER 4: Conclusions 
 
This thesis reports the phytochemical investigation of two Zulu medicinal plants, namely, 
E. rhinocerotis (Asteraceae) and R. tridentata (Vitaceae). E. rhinocerotis, commonly 
known as renosterbos, became popular for the treatment of influenza and fever in the flu 
epidemic of 1918. This plant is also used in the treatment of colic, wind, diarrhoea, 
indigestion, dyspepsia, gastric ulcers, stomach cancer and the infusions of the twigs are 
used as a tonic drink to improve appetite (Hutchings et al., 1996; Watt and Breyer-
Brandwijk, 1962). The phytochemistry of this species was previously studied by Dekker et 
al. (1988) and Proksch and co-workers (1982). In this study, the isolation and identification 
of compounds from the aerial parts of E. rhinocerotis was re-investigated to confirm the 
occurrence of the previously reported compounds and to isolate new chemical constituents. 
In addition, the variation in chemical profiles of E. rhinocerotis plants collected from 
different geographic locations was studied.  
Two labdane diterpenes, namely, (+)-13-epi-labdanolic acid (2.57), (+)-labdanolic acid 
(2.62) were isolated as major compounds from the ethyl acetate extract of the aerial parts of 
E. rhinocerotis. This extract also yielded (+)-labdanolic acid methyl ester (2.64), (+)-
labdanediol (2.66), as well as several flavonoids. The isolation of labdane diterpenes is of 
taxonomical importance as this type of compounds very rarely occurs in the plants in the 
Asteraceae family. Flavonoids abundantly occur in this plant and this is not surprising since 
this species usually grows in high-altitude areas where it uses flavonoids for protection 
against high UV-B radiation exposure (Paula and Virginia, 2005). At high altitudes, UV-B 
solar radiation exposure increases as there is less air mass, greater transparency of the 
atmosphere to shorter wavelength radiations, and the recent damage of stratospheric ozone. 
As a result, plants occurring in these habitats have developed mechanisms (such as, 
accumulating UV-absorbing compounds in their leaf surfaces) to prevent cellular damage 
caused by exposure to UV-B radiation (Paula and Virginia, 2005).   
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The reported anticancer activity of E. rhinocerotis extract in traditional medicine may be 
attributed to the flavonoids found in this extract. In addition, literature indicates that C-13 
epimers of the labdane diterpenes isolated in the present study exhibit promising anti-
inflammatory activity (Girón et al., 2010). Inflammation has been linked to the initiation 
and progression of cancer and several studies have shown that the use of anti-inflammatory 
agents decreased the incidence, recurrence of various cancers, and improved the prognosis 
for patients (Rayburn et al., 2009). A reverse-phase HPLC method which separated the 
chemical components of E. rhinocerotis was successfully developed and this method was 
used to analyse the variations in the chemical compositions of three E. rhinocerotis plants 
collected from different locations in a farm in Western Cape. Although there were 
significant variations in the chemical profiles of the branches collected from different 
locations in the farm, the overall chemical constituents of the aerial parts (leaves and 
branches) collected from different locations were similar. The plants used in this study 
were collected during the same season; therefore, further investigation is required to 
evaluate the seasonal variations in the chemical composition of E. rhinocerotis.  
The phytochemistry of the acetone fraction from the methanol extract of the roots of R. 
tridentata was studied. This plant, commonly known as Isinwazi (Zulu) is one of the six 
most frequently cited plants used in the preparation of Isihlambezo, a herbal drink taken 
during the 3rd trimester of pregnancy to induce or facilitate labour and tone the uterus after 
childbirth (Brookes and Katsoulis, 2006; Hutchings et al., 1996; Veale et al., 1992). In this 
study, the isolation and identification of compounds from the root MeOH extract of the 
plant, followed by screening of the isolated compounds for their uterotonic activity was 
investigated. 
Eight known compounds, namely, quercetrin (3.61), morin 3-O-α-L-rhamnopyranoside 
(3.62), catechin (3.63), trans-resveratrol glucoside (3.64), an inseparable mixture of asiatic 
acid (3.65) and arjunolic acid (3.66), β-sitosterol (3.22) and linoleic acid (3.18) were 
isolated. Except for catechin and β-sitosterol, all the isolated compounds are reported for 
the first time from Rhoicissus plants and the occurrence of morin 3-O-α-L-
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rhamnopyranoside in the family Vitaceae is reported for the first time (Burns et al., 2002; 
Joshi et al., 2013; Wang et al., 2006). 
The compounds (β-sitosterol, an inseparable mixture of asiatic acid and arjunolic acid and 
linoleic acid) showed promising uterotonic activity. The uterotonic activity of the 
inseparable mixture of asiatic acid (3.65) and arjunolic acid (3.66) is reported for the first 
time and this mixture was determined as the active principle in the methanol extract of R. 
tridentata. Therefore, we have successfully validated the uterotonic activity of the polar 
extract of the root of R. tridentata and the uterotonic component in this plant was 
determined.  
Two compounds (morin 3-O-α-L-rhamnopyranoside and trans-resveratrol glucoside) 
caused a relaxation of the uterine smooth muscle contractility and this could explain the use 
of R. tridentata extract in traditional medicine in the prevention of miscarriage and 
dysmenorrhea (Hutchings et al., 1996). Therefore, this plant showed opposing activities 
(oxytocic and tocolytic), and further studies are required to determine how these activities 
are modulated. It is assumed that the extract exerts different activities at different dosages, 
since the preparation method is similar. In addition, future investigations are essential to 
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Plate 7b: 13C NMR spectrum of p-bromophenacyl ester of (+)-13-epi-labdanolic acid (2.61) in CDCl3 
 





































































































































































































































































































Plate 7d: DEPT 135 NMR spectrum of p-bromophenacyl ester of (+)-13-epi-labdanolic acid (2.61) in CDCl3 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Plate 9d: DEPT 135 NMR spectrum of p-bromophenacyl ester of (+)-labdanolic acid (2.63) in CDCl3 
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Plate 16d: DEPT NMR spectrum of asiatic acid-arjunolic acid (3.65 & 3.66) mixture in CD3OD 
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